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Supplementary Information. Literature search for additional data sources. 
To identify any major sources not accessed through the routes described in Methods, we 
searched Medline (via PubMed) for articles published between 1st January 1950 and 23rd April 
2015 using the search terms ("Cholesterol"[Mesh] OR "Lipoproteins, LDL"[Mesh] OR 
"Lipoproteins, HDL"[Mesh] OR "Hypercholesterolemia"[Mesh] OR "Cholesterol 
Esters"[Mesh] OR "Dyslipidemias"[Mesh:NoExp] OR "Hyperlipidemias"[Mesh:NoExp]) 
AND ("Humans"[Mesh]). We excluded the USA from the search because multiple nationally 
representative health examination surveys with individual records were publicly accessible and 
accessed before the search had begun. Articles identified through this search were screened 
according to the inclusion and exclusion criteria described in Methods. The number of articles 
identified and retained is summarised in Supplementary Figure 1. We contacted the 
corresponding authors of all eligible studies and invited them to join NCD-RisC. We did similar 
searches for other cardiometabolic risk factors including body mass index (BMI),1 height,2 
diabetes,3 and blood pressure.4 All eligible studies were invited to analyse data on all 
cardiometabolic risk factors and join NCD-RisC. 
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Supplementary Table 1. Data sources used in the analysis. 
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Male Female Male Female Male Female Male Female
1 Afghanistan 2018 STEPS National both  18-69  18-69 1,507 1,323 CardioChek
2 Albania 2001
Shapo et al., J Epidemiol Community Health 2003; 57: 
734-9 Community urban  25+  25+ 535 585
3 Algeria 2003 STEPS Subnational both  25-64  25-64 1,575 2,408 148 235 147 234
4 Algeria 2005 Transition and Health Impact in North Africa National both  35-69  35-69 1,250 1,959 Accutrend
5 Algeria 2007-2009 The ISOR (InSulino-resistance in ORan) study Community urban  30-64  30-64 378 409 376 408 376 408
6 Algeria 2016-2017 STEPS National both  18-69  18-69 2,761 3,407
7 American Samoa 1994 McGarvey, Pac Health Dialog 2001; 8: 157-62 National both  29+  29-79 141 214 132 210 132 210
8 American Samoa 2004 STEPS National both  25-64  25-64 542 667 Accutrend
9 Argentina 2004-2005
CArdiovascular Risk factors Multiple Evaluation in 
Latin America (CARMELA) Community urban  25-64  25-64 734 748 734 748 734 748
10 Argentina 2005 Encuensta Nacional de Nutrición y Salud 2005 National both  18-49 3,813
11 Argentina 2011-2012 CESCAS Study Community urban  30-79  30-79 1,560 2,351 1,559 2,350 1,559 2,350
12 Argentina 2018 Encuesta Nacional de Factores de Riesgo 2018 National both  18+  18+ 1,786 2,626 Accutrend
13 Armenia 2016 STEPS National both  18-69  18-69 482 1,163 519 1,237 474 1,156 CardioChek CardioChek
14 Australia 1980 Risk Factor Prevalence Study National urban  25-64  25-64 2,739 2,756 2,547 2,564 2,546 2,564
15 Australia 1983 MONICA, Newcastle Subnational urban  35-64  35-64 1,197 1,194 1,150 1,169 1,147 1,160
16 Australia 1983 Risk Factor Prevalence Study National urban  25-64  25-64 3,655 3,732 3,650 3,759 3,596 3,711
17 Australia 1988-1989 Dubbo Study of Australian Elderly Community urban  59+  59+ 877 1,216 875 1,215 875 1,215
18 Australia 1988-1989 MONICA, Newcastle Subnational urban  35-64  35-64 668 654 666 654 666 654
19 Australia 1988-1989 MONICA, Newcastle Community urban  25-34  25-34 70 83 70 83 70 83
20 Australia 1989 Risk Factor Prevalence Study National urban  20-69  20-69 4,501 4,611 4,501 4,611 4,500 4,611
21 Australia 1992-1993 Australia Longitudinal Study of Ageing Community urban  65+  65+ 600 550 599 550 599 550
22 Australia 1994 MONICA, Newcastle Subnational urban  35-64  35-64 627 676 625 675 625 675
23 Australia 1994 MONICA, Perth inner Community urban  25-64  25-64 356 338 356 338 356 338
24 Australia 1994 MONICA, Perth outer Community urban  25-64  25-64 370 374 370 374 370 374
25 Australia 1999-2000
The Australian Diabetes, Obesity and Lifestyle Study 
1999-2000 National both  25+  25+ 5,043 6,136 5,041 6,135 5,041 6,135
26 Australia 1999-2003 North West Adelaide Health Study Community urban  18+  18+ 1,902 2,103 1,903 2,103 1,901 2,103
27 Australia 2004-2005
The Australian Diabetes, Obesity and Lifestyle Study 
2004-2005 National both  30+  30+ 2,852 3,444 2,851 3,442 2,851 3,442
28 Australia 2004-2006 North West Adelaide Health Study Community urban  20+  20+ 1,513 1,674 1,513 1,674 1,513 1,674
29 Australia 2008-2010 North West Adelaide Health Study Community urban  24+  24+ 1,153 1,301 1,153 1,301 1,153 1,301
30 Australia 2011-2012 Australian Health Survey National both  20+  20+ 4,147 5,123 4,147 5,123 4,147 5,123
31 Australia 2012
The Australian Diabetes, Obesity and Lifestyle Study 
2012 National both  37+  37+ 2,040 2,530 2,040 2,531 2,040 2,530
32 Austria 1986 CINDI; Schwarz et al., Eur J Epidemiol 1992; 8: 40-7 Community urban  25-64  25-64 657 715
33 Austria 1991 CINDI survey Vorarlberg/Austria Subnational both  25-64  25-64 697 736 653 686 653 686
34 Austria 1992
Vorarlberg Health Monitoring and Promotion 
Programme Subnational both  18+  18+ 14,162 18,837
35 Austria 1998
Vorarlberg Health Monitoring and Promotion 
Programme Subnational both  18+  18+ 16,154 20,918
36 Austria 1998-1999 CINDI survey Vorarlberg/Austria Subnational both  25-64  25-64 347 350 346 349 346 349
37 Austria 2004
Vorarlberg Health Monitoring and Promotion 
Programme Subnational both  18+  18+ 20,162 23,893
38 Austria 2010-2012 Austrian Study on Nutritional Status 2012 National both  18-80  18-80 246 356 245 356 245 356
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40 Barbados 2011-2013 Health of the Nation (HotN) National both  25+  25+ 412 652 389 606 381 597 Reflotron Reflotron
41 Belarus 2016-2017 STEPS National both  18-69  18-69 1,963 2,751 1,957 2,700 1,914 2,666 CardioChek CardioChek
42 Belgium 1983-1985 MONICA, Luxembourg Community urban  35-64  35-64 978 949 973 946 973 946
43 Belgium 1984-1985
Belgian Interuniversity Research on Nutrition and 
Health National both  25-74  25-74 5,735 5,037 5,668 5,017 5,667 5,015
44 Belgium 1985-1987 MONICA, Charleroi Community urban  25-64  25-64 337 304 334 304 334 304
45 Belgium 1985-1987 MONICA, Ghent Community urban  25-64  25-64 537 434 531 432 531 432
46 Belgium 1985-1990
Flemish Study on Environment, Genes and Health 
Outcomes Community rural  20-90  20-90 635 653 468 481 468 481
47 Belgium 1987-1990 MONICA, Charleroi Community urban  25-64  25-64 305 266 302 266 302 266
48 Belgium 1988-1990 MONICA, Ghent Community urban  25-64  25-64 443 416 441 415 441 415
49 Belgium 1990-1992 MONICA, Ghent Community urban  25-64  25-64 498 445 498 445 498 445
50 Belgium 1990-1993 MONICA, Charleroi Community urban  25-64  25-64 298 271 296 266 296 266
51 Belgium 1991-1994
Flemish Study on Environment, Genes and Health 
Outcomes Community rural  26-88  26-88 388 396 386 396 386 396
52 Belgium 1996-1998
Flemish Study on Environment, Genes and Health 
Outcomes Community rural  18-84  18-84 345 335 343 334 343 334
53 Belgium 1998
Flemish Study on Environment, Genes and Health 
Outcomes Community rural  32-86  32-86 319 351 319 351 319 351
54 Belgium 1999-2001
Flemish Study on Environment, Genes and Health 
Outcomes Community rural  18-81  18-79 212 226 212 226 212 226
55 Belgium 2001
Flemish Study on Environment, Genes and Health 
Outcomes Community rural  18-78  18-78 228 208 228 208 228 208
56 Belgium 2002-2003
Flemish Study on Environment, Genes and Health 
Outcomes Community rural  18-81  18-81 167 180 167 180 167 180
57 Belgium 2003 The European Male Ageing Study Community both  40+ 444 443 443
58 Belgium 2002-2005
Flemish Study on Environment, Genes and Health 
Outcomes Community rural  18-88  18-88 386 397 385 397 385 397
59 Belgium 2005-2008
Flemish Study on Environment, Genes and Health 
Outcomes Community rural  18-89  18-89 445 450 445 450 445 450
60 Belgium 2008 The European Male Ageing Study Community both  40+ 377 378 376
61 Belgium 2009-2013
Flemish Study on Environment, Genes and Health 
Outcomes Community rural  20-88  20-88 328 332 327 331 327 331
62 Belgium 2010-2015
Flemish Study on Environment, Genes and Health 
Outcomes Community rural  18-87  18-87 386 396 386 396 386 396
63 Belize 2004-2005 CAMDI National both  20+  20+ 600 1,021 600 1,019 600 1,019
64 Benin 2008 STEPS National both  25-64  25-64 758 937 Accutrend
65 Benin 2015 STEPS National both  18-69  18-69 1,843 2,189 CardioChek
66 Bhutan 2007 STEPS Community urban  25-74  25-74 1,126 1,320 1,049 1,223 1,048 1,221
67 Bhutan 2014 STEPS National both  18-69  18-69 877 1,425 CardioChek
68 Bolivia 2005-2007
Cardiovascular and metabolic syndrome risk 
assessment of Bolivian school children and adolescents 
– Relationships to obesity, diabetes, income, food 
intake and physical activity National both  18-18  18-18 108 109 101 103 98 102
69 Bosnia and Herzegovina 2012
Non-communicable disease risk factor survey, 
Federation of B&H Subnational rural  18+  18+ 1,159 1,253
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70 Bosnia and Herzegovina 2012
Non-communicable disease risk factor survey, 
Federation of B&H Subnational urban  18+  18+ 571 688
71 Botswana 2014 STEPS National both  18-69  18-69 764 1,740 1,045 2,099 729 1,625 CardioChek CardioChek
72 Brazil 1991 Fornes et al., Rev Saude Publica 2000; 34: 380-7 Community urban  25+  25+ 387 548
73 Brazil 1992 EPIDOSO; Ramos, Cad Saude Publica 2003; 19: 793-8 Community urban  65+  65+ 158 280
74 Brazil 1996-1997 The Bambui Cohort Study of Ageing Community urban  18+  18+ 947 1,368 947 1,368 947 1,368
75 Brazil 1998 Belo Horizonte Heart Study Community urban  18-18  18-18 31 46 31 46 31 46
76 Brazil 2000
The 1982 Pelotas (Brazil) Birth Cohort: 18 years follow-
up Community urban  18-18 2,079 2,059 2,055
77 Brazil 1999-2000
Prevalence of Risk Factors for Coronary Artery Disease 
in the State of Rio Grande do Sul Subnational urban  20+  20+ 463 519
78 Brazil 2004 Caju & Virgen das Gracas Community rural  18+  18+ 268 275 268 275 268 275
79 Brazil 2002-2004 Ribeira Preto Birth Cohort Community urban  22-25  22-25 1,007 1,067 1,006 1,067 1,006 1,067
80 Brazil 2003-2005 São Paulo Health & Ageing Study Community urban  65+  65+ 762 1,190 762 1,190 762 1,190
81 Brazil 2004-2006 Hearts of Brazil National urban  18-79  18+ 307 336 Accutrend
82 Brazil 2004-2005
The 1982 Pelotas (Brazil) Birth Cohort: 23 years follow-
up Community urban  23-23  23-23 1,918 1,906
83 Brazil 2008 The Bambui Cohort Study of Ageing Community urban  71+  71+ 253 473 253 473 253 473
84 Brazil 2008 Caju & Virgen das Gracas Community rural  18+  18+ 249 278 248 278 248 278
85 Brazil 2010 San Pedro Community rural  18+  18+ 150 208 150 208 150 208
86 Brazil 2011-2012
The 1993 Pelotas (Brazil) Birth Cohort: 18 years follow-
up Community urban  18-19  18-19 1,916 1,925 1,916 1,925 1,916 1,925
87 Brazil 2010-2015 Baependi Heart Study Community rural  18+  18+ 1,064 1,425 1,063 1,424 1,061 1,424
88 Brazil 2012-2013
The 1982 Pelotas (Brazil) Birth Cohort: 30 years follow-
up Community urban  30-30  30-30 1,741 1,791 1,741 1,791 1,741 1,791
89 Brazil 2013 Pesquisas Nacional de Saude National both  18+  18+ 2,761 3,103 2,750 3,096 2,749 3,096
90 Brazil 2011-2014
Profile of Risk Factors for Coronary Arterial Disease in 
Rio Grande Do Sul - Revaluation after 10 years Subnational urban  20+  20+ 365 464 336 411 336 410
91 Brazil 2014-2015
EpiFloripa Cohort Study of Ageing - Wave 2, Clinical 
and Laboratory Exams Community urban  63+  63+ 209 387 209 387 209 387
92 Brazil 2014-2015 EpiFloripa Adults Cohort Study (EpiFloripa) Community urban  25-65  25-65 299 411 296 411 296 411
93 Brazil 2015-2016
The 1993 Pelotas (Brazil) Birth Cohort: 22 years follow-
up Community urban  21-23  21-23 1,660 1,818 1,659 1,818 1,659 1,818
94 Brunei Darussalam 2010-2011
National Health And Nutritional Status Survey 
(NHANSS) National both  20-75  20-75 629 762 628 762 628 761
95 Brunei Darussalam 2015-2016
National Non-Communicable Diseases Survey 
(NNCDS) National both  18-69  18-69 835 1,103 830 1,096 828 1,093
96 Burkina Faso 2013 STEPS National both  25-64  25-64 952 1,144 1,827 1,912 876 1,068 CardioChek CardioChek
97 Cabo Verde 2007 STEPS National both  25-64  25-64 118 282 Accutrend
98 Cambodia 2010 STEPS National both  25-64  25-64 1,264 2,502 Accutrend
99 Canada 1985-1988 MONICA, Halifax Community both  25-64  25-64 423 414 421 414 421 414
100 Canada 1986-1992 Canada Heart Health Survey National both  18-74  18-74 9,592 9,804 9,515 9,747 9,511 9,746
101 Canada 1995 MONICA, Halifax Community both  25-64  25-64 269 281 268 281 268 281
102 Canada 1995-1997 Canadian Multicentre Osteoporosis Study (CaMos) Community both  50+  50+ 139 369 139 369 139 369
103 Canada 2005-2008 Canadian Multicentre Osteoporosis Study (CaMos) Subnational both  50+  50+ 605 1,466 605 1,466 605 1,466
104 Canada 2007-2009 Canadian Health Measures Survey, Cycle 1 National both  20-79  20-79 1,607 1,805 1,607 1,805 1,607 1,805
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105 Canada 2009-2011 Canadian Health Measures Survey, Cycle 2 National both  20-79  20-79 1,672 1,907 1,674 1,908 1,672 1,907
106 Canada 2012-2013 Canadian Health Measures Survey, Cycle 3 National both  20-79  20-79 1,560 1,574 1,560 1,574 1,560 1,574
107 Canada 2014-2015 Canadian Health Measures Survey, Cycle 4 National both  20-79  20-79 1,552 1,551 1,550 1,551 1,550 1,551
108 Canada 2016-2017 Canadian Health Measures Survey, Cycle 5 National both  20-79  20-79 1,512 1,502 1,511 1,502 1,510 1,502
109 Chile 1992-1993 Miquel et al., Gastroenterology 1998; 115: 937-46 Community urban  18+  18+ 660 1,032 659 1,032 659 1,032
110 Chile 2000 Nervi et al., J Hepatol 2006; 45: 299-305 Community urban  20+  20+ 335 625 334 625 334 625
111 Chile 2003 Encuesta Nacional de Salud National both  18+  18+ 904 1,055 901 1,055 901 1,055
112 Chile 2004-2005
CArdiovascular Risk factors Multiple Evaluation in 
Latin America (CARMELA) Community urban  25-64  25-64 783 872 783 872 783 872
113 Chile 2009-2010 Encuesta Nacional de Salud National both  18+  18+ 1,066 1,550 1,065 1,549 1,065 1,549
114 Chile 2011-2012 CESCAS Study Community urban  30-79  30-79 895 976 895 976 895 976
115 Chile 2016-2017 Encuesta Nacional de Salud National both  18+  18+ 1,299 2,274 1,299 2,274 1,299 2,274
116 China 1983 Sino-MONICA Shanghai Community rural  30-64  30-64 621 627 618 624 618 624
117 China 1984-1985 Sino-MONICA Beijing Community both  25-64  25-64 816 857 814 854 814 854
118 China 1988 Sino-MONICA Hebei Community both  25-64 704 686 686
119 China 1988 Sino-MONICA Heilongjiang Community urban  25-64  25-64 800 800 800 800 800 800
120 China 1988 Sino-MONICA Henan Community urban  25-64  25-64 345 427 345 427 345 427
121 China 1988 Sino-MONICA Neimenggu Community urban  25-64  25-64 397 400 349 400 349 400
122 China 1988 Sino-MONICA Sichuan Community both  25-64  25-64 313 333 312 333 312 333
123 China 1988 Sino-MONICA Shandong Community urban  25-64  25-64 211 221 211 221 211 221
124 China 1986-1989 Sino-MONICA Shanghai Community rural  25-64  25-64 674 752 675 753 674 751
125 China 1988-1989 Sino-MONICA Beijing Community both  25-64  25-64 700 861 697 860 696 859
126 China 1989 Sino-MONICA Fujian Community urban  25-64  25-64 178 189 178 189 178 189
127 China 1988-1989 Sino-MONICA Jilin Community urban  25-64  25-64 391 408 378 388 378 388
128 China 1989 Sino-MONICA Jiangsu Community rural  25-64  25-64 397 399 398 399 397 399
129 China 1988-1989 Sino-MONICA Jiangxi Community urban  25-64  25-64 348 360 349 360 348 360
130 China 1988-1989 Sino-MONICA Liaoning Community both  25-64  25-64 728 733 728 733 728 732
131 China 1991 Sino-MONICA Shanghai Community rural  30-64  30-64 564 624 564 624 564 624
132 China 1992-1993 Anzhen 02 Cohort Study Community urban  34-65  34-65 2,029 2,112 2,023 2,109 2,023 2,107
133 China 1991-1992 Fangshan Cohort Study Community urban  34-79  34-69 272 562 258 544 256 537
134 China 1992 Huashan Study Community urban  35-75  35-75 866 936 863 933 863 932
135 China 1992 Sino-MONICA Sichuan Community both  25-64  25-64 626 537 626 537 626 537
136 China 1993 Sino-MONICA Anhui Community urban  25-64  25-64 192 195 192 195 192 195
137 China 1993 Sino-MONICA Beijing Community both  25-64  25-64 609 814 609 814 609 814
138 China 1993 Sino-MONICA Jiangsu Community urban  25-64  25-64 462 365 462 365 462 365
139 China 1993 Sino-MONICA Liaoning Community both  25-64  25-64 493 500 492 500 492 500
140 China 2000-2001
The International Collaborative Study of Cardiovascular
Disease in ASIA National both  35-74  35-74 7,355 7,860 7,353 7,854 7,350 7,851
141 China 2002 Fan et al., World J Gastroenterol 2008; 14: 2418-24 Subnational both  25-84  25-74 5,526 7,766
142 China 2002 China National Nutrition and Health Survey National both  20+  20+ 22,747 25,643 22,809 25,713 22,741 25,637
143 China 2004-2005 Xinjiang Children and Adolescent Survey Community urban  18-18  18-18 6 4 6 4 6 4
144 China 2006 Beijing Eye Study Community both  45+  45+ 1,247 1,647 1,260 1,664 1,244 1,644
145 China 2006-2007 Handan Eye Study Community rural  30+  30+ 2,494 3,120 2,494 3,122 2,492 3,120
146 China 2008
China Health and Retirement Longitudinal Study 
(CHARLS), pilot survey Subnational both  45+  45+ 1,664 1,718 1,674 1,714 1,592 1,646 CardioChek CardioChek
147 China 2007-2008
China National Diabetes and Metabolic Disorders 
Study; Yang et al., Circulation 2012; 125: 2212-21 National both  20+  20+ 18,227 27,530 18,227 27,530 18,227 27,530
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148 China 2009 China Health and Nutrition Study National both  18+  18+ 4,035 4,524 4,027 4,514 4,026 4,514 3
149 China 2010 China Noncommunicable  Disease Surveillance National both  18+  18+ 44,378 52,553 44,489 52,822 44,282 52,502
150 China 2011 Beijing Eye Study Community both  50+  50+ 1,033 1,419 1,033 1,420 1,033 1,419
151 China 2011-2012
China Health and Retirement Longitudinal Study 
(CHARLS), baseline survey National both  45+  45+ 9,086 10,450 9,078 10,452 9,064 10,436
152 China 2012-2013 The Kailuan Study Community urban  18+  18+ 81,363 22,443 81,090 22,400 81,066 22,395
153 China 2014-2015 The Kailuan Study Community urban  18+  20+ 73,445 19,261 73,361 19,256 73,304 19,244
154 China (Hong Kong SAR) 1991
The Hong Kong study on Health, health risk and quality 
of life in the Chinese elderly cohort Community both  70+  70+ 94 101 94 101 94 101
155 China (Hong Kong SAR) 1995-1996
Hong Kong Cardiovascular Risk Factor Prevalence 
Study 1995-1996 National both  25-74  25-74 1,409 1,479 1,409 1,479 1,408 1,479
156 Colombia 2001
CINDI/CARMEN-Bucaramaga; Bautista et al., Eur J 
Cardiovasc Prev Rehabil 2006; 13:769-75 Community urban  25-64  25-64 620 1,216
157 Colombia 2004-2005
CArdiovascular Risk factors Multiple Evaluation in 
Latin America (CARMELA) Community urban  25-64  25-64 738 815 738 815 738 815
158 Colombia 2007 Encuesta Nacional de Salud National both  18-69  18-69 4,943 7,182 4,832 7,340 4,553 6,987 Cholestech Cholestech
159 Colombia 2010 STEPS Subnational urban  18-64  18-64 429 609 Accutrend
160 Colombia 2015 STEPS Subnational both  18-64  18-64 341 579 341 579 341 578
161 Comoros 2011 STEPS National both  25-64  25-64 267 966 Accutrend
162 Cook Islands 1981 Egusa et al., Atherosclerosis 1984; 53: 241-54 Community both  20-59  20-59 138 159
163 Cook Islands 2013-2015 STEPS National both  18-64  18-64 334 400 Accutrend
164 Costa Rica 1987 Campos et al., Circulation 1992; 85: 648-58 Community both  25-64  25-64 198 215
165 Costa Rica 2004 CAMDI Community urban  20+  20+ 390 756 390 756 390 756
166 Costa Rica 2004-2006
Costa Rican Longevity and Healthy Aging Study Pre-
1945 Cohort Wave 1 National both  60+  60+ 1,208 1,448 1,206 1,443 1,205 1,443
167 Costa Rica 2006-2008
Costa Rican Longevity and Healthy Aging Study Pre-
1945 Cohort Wave 2 National both  62+  62+ 1,018 1,215 1,016 1,215 1,016 1,215
168 Costa Rica 2010
Costa Rican National Cardiovascular Risk Factors 
Survey, 2010 National both  20+  20+ 725 1,937 703 1,837 689 1,814
169 Costa Rica 2010-2011
Costa Rican Longevity and Healthy Aging Study 1945-
1955 Cohort Wave 1 National both  54-66  54-66 1,029 1,590 1,025 1,590 1,025 1,590
170 Croatia 2008
Endemic Nephropathy and Arterial hypertension 
(ENAH) Subnational rural  18+  18+ 343 551 343 551 343 550
171 Croatia 2010
Endemic Nephropathy and Arterial hypertension 
(ENAH) Subnational rural  18+  18+ 259 391 259 391 259 391
172 Croatia 2015
Endemic Nephropathy and Arterial hypertension 
(ENAH) Follow-up Study Subnational rural  20+  20+ 223 461 222 461 222 461
173 Cuba 2010 National Risk Factor Survey National both  15+  15+ 1,176 1,441 171 211 171 211 1
174 Cuba 2011 Non communicable disease risk factor in Cienfuegos Community urban  15-74  15-74 616 880 616 880 616 880 1
175 Czech Republic 1985 MONICA, Czech Republic National both  25-64  25-64 1,244 1,307 1,241 1,306 1,241 1,306
176 Czech Republic 1988 MONICA, Czech Republic National both  25-64  25-64 1,353 1,409 1,353 1,408 1,352 1,408
177 Czech Republic 1992 MONICA, Czech Republic National both  25-64  25-64 1,127 1,189 1,120 1,187 1,120 1,187
178 Czech Republic 1997-1998 Czech post-MONICA National both  25-64  25-64 1,527 1,664 1,519 1,664 1,519 1,664
179 Czech Republic 2000-2001 Czech post-MONICA National both  25-64  25-64 1,612 1,661 1,606 1,656 1,606 1,656
180 Czech Republic 2005 HELEN   National urban  45-54  45-54 761 1,063
181 Czech Republic 2006-2009 Czech post-MONICA National both  25-64  25-64 1,718 1,860 1,700 1,820 1,700 1,820
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182 Czech Republic 2015-2018 MONICA National both  25-65  25-65 1,239 1,361 1,238 1,359 1,238 1,359
183 Denmark 1981-1983 Copenhagen City Heart Study Subnational urban  20+  20+ 5,612 6,884 5,596 6,870 5,596 6,870
184 Denmark 1982-1984 MONICA, Glostrup Community urban  30-61  30-61 1,938 1,842 1,935 1,842 1,935 1,842
185 Denmark 1986-1987 MONICA, Glostrup Community urban  29-61  29-61 747 755 746 755 746 755
186 Denmark 1991-1992 MONICA, Glostrup Community urban  29-61  29-61 805 809 807 810 805 807
187 Denmark 1991-1994 Copenhagen City Heart Study Subnational urban  20+  20+ 4,339 5,581 4,328 5,570 4,328 5,570
188 Denmark 2001-2003 Copenhagen City Heart Study Subnational urban  20+  20+ 2,529 3,388 2,525 3,384 2,524 3,384
189 Denmark 2003-2004 Copenhagen General Population Study 1 Subnational urban  20+  20+ 4,829 5,398 4,827 5,398 4,827 5,398
190 Denmark 2005 Copenhagen General Population Study 1 Subnational urban  20+  20+ 5,173 6,029 5,169 6,025 5,169 6,025
191 Denmark 2006 Copenhagen General Population Study 1 Subnational urban  20+  20+ 5,053 4,855 5,052 4,855 5,052 4,855
192 Denmark 2007 Copenhagen General Population Study 1 Subnational urban  20+  20+ 4,030 6,913 4,027 6,913 4,027 6,913
193 Denmark 2006-2008 The Health2006 Cohort Subnational urban  18-71  20-69 1,548 1,850 1,548 1,849 1,548 1,849
194 Denmark 2008 Copenhagen General Population Study 1 Subnational urban  20+  20+ 4,742 6,473 4,743 6,470 4,742 6,470
195 Denmark 2007-2008 The Danish Health Examination Survey 2007-2008 National both  18+  18+ 7,204 10,427
196 Denmark 2009 Copenhagen General Population Study 1 Subnational urban  20+  20+ 4,217 5,239 4,217 5,239 4,217 5,239
197 Denmark 2010 Copenhagen General Population Study 1 Subnational urban  20+  20+ 3,923 4,842 3,917 4,838 3,916 4,838
198 Denmark 2009-2010 The European Youth Heart Study Community both  20-28  20-28 303 325 303 325 303 325
199 Denmark 2011 Copenhagen General Population Study 1 Subnational urban  20+  20+ 4,870 5,738 4,869 5,733 4,868 5,733
200 Denmark 2012 Copenhagen General Population Study 1 Subnational urban  20+  20+ 4,407 5,276 4,403 5,272 4,403 5,272
201 Denmark 2011-2012 The Health2006 cohort - 5-year follow-up Subnational urban  24-76  24-76 1,056 1,242 1,056 1,242 1,056 1,242
202 Denmark 2013 Copenhagen General Population Study 1 Subnational urban  20+  20+ 3,940 4,610 3,937 4,610 3,937 4,609
203 Denmark 2014 Copenhagen General Population Study 2 Subnational urban  20+  20+ 1,354 1,745 1,354 1,743 1,353 1,743
204 Denmark 2012-2015 Danish study of Functional Disorders (DanFunD) Subnational urban  18-72  18-72 3,450 4,015 3,452 4,017 3,450 4,015
205 Denmark 2014-2015 Copenhagen General Population Study 1 Subnational urban  20+  20+ 2,226 2,815 2,225 2,815 2,224 2,815
206 Denmark 2015 Copenhagen General Population Study 2 Subnational urban  20+  20+ 3,988 4,980 3,994 4,996 3,982 4,976
207 Denmark 2016 Copenhagen General Population Study 2 Subnational urban  20+  20+ 4,434 5,417 4,430 5,412 4,427 5,409
208 Denmark 2017 Copenhagen General Population Study 2 Subnational urban  20+  20+ 3,184 4,399 3,188 4,392 3,184 4,392
209 Dominica 2007 STEPS National both  18-64  18-64 37 69 38 75 35 67 CardioChek CardioChek
210 Dominican Republic 1993 Aono et al., J Epidemiol 1997; 7: 238-43 National both  20-69  20-69 737 1,149
211 Dominican Republic 1996-1998
Estudio factores de riesgo cardiovascular y sindrome 
metabolico en la Republica Dominicana I (EFRICARD 
I) National both  18-75  18-75 1,854 3,713 2,085 4,089 1,852 3,706 Reflotron Reflotron
212 Dominican Republic 2010-2012
Estudio factores de riesgo cardiovascular y sindrome 
metabolico en la Republica Dominicana II (EFRICARD 
II) National both  18-75  18-75 1,631 3,284 1,631 3,283 1,629 3,282
213 Ecuador 2004-2005
CArdiovascular Risk factors Multiple Evaluation in 
Latin America (CARMELA) Community urban  25-64  25-64 813 825 813 825 813 825
214 Ecuador 2009 National Survey of Health, Wellbeing, and Aging National both  60+  60+ 1,070 1,293 1,069 1,292 1,069 1,292
215 Egypt 2003-2004
Metabolic and cardiovascular risk profiles and hepatitis 
C virus infection in rural Egypt Community rural  25+  25+ 317 450 317 450 317 450
216 Egypt 2005 STEPS National both  18-65  18-65 934 980 788 912 750 878 Reflotron Reflotron
217 Egypt 2007-2009
Hepatitis C infection and clearance: impact on 
atherosclerosis and cardiometabolic risk factors Community rural  35+  35+ 640 845 590 804 588 802
218 Egypt 2011 STEPS National both  18-65  18-65 767 1,441 767 1,446 766 1,441
219 Egypt 2017 STEPS National both  18-69  18-69 1,023 2,339 1,396 2,748 967 2,225 CardioChek CardioChek
220 El Salvador 2004 CAMDI Community urban  20+  20+ 407 824
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221 El Salvador 2014-2015
Encuesta Nacional de Enfermedades Crónicas (ENECA-
ELS 2014-2015) National both  20+  20+ 1,706 2,968 1,695 2,958 1,695 2,958
222 Eritrea 2010 STEPS National both  25-74  25-74 1,216 3,320 Accutrend
223 Estonia 1985 Volozh et al., Eur J Public Health 2002; 12: 16-21 Community urban  30-54 1,747
224 Estonia 1991 Olferev et al., Cor Vasa 1991; 33: 472-9; Site 1 Community urban  35-54 250
225 Estonia 1991 Olferev et al., Cor Vasa 1991; 33: 472-9; Site 2 Community urban  35-54 232
226 Estonia 1993 Volozh et al., Eur J Public Health 2002; 12: 16-21 Community urban  30-54 292
227 Estonia 1997 Johansson et al., J Intern Med 2002; 252: 551-60 Community urban  35-55  35-55 144 133
228 Estonia 2003 The European Male Ageing Study Community both  40+ 426 428 426
229 Estonia 2008 The European Male Ageing Study Community both  40+ 312 314 312
230 Fiji 2002 STEPS National both  18-64  20-64 923 1,466 914 1,451 904 1,446 Reflotron Reflotron
231 Finland 1980 Young Finns Study 1980 rural National rural  18-18  18-18 120 148 120 148 120 148
232 Finland 1980 Young Finns Study 1980 urban National urban  18-18  18-18 131 130 131 130 131 130
233 Finland 1982 MONICA, North Karelia/Kuopio/Turku/Loimaa Subnational both  25-64  25-64 4,555 4,655 4,551 4,654 4,551 4,654
234 Finland 1983 Young Finns Study 1983 rural National rural  18-21  18-21 165 197 163 197 163 197
235 Finland 1983 Young Finns Study 1983 urban National urban  18-21  18-21 184 202 183 202 183 202
236 Finland 1984 Finnish cohort of the FINE study Community rural  65-84 692 693 692
237 Finland 1986 Young Finns Study 1986 rural National rural  18-24  18-24 205 235 205 237 205 235
238 Finland 1986 Young Finns Study 1986 urban National urban  18-24  18-24 259 330 261 331 258 329
239 Finland 1984-1989 Kuopio Ischaemic Heart Disease Risk factor Study Subnational both  42-61 2,615 2,615 2,615
240 Finland 1987 MONICA, North Karelia/Kuopio/Turku/Loimaa Subnational both  25-64  25-64 2,897 3,143 2,895 3,143 2,895 3,143
241 Finland 1989 Finnish cohort of the FINE study Community rural  70-89 445 445 445
242 Finland 1990-1992 Oulu 35 Study Community urban  56-56  56-56 231 327 231 327 231 327
243 Finland 1992 The National FINRISK Study Subnational both  25-64  25-64 2,844 3,106 2,843 3,106 2,843 3,106
244 Finland 1991-1993 Kuopio Ischaemic Heart Disease Risk factor Study Subnational both  46-65 1,032 1,032 1,032
245 Finland 1997 The National FINRISK Study National both  25-74  25-74 4,225 4,087 4,222 4,087 4,222 4,087
246 Finland 1997 North Finland Birth Cohort 1966 Community both  30-31  30-31 2,791 268 2,790 268 2,790 268
247 Finland 1996-1998 Oulu 35 Study Community urban  60-63  60-63 244 344 244 344 244 344
248 Finland 1996-1998 Savitaipale Study, Baseline Community rural  40-66  40-66 572 575 569 573 569 573
249 Finland 2000 Viiri et al., Atherosclerosis 2005; 179: 161-7; Site 1 Community urban  50-59 74
250 Finland 2000 Viiri et al., Atherosclerosis 2005; 179: 161-7; Site 2 Community urban  50-59 101
251 Finland 2000 Viiri et al., Atherosclerosis 2005; 179: 161-7; Site 3 Community urban  50-59 42
252 Finland 2000 Finnish cohort of the FINE study Community rural  81-96 96 96 96
253 Finland 1998-2001 Kuopio Ischaemic Heart Disease Risk factor Study Subnational both  53-73  53-73 853 916 853 916 853 916
254 Finland 2000-2001 Health 2000 Survey National both  30+  30+ 2,988 3,702 2,988 3,702 2,988 3,702
255 Finland 2001 Young Finns Study 2001 rural National rural  24-39  24-39 344 395 343 395 343 395
256 Finland 2001 Young Finns Study 2001 urban National urban  24-39  24-39 660 770 658 770 658 770
257 Finland 2002 The National FINRISK Study National both  25-74  25-74 3,263 3,762 3,262 3,762 3,262 3,762
258 Finland 2001-2003 Oulu 45 Study Community urban  55-58  55-58 427 550 427 549 427 549
259 Finland 2001-2004 Helsinki Birth Cohort Study Community urban  56-69  56-69 927 1,074 927 1,074 927 1,074
260 Finland 2005 Mantyselka et al., Rheumatology 2008; 47: 1235-8 Community rural  30-65  30-65 230 250
261 Finland 2007 The National FINRISK Study National both  25-74  25-74 2,923 3,251 2,923 3,251 2,923 3,251
262 Finland 2005-2008 Kuopio Ischaemic Heart Disease Risk factor Study Subnational both  60-81  60-81 1,240 633 1,240 633 1,240 633
263 Finland 2007 Oulu 35 Study Community urban  72-72  72-72 182 270 182 272 182 270
264 Finland 2007 Young Finns Study 2007 rural National rural  30-45  30-45 378 439 376 438 376 438
265 Finland 2007 Young Finns Study 2007 urban National urban  30-45  30-45 605 719 597 719 597 719
266 Finland 2008 Control group for Finnish male former elite athletes National both  61+ 207 207 207
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267 Finland 2007-2008 Savitaipale Study, Follow-up Community rural  51-75  51-75 427 477 427 477 427 477
268 Finland 2011 Young Finns Study 2011 rural National rural  34-49  34-49 365 423 364 423 364 423
269 Finland 2011 Young Finns Study 2011 urban National urban  34-49  34-49 502 632 501 632 501 632
270 Finland 2012 The National FINRISK Study National both  25-74  25-74 2,771 2,998 2,771 2,997 2,771 2,997
271 Finland 2011-2012 Health 2011 Survey National both  30+  30+ 1,957 2,416 1,956 2,416 1,956 2,416
272 Finland 2012 North Finland Birth Cohort 1966 Community both  45-47  45-47 2,540 3,225 2,542 3,225 2,540 3,225
273 Finland 2017 The FinHealth Survey National both  18+  18+ 3,185 3,728 3,185 3,728 3,185 3,728
274 France 1985-1987 MONICA, Strasbourg Subnational both  35-64  35-64 639 667 637 665 637 665
275 France 1985-1987 MONICA, Strasbourg Subnational both  25-34  25-34 64 75 64 75 64 75
276 France 1985-1987 MONICA, Toulouse Subnational both  35-64  35-64 659 606 652 602 652 602
277 France 1986-1989 MONICA, Lille Community urban  25-64  25-64 778 595 773 593 773 593
278 France 1988-1991 MONICA, Toulouse Subnational both  35-64 584 584 584
279 France 1994-1996 MONICA, Toulouse Subnational both  35-64  35-64 609 565 609 565 609 565
280 France 1995-1997 MONICA, Lille Community urban  36-67  36-66 590 580 585 579 585 579
281 France 1995-1997 MONICA, Strasbourg Subnational both  35-64  35-64 522 523 514 507 514 507
282 France 1999-2001 The Three City Study Community urban  65+  65+ 3,444 5,263 3,440 5,261 3,440 5,261
283 France 2003-2005 The Three City Study Community urban  68+  68+ 629 994 629 994 629 994
284 France 2004-2006
National Monitoring of Arterial Risk in Lille (MONA 
LISA Lille) Community urban  35-75  35-75 795 787 795 787 795 787
285 France 2005-2007
National Monitoring of Arterial Risk in Bas-Rhin 
(MONA LISA Bas-Rhin) Subnational both  35-74  35-74 777 769 777 769 777 769
286 France 2005-2007
Monitoring National du Risque Artériel (MONA LISA 
study Haute-Garonne) Subnational both  35-74  35-74 829 797 829 797 829 797
287 France 2006-2007 Etude Nationale Nutrition Santé National both  18-74  18-74 784 1,318 769 1,298 769 1,298
288 France 2008-2010 The Three City Study Community urban  73+  73+ 256 458 256 458 256 458
289 France 2011-2013
Enquête LIttorale Souffle Air Biologie EnvironnemenT 
(ELISABET) Dunkerque Community both  40-64  40-64 753 785 753 785 753 785
290 France 2011-2013
Enquête LIttorale Souffle Air Biologie EnvironnemenT 
(ELISABET) Lille Community both  40-64  40-64 751 834 751 835 751 834
291 France 2014-2016
The Health Study on Environment, Biomonitoring, 
Physical Activity and Nutrition (Esteban) National both  18-74  18-74 924 1,127 910 1,113 910 1,113
292 French Polynesia 2010 STEPS National both  18-64  18-64 815 1,075 Accutrend
293 Gambia 1997
van der Sande et al., J Hum Hypertens 2000; 14: 489-
96 Community urban  25+  25+ 351 549
294 Georgia 2010 STEPS National both  18-64  18-64 952 3,190 Accutrend
295 Georgia 2016 STEPS National both  18-69  18-69 788 2,179 873 2,275 767 2,162 CardioChek CardioChek
296 Germany 1982 MONICA, Erfurt Community urban  25-64  25-64 106 103
297 Germany 1982-1984 MONICA, Chemnitz Community urban  25-64  25-64 264 285 254 273 253 272
298 Germany 1982-1984 MONICA, Zwickau Community urban  25-64  25-64 233 252 229 258 227 250
299 Germany 1984
German Cardiovascular Prevention Study (GCP) - 
National Health Survey 1984 Subnational both  25-69  25-69 2,404 2,261 2,182 2,069 2,178 2,063
300 Germany 1984-1985 MONICA, Berlin-Lichtenberg Community urban  25-64  25-64 583 614 567 603 566 599
301 Germany 1984 MONICA, Bremen North/West Community urban  25-64  25-64 797 822 713 733 703 726
302 Germany 1983-1984 MONICA, Halle County Subnational urban  25-64  25-64 1,073 1,135 964 1,028 950 1,012
303 Germany 1982-1985 MONICA, Rest of Karl-Marx-Stadt County Subnational urban  25-64  25-64 565 629
304 Germany 1982-1985 MONICA, Rest of DDR-MONICA Subnational urban  25-64  25-64 227 229 99 105 99 105
305 Germany 1984-1985 MONICA, Augsburg Community both  25-64  25-64 1,895 1,868 1,918 1,922 1,817 1,825
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306 Germany 1984-1986 MONICA, Cottbus County Community urban  25-64  25-64 645 732 641 728 639 728
307 Germany 1983-1987 MONICA, Rhein-Neckar Region Community urban  25-64  25-64 1,458 1,569 1,458 1,567 1,458 1,567
308 Germany 1987-1988 MONICA, Erfurt Community urban  25-64  25-64 877 912 876 911 876 911
309 Germany 1988
German Cardiovascular Prevention Study (GCP) - 
National Health Survey 1988 Subnational both  25-69  25-69 2,606 2,576 2,573 2,562 2,573 2,556
310 Germany 1988 MONICA, Berlin-Lichtenberg Community urban  25-64  25-64 687 709 686 709 686 709
311 Germany 1988 MONICA, Bremen North/West Community urban  25-69  25-69 611 609 575 565 575 565
312 Germany 1988 MONICA, Bremen Center/South/East Community urban  25-69  25-69 493 562 483 548 483 548
313 Germany 1988 MONICA, Chemnitz Community urban  25-64  25-64 274 369 274 366 272 365
314 Germany 1988 MONICA, Zwickau Community urban  25-64  25-64 182 241 180 236 180 235
315 Germany 1989-1990 MONICA, Cottbus County Community urban  25-64  25-64 536 526 525 516 525 516
316 Germany 1988-1989 MONICA, Halle County Subnational urban  25-64  25-64 911 1,143 906 1,137 902 1,135
317 Germany 1988-1989 MONICA, Rest of Karl-Marx-Stadt County Subnational urban  25-64  25-64 520 587 517 587 517 586
318 Germany 1989-1990 MONICA, Augsburg Community both  25-64  25-64 1,915 1,929 1,895 1,923 1,895 1,923
319 Germany 1991-1992 MONICA, Bremen North/West Community urban  25-69  25-69 573 604 527 558 527 557
320 Germany 1991-1992 MONICA, Bremen Center/South/East Community urban  25-69  25-69 517 523 503 508 503 508
321 Germany 1991-1992
German Cardiovascular Prevention Study (GCP) - 
National Health Survey 1991 Subnational both  25-69  25-69 2,592 2,645 2,478 2,549 2,477 2,548
322 Germany 1991-1992
First National Examination of life conditions, 
Environment and Health in East Germany 1991/92 Subnational both  25-69  25-69 1,050 1,152 950 1,042 950 1,041
323 Germany 1991-1992 MONICA, Erfurt Community urban  25-64  25-64 585 571 583 570 583 570
324 Germany 1993-1994 MONICA, Chemnitz Community urban  25-64  25-64 406 425 405 425 405 425
325 Germany 1993-1994 MONICA, Zwickau Community urban  25-64  25-64 107 131 107 131 107 131
326 Germany 1994-1995 MONICA, Augsburg Community both  25-64  25-64 1,872 1,908 1,863 1,908 1,863 1,908
327 Germany 1997-1999
German National Health Interview and Examination 
Survey (GNHIES98) National both  18-79  18-79 3,278 3,442 3,274 3,442 3,274 3,442
328 Germany 1997-2001 Study of Health in Pomerania (SHIP-0)  baseline study Subnational both  20-80  20-80 2,104 2,182 2,099 2,175 2,098 2,175
329 Germany 1999-2001
KORA S4 Study: Kooperative Research in the Region 
of Augsburg Survey 4 Community both  24-75  24-75 2,069 2,132 2,065 2,130 2,065 2,130
330 Germany 2000-2002
Epidemiological study of the chances of prevention, 
early recognition and optimal treatment of chronic 
diseases in an elderly population (ESTHER) Subnational both  50-75  50-75 4,340 5,270 2,793 3,216 2,769 3,192
331 Germany 2002
Echinoccoccus Multilocularis and Internal Diseases in 
Leutkirch Community urban  20-65  20-65 827 931 827 931 827 931
332 Germany 2000-2003 Heinz Nixdorf Recall Study Subnational urban  45-76  45-76 2,382 2,404 2,380 2,403 2,379 2,403
333 Germany 2002-2006
Study of Health in Pomerania (SHIP-1) 5-year follow-
up Subnational both  25-85  25-85 1,586 1,701 9
334 Germany 2005-2008 Heinz Nixdorf Recall Study Subnational both  50-80  50-80 2,045 2,082 2,045 2,080 2,045 2,080
335 Germany 2006-2008
KORA F4 Study: Kooperative Research in the Region 
of Augsburg Follow-up of Survey 4 Community both  31-81  31-81 1,479 1,580 1,479 1,579 1,479 1,579
336 Germany 2008-2011
Epidemiological study of the chances of prevention, 
early recognition and optimal treatment of chronic 
diseases in an elderly population (ESTHER) Subnational both  58-84  58-84 2,082 2,488 2,082 2,487 2,082 2,487
337 Germany 2008-2011
German Health Interview and Examination Survey for 
adults 2008-11 (DEGS1) National both  18-79  18-79 3,372 3,641 3,376 3,644 3,372 3,640
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Study of Health in Pomerania, second cohort (SHIP-
TREND) Subnational both  20-79  20-79 2,098 2,233 2,096 2,232 2,096 2,232
339 Germany 2011-2014 Heinz Nixdorf Recall Study Subnational both  55-86  55-86 1,494 1,558 1,492 1,559 1,492 1,558
340 Ghana 2003 Women's Health Study of Accra (WHSA-I) Community urban  18+ 874 826 800
341 Ghana 2006 STEPS Community urban  25-69  25-69 342 928 Accutrend
342 Ghana 2012-2014
Research on Obesity and Diabetes among African 
Migrants (RODAM), control group Subnational rural  25+  25+ 427 665 420 658 420 658
343 Ghana 2012-2014
Research on Obesity and Diabetes among African 
Migrants (RODAM), control group Subnational urban  25-79  25-79 416 1,031 412 1,029 412 1,029
344 Greece 2001 Karalis et al., BMC Public Health 2007; 7: 351 Community rural  24+  24+ 91 103
345 Greece 2013-2015
Hellenic National Nutrition and Health Survey 
(HNNHS) National both  18+  18+ 413 680 412 679 412 679
346 Greenland 2005-2010 Population Health Survey in Greenland National both  18+  18+ 1,355 1,726 1,355 1,726 1,355 1,726
347 Guatemala 2001-2002 CAMDI Community urban  20+  20+ 338 626 338 626 338 626
348 Guatemala 2003 Gregory et al., J Nutr 2007; 137: 1314-9; Site 1 Community both  25-44  25-44 123 342
349 Guatemala 2003 Gregory et al., J Nutr 2007; 137: 1314-9; Site 2 Community both  25-44  25-44 295 291
350 Guatemala 2003-2005
The Institute of Nutrition of Central America and 
Panama Nutrition Supplementation Trial Cohort Community both  25-41  25-41 193 263 197 268 187 262 Cholestech Cholestech
351 Guinea 2009 STEPS Subnational both  18-64  18-64 534 665 Accutrend
352 Guyana 2016 STEPS National both  18-69  18-69 331 557 331 560 331 557
353 Honduras 2003-2004 CAMDI Community urban  20+  20+ 434 786 434 786 434 786
354 Hungary 1982-1984 MONICA, Budapest Community urban  25-64  25-64 766 720 178 170 178 170
355 Hungary 1982-1983 MONICA, Pecs Community urban  25-64  25-64 783 800 439 402 439 402
356 Hungary 1985-1988 First Hungarian Representative Nutrition Survey National both  19+  19+ 921 2,932 971 3,111 971 3,111
357 Hungary 1987-1988 MONICA, Budapest Community urban  25-64  25-64 1,328 1,526 1,258 1,472 1,258 1,472
358 Hungary 1987-1988 MONICA, Pecs Community urban  25-64  25-64 1,209 1,199 897 911 897 911
359 Hungary 2003 The European Male Ageing Study Community both  40+ 423 417 415
360 Hungary 2008 The European Male Ageing Study Community both  40+ 348 347 346
361 Iceland 1979-1981 The Reykjavik Study (Men) Subnational urban  45-74 3,240
362 Iceland 1983 MONICA, Arnes County Community rural  25-64  25-64 387 449 386 448 385 448
363 Iceland 1983 MONICA, Reykjavik Subnational urban  25-64  25-64 435 460 433 459 433 459
364 Iceland 1981-1984 The Reykjavik Study (Women) Subnational urban  46-75 3,579
365 Iceland 1983-1985 The Reykjavik Study for the young Subnational urban  29-45  29-45 829 902
366 Iceland 1985-1987 The Reykjavik Study (Men) Subnational urban  51-79 2,590 1,109 1,109
367 Iceland 1988-1989 MONICA, Arnes County Community rural  25-64  25-64 389 438 388 437 388 437
368 Iceland 1988-1989 MONICA, Reykjavik Subnational urban  25-64  25-64 413 444 413 444 413 444
369 Iceland 1987-1991 The Reykjavik Study (Women) Subnational urban  52-82 3,027 3,003 3,003
370 Iceland 1993-1994 MONICA, Arnes County Community rural  25-64  25-64 422 484 421 484 421 484
371 Iceland 1993-1994 MONICA, Reykjavik Subnational urban  25-64  25-64 443 446 443 446 443 446
372 Iceland 1991-1994 The Reykjavik Study (Men) Subnational urban  70-86 824 822 822
373 Iceland 1994-1996 The Reykjavik Study (Women) Subnational urban  69-88 1,187 1,187 1,187
374 Iceland 2001-2003 The Reykjavik Study for the young Subnational urban  47-62  47-62 631 714 631 714 631 714
375 Iceland 2002-2006 AGES-Reykjavik Study Subnational urban  66+  66+ 2,419 3,285 2,418 3,285 2,418 3,285
376 Iceland 2005-2011 Risk Evaluation For INfarct Estimates (REFINE) Subnational urban  20-73  20-73 3,394 3,515 3,393 3,513 3,393 3,513
377 Iceland 2007-2011 AGES-Reykjavik Study - follow up visit Subnational urban  71+  71+ 1,395 1,929 1,395 1,929 1,395 1,929
378 Iceland 2010-2012
Risk Evaluation For INfarct Estimates (REFINE) 
follow-up visit (REFINELO) Subnational urban  26-74  26-74 653 665 654 665 653 665
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Risk Evaluation For INfarct Estimates (REFINE) - 
follow-up visit (REFLOCT) Subnational urban  55-73  55-73 516 560 516 560 516 560
380 India 1995-1997 Aravind Comprehensive Eye Survey Community rural  40+  40+ 2,267 2,783
381 India 1997 Reddy et al., Asia Pac J Clin Nutr 2002; 11: 98-103 Subnational both  20-59  20-59 640 480
382 India 1996-1999 Chennai Urban Population Study Community urban  20+  20+ 532 689 532 688 532 688
383 India 1999-2001 Jaipur Heart Watch 2 Community urban  20-75  20-75 518 555 518 554 518 553
384 India 1998-2002 Vellore Birth Cohort Subnational both  25-31  25-31 1,154 1,053 1,155 1,054 1,152 1,052
385 India 1999-2002 New Delhi Birth Cohort Community urban  26-33  26-33 869 619 869 618 869 617
386 India 2001-2004 Chennai Urban Rural Epidemiology Study Community urban  20+  20+ 1,096 1,252 1,093 1,252 1,093 1,251
387 India 2003-2005 India STEPS, Ballabgarh Subnational rural  20-69  20-69 227 233 226 230 226 230
388 India 2003-2005 India STEPS, Ballabgarh Subnational urban  20-69  20-69 214 228 214 228 214 228
389 India 2003-2005 India STEPS, Chennai Subnational rural  20-69  20-69 234 231 234 231 234 231
390 India 2003-2005 India STEPS, Chennai Subnational urban  20-69  20-69 217 240 217 240 216 240
391 India 2003-2005 India STEPS, Delhi Subnational urban  20-69  20-69 223 211 223 211 225 211
392 India 2003-2005 India STEPS, Dibrugarh Subnational rural  20-69  20-69 224 219 224 219 228 225
393 India 2003-2005 India STEPS, Dibrugarh Subnational urban  20-69  20-69 224 227 224 227 223 227
394 India 2003-2005 India STEPS, Nagpur Subnational rural  20-69  20-69 264 267 264 267 264 267
395 India 2003-2005 India STEPS, Nagpur Subnational urban  20-69  20-69 234 242 234 242 234 242
396 India 2006 Ramachandran et al., Diabetes Care 2008; 31: 893-8 Community both  20+  20+ 3,214 3,644 3,218 3,645 3,211 3,644
397 India 2005-2006
Risk factor profile for chronic non-communicable 
diseases: Results of a community-based study in 
Karela, India Community both  18-64  18-64 494 575 494 575 494 575
398 India 2006-2008 Central India Eye and Medical Study Community rural  30+  30+ 2,149 2,487 2,162 2,495 2,148 2,486
399 India 2006-2009 New Delhi Birth Cohort Community urban  33-38  33-38 646 439 646 439 646 439
400 India 2008-2010 ICMR India Diabetes Study National both  20+  20+ 1,083 981 1,069 978 1,069 977
401 India 2012-2013 Processed and non-processed foods National rural  18+  18+ 213 235 203 242 194 234 Cholestech Cholestech
402 India 2013-2014 Vellore Birth Cohort Subnational both  39-44  39-44 579 499 579 499 579 499
403 India 2015-2016
Diet and nutritional status of urban population and 
prevalence of hypertension National urban  18+  18+ 17,865 22,001 17,976 22,345 17,410 21,823
404 India 2016-2019 Vellore Birth Cohort Subnational both  43-48  43-48 842 758 841 757 841 757
405 Indonesia 2001 STEPS/SURKESNAS   Subnational both  25+  25+ 1,895 2,186
406 Indonesia 2003
A genetic-ecological study of the risk foctors for 
lifestyle-related diseases in Oceanian populations, 
Study A Community rural  18-79  18-79 99 103 99 103 99 103
407 Indonesia 2003
A genetic-ecological study of the risk foctors for 
lifestyle-related diseases in Oceanian populations, 
Study B Community rural  18-79  18-79 96 137 96 137 96 137
408 Indonesia 2007-2008 Indonesian Family Life Surveys National both  40+  40+ 4,687 5,555 4,688 5,633 4,343 5,385 CardioChek CardioChek
409 Indonesia 2013
Population Health Basic Health Research 2013 
(Riskesdas 2013) National both  18+  18+ 15,140 20,469 15,140 20,469 15,140 20,469
410 Iran 1990-1991 National Health Survey I National both  20+  20+ 7,016 9,323
411 Iran 1994
Rafiei-Sarraf-Zadegan et al., East Mediterr Health J 
1999; 5: 766-77 Community urban  19-70  19-70 1,000 1,200
412 Iran 1999-2000 National Health Survey II Subnational both  20+  20+ 10,874 13,913 1,913 2,699 1,913 2,699
413 Iran 1999-2001 Tehran Lipid and Glucose Study Community urban  18+  18+ 4,470 6,212 4,461 6,199 4,460 6,199
414 Iran 2001 Isfahan Healthy Heart Program, Arak rural Community rural  19-80  19-80 1,028 1,091 1,028 1,091 1,028 1,091
415 Iran 2001 Isfahan Healthy Heart Program, Arak urban Community urban  19-80  19-80 2,089 2,131 2,089 2,131 2,089 2,131
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416 Iran 2001 Isfahan Healthy Heart Program, Isfahan rural Community rural  19-80  19-80 234 237 234 238 234 237
417 Iran 2001 Isfahan Healthy Heart Program, Isfahan urban Community urban  19-80  19-80 1,782 1,932 1,782 1,932 1,782 1,932
418 Iran 2001 Isfahan Healthy Heart Program, Najaf Abad rural Community rural  19-80  19-80 409 419 409 419 409 419
419 Iran 2001 Isfahan Healthy Heart Program, Najaf Abad urban Community urban  19-80  19-79 581 578 581 578 581 578
420 Iran 2003-2004
Childhood and Adolescence Surveillance and 
Prevention of Adult Noncommunicable Disease 
(CASPIAN) National both  18-18  18-18 60 77 60 77 60 77
421 Iran 2003-2004 The Persian Gulf Healthy Heart Study Subnational urban  25-75  25-75 1,734 1,968 1,723 1,955 1,723 1,954
422 Iran 2002-2005 Tehran Lipid and Glucose Study Community urban  18+  18+ 2,177 2,904 2,167 2,896 2,167 2,896
423 Iran 2005
Provincial Non-Communicable Disease Surveillance 
Survey 2005 National both  25-64  25-64 23,538 25,072
424 Iran 2007 Isfahan Healthy Heart Program, Arak rural Community rural  19-80  19-80 1,030 1,028 1,030 1,028 1,030 1,028
425 Iran 2007 Isfahan Healthy Heart Program, Arak urban Community urban  19-80  19-80 1,429 1,366 1,429 1,366 1,429 1,366
426 Iran 2007 Isfahan Healthy Heart Program, Isfahan rural Community rural  19-80  19-80 158 153 158 153 158 153
427 Iran 2007 Isfahan Healthy Heart Program, Isfahan urban Community urban  19-80  19-80 1,415 1,436 1,415 1,436 1,415 1,436
428 Iran 2007 Isfahan Healthy Heart Program, Najaf Abad rural Community rural  19-79  19-80 255 254 255 254 255 254
429 Iran 2007 Isfahan Healthy Heart Program, Najaf Abad urban Community urban  19-80  19-80 498 544 498 544 498 544
430 Iran 2007
National Non-Communicable Disease Surveillance 
Survey 2007 National both  25-64  25-64 1,449 1,549 1,433 1,539 1,432 1,539
431 Iran 2007
Provincial Non-Communicable Disease Surveillance 
Survey 2007 National both  25-64  25-64 9,031 9,714 9,027 9,735 8,982 9,677
432 Iran 2005-2008 Tehran Lipid and Glucose Study Community urban  18+  18+ 2,540 3,360 2,538 3,357 2,538 3,356
433 Iran 2008-2010 Amol county study Community rural  18+  18+ 1,676 1,017 1,676 1,017 1,676 1,017
434 Iran 2008-2010 Amol county study Community urban  18+  18+ 1,515 1,468 1,422 1,384 1,421 1,384
435 Iran 2008-2010 Tehran city study Community urban  20+  20+ 388 500 385 499 385 499
436 Iran 2008-2009 Zahedan city study Community urban  20+  20+ 1,069 1,009 1,069 1,009 1,069 1,009
437 Iran 2009-2010
Childhood and Adolescence Surveillance and 
Prevention of Adult Noncommunicable Disease 
(CASPIAN) National both  18-18  18-18 426 428 348 340 346 337
438 Iran 2009-2010 The Persian Gulf Healthy Heart Study Subnational urban  31-79  31-79 832 1,012 833 1,011 831 1,011
439 Iran 2008-2011 Tehran Lipid and Glucose Study Community urban  20+  20+ 4,722 6,038 4,718 6,037 4,718 6,037
440 Iran 2010-2012 Golestan Cohort Study Second Phase Subnational rural  43-82  43-82 4,310 4,900 4,297 4,895 4,294 4,886
441 Iran 2010-2012 Golestan Cohort Study Second Phase Community urban  43-82  43-82 1,082 1,056 1,083 1,056 1,081 1,055
442 Iran 2011
Provincial Non-Communicable Disease Surveillance 
Survey 2011 National both  25-69  25-69 1,975 3,263 1,973 3,263 1,972 3,258
443 Iran 2012-2014 Pars Cohort Study Community rural  40-90  40-90 4,268 4,981 4,267 4,980 4,267 4,980
444 Iran 2013-2014 Bushehr Elderly Health Program (BEH) Community urban  60+  60+ 1,451 1,543 1,452 1,544 1,450 1,543
445 Iran 2014-2015
Childhood and Adolescence Surveillance and 
Prevention of Adult Noncommunicable Disease 
(CASPIAN) National both  18-18  18-18 88 88 88 88 88 88
446 Iran 2014-2016 The PERSIAN Fasa Cohort Study Community both  35-70  35-70 4,414 5,337 4,416 5,339 4,413 5,337
447 Iran 2014-2016 The PERSIAN Guilan Cohort Study Community both  35-70  35-70 4,873 5,607 4,874 5,607 4,873 5,607
448 Iran 2014-2016 The PERSIAN Kermanshah Cohort Study Community both  35-69  35-69 4,725 5,149 4,727 5,150 4,724 5,149
449 Iran 2014-2016 The PERSIAN Kharameh Cohort Study Community both  35-70  35-70 4,688 5,821 4,683 5,815 4,682 5,812
450 Iran 2014-2016 The PERSIAN Tabriz Cohort Study Community both  35-70  35-70 6,639 8,140 6,640 8,141 6,639 8,138
451 Iran 2016 Iran STEPS 2016 National both  25+  25+ 9,009 10,372 9,008 10,367 8,999 10,361
452 Iran 2016-2018 The PERSIAN BandarKong Cohort Study Community both  35-70  35-70 1,700 2,257 1,701 2,256 1,700 2,256
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453 Iran 2016-2017 IraPEN Study Community rural  30+  30+ 2,788 3,097 LipidPro
454 Iran 2016-2018 The PERSIAN Urmia Cohort Study Community both  35-70  35-70 2,188 2,834 2,188 2,831 2,188 2,831
455 Iran 2016-2019 The PERSIAN Ardabil Cohort Study Community both  35-70  35-70 5,354 6,514 5,355 6,514 5,354 6,514
456 Iran 2018-2019
Prevalence of risk factors for cardiovascular disease 
among a rural population in eastern Iran Subnational rural  18-79  18+ 152 145
457 Iran 2017-2018 The PERSIAN Kavar Cohort Study Community urban  35-70  35-70 2,386 2,506 2,373 2,479 2,372 2,477
458 Iran 2017-2019 The PERSIAN Mashhad Cohort Study Community both  35-70  35-69 2,257 2,603 2,255 2,604 2,255 2,603
459 Iran 2016-2019 The PERSIAN Shahrekord Cohort Study Community both  35-70  35-70 4,273 4,532 4,274 4,531 4,272 4,531
460 Iraq 2005-2006 STEPS National both  25-64  25-64 1,819 2,381
461 Iraq 2015 STEPS National both  18+  18+ 1,510 2,198 1,517 2,199 1,505 2,189
462 Ireland 1998
Survey of Lifestyle, Attitudes and Nutritional in Ireland 
1998 National both  18+  18+ 120 277 113 264 113 264
463 Ireland 2002
Survey of Lifestyle, Attitudes and Nutritional in Ireland 
2002 National both  18-79  18+ 153 191 153 191 153 191
464 Ireland 2006-2007
Survey of Lifestyle, Attitudes and Nutritional in Ireland 
2006-2007 National both  45-79  45-79 514 648 511 648 511 647
465 Ireland 2008-2010 National Adult Nutrition Survey National both  18+  18+ 569 562 567 556 567 556
466 Ireland 2009-2011 The Irish Longitudinal Study on Ageing National both  50+  50+ 2,606 3,017 2,607 3,017 2,606 3,017
467 Israel 1985-1986 MONICA, Tel Aviv Community urban  25-64  25-64 391 361 384 359 384 359
468 Israel 1990-1991 The Jerusalem Longitudinal Cohort Study Community urban  69-70  69-70 245 207
469 Israel 1997-1998 The Jerusalem Longitudinal Cohort Study Community urban  76-77  76-77 248 234 243 232 242 231
470 Israel 1999-2005
The Israel Glucose Intolerance, Obesity and 
Hypertention Study National urban  58+  58+ 497 477 493 474 493 474
471 Israel 2002-2009 Hadera District Study Subnational urban  25-78  25-78 383 374 382 374 382 374
472 Israel 2005-2006 The Jerusalem Longitudinal Cohort Study Community urban  83-85  83-85 312 385 309 380 308 380
473 Italy 1981 Gualandri et al., Metabolism 1985; 34: 212-21 Community urban  25-84  25-84 271 302
474 Italy 1982-1987 MONICA, Latina Community both  24-66  24-66 845 861 846 858 845 858
475 Italy 1985 Finland, Italy, Netherlands, Elderly (Fine-Italy) Community rural  65-84 680 679 679
476 Italy 1986 MONICA, Friuli Subnational urban  25-64  25-64 924 915 920 905 920 904
477 Italy 1987 Palli et al., Eur J Nutr 1999; 38: 90-8 Subnational urban  30-64  30-64 331 245
478 Italy 1986-1987 MONICA-Brianza survey Subnational urban  25-64  25-64 816 831 816 832 815 830
479 Italy 1989 MONICA, Friuli Subnational urban  25-64  25-64 895 896 893 896 890 893
480 Italy 1989 Ventimiglia Heart Study Community rural  20+  20+ 482 587 482 586 480 586
481 Italy 1990 Bruneck Study Community rural  40-79  40-79 468 450 468 450 468 450
482 Italy 1983-1996
Malattie cardiovascolari ATerosclerotiche Istituto 
Superiore di Sanità Community rural  18-77  18-77 3,954 4,475 3,951 4,473 3,950 4,472
483 Italy 1989-1990 MONICA-Brianza survey Subnational urban  25-64  25-64 794 786 795 786 793 786
484 Italy 1992-1993 Italian Longitudinal Study on Aging National both  65-84  65-84 1,713 1,580 1,717 1,566 1,697 1,560
485 Italy 1994 MONICA, Friuli Subnational urban  25-64  25-64 881 887 880 886 880 885
486 Italy 1993-1994 MONICA-Brianza survey Subnational urban  25-64  25-64 808 864 808 863 807 863
487 Italy 1995 Vobarno Study   Community both  35-64  35-64 265 309
488 Italy 1995 Bruneck Study Community rural  45-84  45-84 412 412 412 412 412 412
489 Italy 1995-1996 Italian Longitudinal Study on Aging National both  68-90  68-90 1,049 925 1,025 902 1,023 902
490 Italy 1995-1999 PROgetto Veneto Anziani (PROVA) Subnational both  65+  65+ 1,225 1,832 1,222 1,824 1,218 1,824
491 Italy 1999
InCHIANTI; Antonelli-Incalzi et al., Atherosclerosis 
2006; 186: 200-6 Community both  25+  25+ 582 725
492 Italy 1998-1999 progetto VIP Community both  25-74  25-74 582 589 564 560 563 559
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493 Italy 2000 Bruneck Study Community rural  50-89  50-89 331 361 331 361 331 361
494 Italy 1998-2002 Osservatorio Epidemiologico Cardiovascolare National both  35-74  35-74 4,831 4,705 4,836 4,711 4,828 4,704
495 Italy 2000-2001 Italian Longitudinal Study on Aging National both  73-93  73-93 695 681 684 672 683 672
496 Italy 2002
Vobarno Study; Muiesan et al., Blood Press 2006; 15: 
14-9 Community both  35-74  35-74 168 212
497 Italy 2001-2003 The Study of Asti Community both  45-64  45-64 780 878 780 878 780 878
498 Italy 2000-2003 PROgetto Veneto Anziani (PROVA) Subnational both  67+  67+ 789 1,334 658 1,113 657 1,111
499 Italy 2003 The European Male Ageing Study Community both  40+ 433 433 433
500 Italy 2002-2005 PROgetto Veneto Anziani (PROVA) Subnational both  70+  70+ 557 1,028 559 1,023 557 1,022
501 Italy 2005 Bruneck Study Community rural  55-93  55-93 264 307 264 307 264 307
502 Italy 2004-2005
Italian Project on the Epidemiology of Alzheimer's 
Disease National both  65-84  65-84 1,349 1,196
503 Italy 2004-2005 Vobarno study Community rural  55-74  55-74 99 112 96 110 96 110
504 Italy 2005-2007 Moli-family Study Subnational both  18+  18+ 216 270 216 270 216 270
505 Italy 2008 The European Male Ageing Study Community both  40+ 288 289 288
506 Italy 2005-2010 Moli-sani Study Subnational both  35+  35+ 11,621 12,550 11,620 12,551 11,618 12,549
507 Italy 2008-2009 progetto VIP Community both  25-74  25-74 600 599 600 599 600 599
508 Italy 2010 Bruneck Study Community rural  60-98  60-98 225 259 225 259 225 259
509 Italy 2009-2010 Grosso et al., J Epidemiol. 2014; 24: 327-33 Community both  19+  19+ 760 1,129 760 1,129 760 1,129
510 Italy 2008-2012
Osservatorio Epidemiologico Cardiovascolare/Health 
Examination Survey National both  35-80  35-80 4,331 4,302 4,332 4,301 4,330 4,301
511 Italy 2010-2012
CArdiovascular risk MEtabolic syndrome LIver and 
Autoimmunity diseases (CA.ME.LI.A) Community both  18-75  18-75 477 514 476 515 476 514
512 Italy 2011-2012 Vobarno study Community rural  49-62  49-62 107 142 106 142 106 142
513 Italy 2015 Bruneck Study Community rural  65-98  65-98 168 163 168 163 168 163
514 Italy 2016 EVA Tyrol Study South Italy Subnational both  18-18 2 2 2
515 Italy 2018-2019 progetto VIP Community both  25-74  25-74 600 598 599 598 599 598
516 Jamaica 2000-2001 Jamaica Health and Lifestyle Survey National both  18-74  18-74 362 865 Accutrend
517 Jamaica 2006-2007
Jamaica Youth Risk and Resiliency Behaviour Survey 
2006 National both  18-19  18-19 5 21 Accutrend
518 Jamaica 2007-2008 Jamaica Health and Lifestyle Survey National both  18-74  18-74 442 1,207 Accutrend
519 Jamaica 2012 Older Persons in Jamaica 2012 National both  60+  60+ 158 206 158 206 158 206 5
520 Japan 1980 APCSC-Hisayama   Community urban  20+  20+ 5,018 3,760
521 Japan 1980 National Cardiovascular Survey National both  30+  30+ 4,689 5,973
522 Japan 1981 APCSC-Hisayama   Community urban  40-69  40-69 820 1,074
523 Japan 1980-1983 Aito Town Study Community rural  20-77  20-77 725 946 442 449 442 449
524 Japan 1985-1986 Akabane Study Community urban  40-69  40-69 812 1,022 812 1,022 812 1,022
525 Japan 1987 Konan Town Study Community rural  20-79  20-79 69 88 69 88 69 88
526 Japan 1988 Konan Town Study Community rural  20-79  20-79 76 85 76 85 76 85
527 Japan 1989 Konan Town Study Community rural  20-79  20-79 59 63 59 63 59 63
528 Japan 1988-1990 Miyama Cohort Study Community rural  40-80  40-80 157 256 153 255 153 255
529 Japan 1989 National Nutrition Survey National both  30+  30+ 2,706 4,037 2,704 4,036 2,703 4,036
530 Japan 1990
Serum Lipid Survey; Yamamoto et al., J Atheroscler 
Thromb 2003; 10: 176-85 National both  20+  20+ 17,424 11,917
531 Japan 1990 Konan Town Study Community rural  20-79  20-79 30 58 30 58 30 58
532 Japan 1990
National Nutrition Survey and National Cardiovascular 
Survey National both  30+  30+ 3,303 4,591 3,301 4,591 3,301 4,591
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533 Japan 1991 Konan Town Study Community rural  20-79  20-79 93 117 93 117 93 117
534 Japan 1991 Shigaraki Town Study Community rural  30-89  30-89 233 330 233 330 233 330
535 Japan 1991 National Nutrition Survey National both  20+  20+ 3,386 4,761 3,385 4,760 3,385 4,760
536 Japan 1992 Konan Town Study Community rural  20-79  20-79 55 52 55 52 55 52
537 Japan 1992 Shigaraki Town Study Community rural  30-89  30-89 288 387 288 387 288 387
538 Japan 1990-1994
Japan Public Health Center-based prospective Study 
(JPHC Study), Cohort I Subnational both  40-59  40-59 8,762 14,504 2,856 3,708 2,851 3,702
539 Japan 1992 National Nutrition Survey National both  30+  30+ 2,838 4,086 2,838 4,086 2,838 4,086
540 Japan 1993 Fukuda et al., Hypertens Res 2002; 25: 179-84 Community rural  35+  35-84 669 1,228
541 Japan 1993 Konan Town Study Community rural  20-79  20-79 54 65 54 65 54 65
542 Japan 1993 Shigaraki Town Study Community rural  30-89  30-89 300 453 300 453 300 453
543 Japan 1993 National Nutrition Survey National both  30+  30+ 2,559 3,791 2,560 3,791 2,559 3,791
544 Japan 1993-1994
Japan Public Health Center-based prospective Study 
(JPHC Study), Cohort II Subnational both  40-69  40-69 8,557 16,214 8,549 16,207 8,549 16,206
545 Japan 1994 Konan Town Study Community rural  20-79  20-79 42 59 42 59 42 59
546 Japan 1994 Shigaraki Town Study Community rural  30-89  30-89 251 336 251 336 251 336
547 Japan 1994 National Nutrition Survey National both  20-59  20-59 1,785 2,811 1,785 2,811 1,785 2,811
548 Japan 1995 Konan Town Study Community rural  20-79  20-79 45 60 45 60 45 60
549 Japan 1995 Shigaraki Town Study Community rural  30-89  30-89 297 470 297 470 297 470
550 Japan 1995 National Nutrition Survey National both  20-59  20-59 1,710 2,775 1,710 2,775 1,710 2,775
551 Japan 1996 Shigaraki Town Study Community rural  30-79  30-89 85 152 85 152 85 152
552 Japan 1996 National Nutrition Survey National both  30+  30+ 2,215 3,423 2,215 3,422 2,215 3,422
553 Japan 1997 Mannami et al., Stroke 2000; 31: 2958-65 Community urban  30-89  30-89 2,033 2,354
554 Japan 1997 Shigaraki Town Study Community rural  30-79  30-89 61 100 61 100 61 100
555 Japan 1997 National Nutrition Survey National both  20+  20+ 2,517 3,807 2,516 3,807 2,516 3,807
556 Japan 1998 Niigata Study Community urban  70-70  70-70 304 290
557 Japan 1998 National Nutrition Survey National both  20+  20+ 2,643 3,928 2,642 3,928 2,642 3,928
558 Japan 1999 Niigata Study Community urban  71-71  71-71 242 214 242 214 242 214
559 Japan 1999 National Nutrition Survey National both  20+  20+ 2,061 3,205 2,060 3,205 2,060 3,205
560 Japan 2000 Niigata Study Community urban  72-72  72-72 233 199 233 199 233 199
561 Japan 2000
National Nutrition Survey and National Cardiovascular 
Survey National both  20+  20+ 2,285 3,280 2,285 3,280 2,284 3,280
562 Japan 2001 The Japan Association of Health Service Database Subnational both  20+  20+ 1,173,802 1,022,217 1,173,802 1,022,217 1,173,802 1,022,217
563 Japan 2001 Niigata Study Community urban  73-73  73-73 235 199 235 199 235 199
564 Japan 2001 National Nutrition Survey National both  20+  20+ 2,132 3,359 2,131 3,359 2,131 3,359
565 Japan 2002 Niigata Study Community urban  74-74  74-74 226 201 226 201 226 201
566 Japan 2002 National Nutrition Survey National both  20+  20+ 2,129 3,154 2,128 3,154 2,128 3,154
567 Japan 2002-2003 The Hisayama Study Community rural  40+  40+ 1,413 1,883 1,413 1,883 1,413 1,883
568 Japan 2003 National Health and Nutrition Survey National both  20+  20+ 2,108 3,170 2,107 3,169 2,107 3,169
569 Japan 2003 Niigata Study Community urban  75-75  75-75 215 191 215 191 215 191
570 Japan 2004 National Health and Nutrition Survey National both  20+  20+ 1,548 2,367 1,547 2,367 1,547 2,367
571 Japan 2004 Niigata Study Community urban  76-76  76-76 213 184 213 184 213 184
572 Japan 2005 Kobayashi et al., Circ J 2007; 71: 1734-7 Subnational urban  25+  25+ 7,339 14,552
573 Japan 2005 National Health and Nutrition Survey National both  20+  20+ 1,557 2,298 1,557 2,298 1,557 2,298
574 Japan 2005 Niigata Study Community urban  77-77  77-77 202 189 202 189 202 189
575 Japan 2006 National Health and Nutrition Survey National both  20+  20+ 1,753 2,549 1,753 2,549 1,753 2,549
576 Japan 2006 Niigata Study Community urban  78-78  78-78 195 195 195 195 195 195
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577 Japan 2007 National Health and Nutrition Survey National both  20+  20+ 1,625 2,376 1,625 2,376 1,625 2,376
578 Japan 2007 Niigata Study Community urban  79-79  79-79 182 193 182 193 182 193
579 Japan 2008 Kobayashi J, 2008 Community both  40+  40+ 6,562 11,944
580 Japan 2008 National Health and Nutrition Survey National both  20+  20+ 1,818 2,620 1,817 2,620 1,817 2,620
581 Japan 2008 Niigata Study Community urban  80-80  80-80 169 176 169 176 169 176
582 Japan 2009 National Health and Nutrition Survey National both  20+  20+ 1,736 2,538 1,735 2,538 1,735 2,538
583 Japan 2010 National Health and Nutrition Survey National both  20+  20+ 1,597 2,254 1,597 2,254 1,597 2,254
584 Japan 2011 National Health and Nutrition Survey National both  20+  20+ 1,463 2,082 1,463 2,082 1,463 2,082
585 Japan 2011 The Tokyo Health Service Association Database Community urban  20+  20+ 39,350 18,888 69,584 45,216 39,350 18,888
586 Japan 2012 National Health and Nutrition Survey National both  20+  20+ 5,766 8,314 5,766 8,314 5,766 8,314
587 Japan 2013 National Health and Nutrition Survey National both  20+  20+ 1,382 1,905 1,382 1,905 1,382 1,905
588 Japan 2012-2016 The Nagahama Study Community rural  35-79  35-79 3,206 6,619 3,206 6,619 3,206 6,619
589 Japan 2014 National Health and Nutrition Survey National both  20+  20+ 1,473 2,020 1,473 2,020 1,473 2,020
590 Japan 2015 National Health and Nutrition Survey National both  20+  20+ 1,336 1,966 1,336 1,966 1,336 1,966
591 Japan 2016 National Health and Nutrition Survey National both  20+  20+ 4,655 6,696 4,655 6,696 4,655 6,696
592 Japan 2017 National Health and Nutrition Survey National both  20+  20+ 1,212 1,695 1,211 1,695 1,211 1,695
593 Jordan 1995 Jaddou et al., J Hum Hypertens 1996; 10: 815-21 Community urban  25+  25+ 839 1,434
594 Jordan 2004 Behavioural Risk Factor Surveillence Survey National rural  18+  18+ 235 465 235 466 235 463
595 Jordan 2007 Behavioural Risk Factor Surveillence Survey National both  18+  18+ 331 431 330 432 329 431
596 Jordan 2009 Metablic abnomalities and vitamin D study National both  18+  18+ 1,141 3,349 1,134 3,343 1,133 3,342
597 Jordan 2016-2017
National Cardiovascular Diseases and Diabetes Study 
(NCDDS) National both  18+  18+ 1,182 2,735 1,179 2,734 1,178 2,734
598 Kazakhstan 2015 Almaty STEPS Subnational both  18-69  18-69 382 1,145 381 1,145 381 1,145
599 Kazakhstan 2015 Shymkent STEPS Subnational both  18-69  18-69 349 803 360 830 343 795
600 Kazakhstan 2015-2016 Aktobe STEPS Subnational both  18-69  18-69 334 1,143 335 1,143 330 1,138
601 Kenya 2015 STEPS National both  18-69  18-69 1,103 1,905 1,585 2,327 1,065 1,859 CardioChek CardioChek
602 Kiribati 1981 Epidemiological survey of Kiribati Subnational rural  20+  20+ 467 522
603 Kiribati 1981 Epidemiological survey of Kiribati Subnational urban  20+  20+ 915 875
604 Kiribati 2004 STEPS National both  20-64  18-64 266 437 Accutrend
605 Kiribati 2015-2016 STEPS National both  18-69  18-69 374 534 402 524 311 455 CardioChek CardioChek
606 Kuwait 2006 STEPS National both  20-64  20-64 914 1,296 912 1,296 912 1,296
607 Kuwait 2011-2014 Kuwait Diabetes Epidemiology Program National urban  18+  18+ 2,781 2,148 2,772 2,146 2,772 2,146
608 Kuwait 2014 STEPS National both  18-69  18-69 995 1,619 993 1,617 993 1,617
609 Kyrgyzstan 2013 STEPS National both  25-64  25-64 881 1,543 CardioChek
610 Lao PDR 2013 STEPS National both  18-64  18-64 834 1,368 947 1,426 822 1,353 CardioChek CardioChek
611 Latvia 2008-2009 Cardiovascular risk factor study National both  25-74  25-74 1,368 2,413 1,368 2,413 1,365 2,411
612 Lebanon 2017 STEPS National both  18-69  18-69 446 747 446 747 446 747
613 Lesotho 2012 STEPS National both  25-64  25-64 463 1,114 659 1,287 431 1,053 CardioChek CardioChek
614 Libya 1999 Kadiki et al., Diabetes Metab 2001; 27: 647-54 Community both  25-84  25-84 182 334
615 Libya 1999 Buysschaert et al., Diabetes Metab 2001; 27: 655-9 Community urban  25-74  25-74 150 241
616 Libya 2009 STEPS National both  25-64  25-64 857 668 Accutrend
617 Lithuania 1983-1985 MONICA, Kaunas Community urban  35-64  35-64 727 735 667 625 666 625
618 Lithuania 1987
Countrywide Integrated Noncommunicable Diseases 
Intervention Programme survey Subnational rural  25-64  25-64 963 1,075 887 1,019 886 1,019
619 Lithuania 1986-1987 MONICA, Kaunas Community urban  35-64  35-64 848 840 814 808 814 808
620 Lithuania 1992-1993 MONICA, Kaunas Community urban  35-64  35-64 596 613 572 583 571 582
18









Age range as used 
for global analysis
Sample size as used for 
global analysis
(Total cholesterol)
Sample size as used for 
global analysis
(HDL cholesterol)














Countrywide Integrated Noncommunicable Diseases 
Intervention Programme survey Subnational rural  25-64  25-64 645 820 552 712 551 712
622 Lithuania 1998-1999
Countrywide Integrated Noncommunicable Diseases 
Intervention Programme survey Subnational rural  25-64  25-64 784 975 769 949 769 949
623 Lithuania 2001-2002 MONICA4 Community urban  35-64  35-64 622 776 603 723 603 723
624 Lithuania 2006-2007
Countrywide Integrated Noncommunicable Diseases 
Intervention Programme survey Subnational rural  25-64  25-64 718 971 718 972 718 971
625 Lithuania 2006-2008 MONICA4 Follow-up Community urban  45-69  45-69 317 424 314 415 314 415
626 Luxembourg 2007-2009
Observation des Risques et de la Santé Cardio-
Vasculaire au Luxembourg (ORISCAV-LUX) National both  18-69  18-69 696 731 696 731 696 731
627 Malawi 2009
Malawi Longitudinal Study of Families and Health 
(MLSFH) Subnational rural  18+  18+ 274 480 274 480 274 480
628 Malawi 2009 STEPS National both  25-64  25-64 538 1,222 Accutrend
629 Malawi 2017 STEPS National both  18-69  18-69 985 2,018 CardioChek
630 Malaysia 1996 National Health and Morbidity Survey (NHMS) National both  30+  20+ 6,861 8,379 Accutrend
631 Malaysia 2004 Rampal et al., Public Health 2008; 122: 11-8 National both  18+  18+ 4,050 6,326 4,050 6,326 4,050 6,326
632 Malaysia 2006 National Health and Morbidity Survey (NHMS) National both  18+  18+ 9,134 12,506 Accutrend
633 Malaysia 2008 Metabolic Syndrome Study in Malaysia National rural  18+  18+ 736 1,334 737 1,334 734 1,333
634 Malaysia 2008 Metabolic Syndrome Study in Malaysia National urban  18+  18+ 747 1,416 740 1,406 740 1,401
635 Malaysia 2011 National Health and Morbidity Survey (NHMS) National both  18+  18+ 7,480 8,696 CardioChek
636 Malaysia 2015 National Health and Morbidity Survey (NHMS) National both  18+  18+ 8,794 9,534
637 Malta 1984 MONICA, Malta Community urban  25-64  25-64 657 635 654 637 652 631
638 Marshall Islands 2002 STEPS National both  18-64  18-64 381 531 376 529 376 529
639 Mauritania 2006 STEPS Community urban  18-64  18-64 1,036 1,187
640 Mauritius 1987 Mauritius non communicable disease survey National both  25-74  25-74 2,326 2,639 2,335 2,649 2,319 2,636
641 Mauritius 1992 Mauritius non communicable disease survey National both  25-74  25-74 2,988 3,480 2,976 3,474 2,975 3,474
642 Mauritius 1998 Mauritius non communicable disease survey National both  25-74  25-74 2,560 3,245
643 Mauritius 2009 Mauritius non communicable disease survey National both  20-74  20-74 2,889 3,424 2,883 3,425 2,881 3,424
644 Mexico 1988 Encuesta Nacional de Seroepidemiologia National both  18+  18+ 7,014 12,541
645 Mexico 1990-1992 Mexico City Diabetes Study Community urban  30-69  30-79 941 1,341 929 1,335 929 1,335
646 Mexico 1992-1993 Encuesta Nacional de Enfermedades Cronicas National urban  20-69  20-69 5,700 7,724 5,672 7,714 5,668 7,709
647 Mexico 1993-1995 Mexico City Diabetes Study Community urban  34-69  34-79 707 1,034 688 1,029 688 1,029
648 Mexico 1997-1999 Mexico City Diabetes Study Community urban  37-79  40-79 701 982 683 963 683 963
649 Mexico 2004-2005
CArdiovascular Risk factors Multiple Evaluation in 
Latin America (CARMELA) Community urban  25-64  25-64 833 889 833 889 833 889
650 Mexico 2006 Encuesta Nacional de Salud y Nutricion National both  20+  20+ 3,168 5,066 3,740 5,935 3,151 5,045
651 Mexico 2006 PREVENIMSS National Coverage Surveys Subnational both  20+  20+ 6,030 7,632 Accutrend
652 Mexico 2007-2009 Mexico City Diabetes Study Community urban  51+  51+ 460 711
653 Mexico 2009-2012
Encuesta Nacional Sobre Niveles de vida de los 
Hogares National both  18+  18+ 2,811 3,925 3,916 4,816 2,752 3,878 CardioChek CardioChek
654 Mexico 2011-2012 Encuesta Nacional de Salud y Nutricion National both  20+  20+ 4,146 6,249 4,144 6,243 4,142 6,240
655 Mexico 2012 The Mexican Health and Aging Study National both  50+  50+ 770 1,082 770 1,082 770 1,082
656 Mexico 2016 Encuesta Nacional de Salud y Nutricion National both  20+  20+ 1,373 2,597 1,366 2,595 1,366 2,595
657 Micronesia (Federated States of) 2002 STEPS Subnational both  25-64  25-64 274 419 258 388 258 384
658 Micronesia (Federated States of) 2006 STEPS Subnational both  20-64  20-64 144 389 Accutrend
659 Micronesia (Federated States of) 2008 STEPS Subnational both  25-64  25-64 278 449 Accutrend
660 Micronesia (Federated States of) 2009 STEPS Subnational both  18-64  18-64 210 295 Accutrend
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661 Micronesia (Federated States of) 2016 STEPS Subnational both  18-69  18-69 468 763 CardioChek
662 Moldova 2013 STEPS National both  18-69  18-69 1,313 2,305 1,254 2,250 1,215 2,201 CardioChek CardioChek
663 Mongolia 2005 STEPS National both  20-64  18-64 322 348 Accutrend
664 Mongolia 2009 STEPS National both  18-64  18-64 520 751 706 995 506 731 Accutrend
665 Mongolia 2013 STEPS National both  18-64  18-64 801 1,057 882 1,085 791 1,033 Multicare
666 Morocco 2017 STEPS National both  18+  18+ 1,133 2,413 1,517 2,825 1,120 2,383 CardioChek CardioChek
667 Mozambique 2014-2015 STEPS National both  18-64  18-64 545 977 649 1,049 501 912 CardioChek CardioChek
668 Myanmar 2003-2004 STEPS Subnational both  25-74  25-74 1,917 2,342 1,905 2,338 1,904 2,338
669 Myanmar 2014 STEPS National both  25-64  25-64 2,797 5,317 2,611 5,222 2,517 5,148 LipidoCare LipidoCare
670 Myanmar 2013-2014 STEPS, Yangon Subnational both  25-74  25-74 675 687 673 687 673 687
671 Namibia 2009 Okambilimbili Survey Community urban  18+  18+ 435 595 Accutrend
672 Nauru 1982
Trends in the prevalence and incidence of non-insulin-
dependent diabetes mellitus and impaired glucose 
tolerance National both  20+  20+ 700 773
673 Nauru 1987
Trends in the prevalence and incidence of non-insulin-
dependent diabetes mellitus and impaired glucose 
tolerance National both  20+  20+ 557 667
674 Nauru 1994
Trends in the prevalence and incidence of non-insulin-
dependent diabetes mellitus and impaired glucose 
tolerance National both  25+  25+ 658 744
675 Nauru 2004 STEPS National both  18-64  18-64 1,015 1,080
676 Nepal 2006-2011
Early detection and management of Kidney disease, 
Hypertension, Diabetes and Cardiovascular disease 
(KHDC Nepal), Tarahara Community rural  18+  18+ 1,175 2,347 308 671 308 671
677 Nepal 2006-2011
Early detection and management of Kidney disease, 
Hypertension, Diabetes and Cardiovascular disease 
(KHDC Nepal), Damak Community urban  18+  18+ 1,074 1,547 474 739 473 737
678 Nepal 2006-2011
Early detection and management of Kidney disease, 
Hypertension, Diabetes and Cardiovascular disease 
(KHDC Nepal), Dharan Community urban  18+  18+ 2,173 3,071 60 33 60 33
679 Nepal 2013 STEPS National both  18-69  18-69 1,155 2,486 1,153 2,487 1,153 2,483
680 Nepal 2015
Community based intervention for prevention and 
control of non-communicable diseases risk factors 
(CIPCON) baseline survey, Dhankuta Subnational rural  18-69  18-69 387 629 CardioChek
681 Nepal 2015
Community based intervention for prevention and 
control of non-communicable diseases risk factors 
(CIPCON) baseline survey, Ilam Subnational rural  18-69  18-69 255 366 CardioChek
682 Nepal 2016-2018
The Population Based Prevalence of Selected Non-
Communicable Diseases In Nepal National both  20+  20+ 4,274 6,780 4,286 6,807 4,263 6,765
683 Netherlands 1985 Zutphen Elderly Study Community urban  65-85 886 886 886
684 Netherlands 1990 Zutphen Elderly Study Community urban  69-90 555 555 555
685 Netherlands 1989-1993 the Rotterdam Study, first subcohort Community urban  55+  55+ 2,825 4,214 2,814 4,194 2,813 4,194
686 Netherlands 1992-1993 The Longitudinal Aging Study Amsterdam (LASA) Subnational both  55-85  55-85 756 751 374 396 374 396 6
687 Netherlands 1993-1997 PROSPECT-EPIC Subnational both  50-69 15,849 15,849 15,849
688 Netherlands 1995-1996 The Longitudinal Aging Study Amsterdam (LASA) Subnational both  65-88  65-88 635 671 193 208 193 208 6
689 Netherlands 1997-1999 the Rotterdam Study, first subcohort Community urban  61+  61+ 1,684 2,313 1,656 2,264 1,656 2,264
690 Netherlands 1998-2001 Regenboog Project National both  18-89  18-89 2,406 2,276 2,404 2,276 2,404 2,276
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691 Netherlands 2000-2001 the Rotterdam Study, second subcohort Community urban  55+  55+ 1,177 1,417 1,177 1,417 1,177 1,417
692 Netherlands 2001-2003
Surinamese in the Netherlands: Study on Ethnicity and 
Health (SUNSET) Community urban  35-60  35-60 249 254 248 254 248 254
693 Netherlands 2002-2003 The Longitudinal Aging Study Amsterdam (LASA) Subnational both  54-65  54-65 341 403 121 162 121 162 6
694 Netherlands 2002-2004 the Rotterdam Study, first subcohort Community urban  65+  65+ 1,226 1,736 1,226 1,736 1,226 1,736
695 Netherlands 2004-2005 the Rotterdam Study, second subcohort Community urban  58+  58+ 964 1,242 963 1,242 963 1,242
696 Netherlands 2006-2008 the Rotterdam Study, third subcohort Community urban  45+  45+ 1,547 2,006 1,545 2,006 1,545 2,006
697 Netherlands 2008-2009 The Longitudinal Aging Study Amsterdam (LASA) Subnational both  60-100  60-100 432 491 6
698 Netherlands 2009-2010 Measuring the Netherlands (NL de Maat) Subnational both  30-69  30-69 1,760 1,950 1,760 1,950 1,760 1,950
699 Netherlands 2009-2011 the Rotterdam Study, first subcohort Community urban  72+  72+ 661 955 661 955 661 955
700 Netherlands 2011-2012 the Rotterdam Study, second subcohort Community urban  65+  65+ 721 903 721 903 721 903
701 Netherlands 2011-2015 Healthy Life in an Urban Setting (HELIUS) Community urban  18-71  18-71 2,081 2,461 2,080 2,461 2,080 2,460
702 Netherlands 2012-2014 the Rotterdam Study, third subcohort Community urban  51+  51+ 1,227 1,593 1,228 1,593 1,227 1,593
703 New Zealand 1982 MONICA, Auckland Community urban  35-64  35-64 1,005 562 867 522 867 521
704 New Zealand 1989 The Life in New Zealand Survey National both  15+  15+ 1,418 1,571 1
705 New Zealand 1993-1994 MONICA, Auckland Community urban  35-64  35-64 744 720 741 715 741 715
706 New Zealand 1994 Bullen et al., N Z Med J 1998; 111: 4-7 Community urban  65-84  65-84 476 510
707 New Zealand 1996-1997 National Nutrition Survey National both  15+  15+ 1,428 1,763 1,427 1,760 1,426 1,759 1
708 New Zealand 2002-2003 Diabetes, Heart and Health Survey Subnational urban  35-84  35-84 1,920 2,086 1,917 2,086 1,917 2,086
709 New Zealand 2008-2009 2008/09 New Zealand Adult Nutrition Survey National both  15+  15+ 1,444 1,865 1,443 1,865 1,443 1,864 1
710 Nicaragua 2003-2004 CAMDI Community urban  20+  20+ 780 919
711 Nigeria 1990 Non-communicable Diseases National Survey National both  15+  15+ 7,857 7,207 1
712 Nigeria 1996 Okesina et al., East Afr Med J 1999; 76: 212-6 Community rural  21-50  21-40 205 96
713 Niue 2011 STEPS National both  18+  18+ 291 345 Accutrend
714 Norway 1979-1980 The Tromsø Study: Tromsø 2 Community both  20-54  20-49 8,447 7,888 8,424 7,881 8,424 7,880
715 Norway 1986-1987 The Tromsø Study: Tromsø 3 Community both  20-61  20-56 10,369 9,805 10,358 9,803 10,353 9,799
716 Norway 1992-1993
The Hordaland Health Study (HUSK) 1925-1927 birth 
cohort Community urban  65-67  65-67 2,127 2,636
717 Norway 1992-1993
The Hordaland Health Study (HUSK) 1928-1949 birth 
cohort Community urban  43-64  43-64 335 348
718 Norway 1992-1993
The Hordaland Health Study (HUSK) 1950-1952 birth 
cohort Subnational both  40-42  40-42 6,113 6,481
719 Norway 1994-1995 The Tromsø Study: Tromsø 4 Community both  25+  25+ 12,780 13,843 12,753 13,826 12,747 13,819
720 Norway 1995-1997 HUNT2 study Subnational rural  20+  20+ 30,370 34,567 30,349 34,561 30,349 34,560
721 Norway 1997-1999
The Hordaland Health Study (HUSK) 1925-1927 birth 
cohort Community urban  70-74  70-74 1,468 1,842 1,468 1,842 1,468 1,842
722 Norway 1997-1999
The Hordaland Health Study (HUSK) 1950-1957 birth 
cohort Subnational both  40-47  40-47 10,165 11,937 10,167 11,936 10,163 11,934
723 Norway 2000-2003
the Oslo cohort (HUBRO), the Oppland and Hedmark 
cohort (OPPHED), and the Troms and Finnmark cohort 
(TROFINN ) of COHORT NORWAY Subnational both  30-76  30-76 16,792 20,241 16,786 20,241 16,784 20,240
724 Norway 2001-2002 The Tromsø Study: Tromsø 5, Tromsø Study Panel Community both  30-89  30-89 2,533 3,582 2,533 3,581 2,533 3,581
725 Norway 2006-2008 HUNT3 Study Subnational rural  20+  20+ 22,351 26,791 22,351 26,791 22,351 26,790
726 Norway 2007-2008 The Tromsø Study: Tromsø 6 Community both  30-87  30-87 5,994 6,809 5,993 6,807 5,993 6,807
727 Occupied Palestinian Territory 1996-1998 Kobar, rural Community rural  30-64  18-64 204 439 205 440 203 436
728 Occupied Palestinian Territory 1996-1998 Old Ramallah, urban Community urban  30-64  18-64 182 456 170 449 170 448
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729 Occupied Palestinian Territory 2010 STEPS National both  18-64  18-64 2,198 3,724 2,198 3,719 2,194 3,714
730 Oman 2008 Gulf Cooperation Council World Health Survey National both  18+  18+ 1,880 1,808 1,805 1,715 1,805 1,715
731 Oman 2017 STEPS National both  18+  18+ 2,744 2,483 3,157 2,713 2,718 2,433 Multicare Multicare
732 Pakistan 1990-1994 National Health Survey Of Pakistan 1990-1994 National both  18+  18+ 3,221 3,937 Reflotron
733 Pakistan 2004 COBRA-1   Community urban  40+  40-84 1,376 1,496
734 Palau 2011-2013 STEPS National both  25-64  25-64 605 651 Accutrend
735 Panama 2010-2011
Prevalencia de factores de riesgo asociados a 
enfermedad cardiovascular 2010-2011 Subnational both  18+  18+ 1,073 2,476 1,073 2,477 1,072 2,476
736 Papua New Guinea 1986 Scrimgeour et al., Pathology 1989; 21: 46-50 Community both  17-59  17-59 43 68 1
737 Peru 2004 Factores de Riesgo de Enfermedades No Transmisibles Community urban  18+  18+ 208 427 208 428 208 427
738 Peru 2004-2005
CArdiovascular Risk factors Multiple Evaluation in 
Latin America (CARMELA) Community urban  25-64  25-64 769 883 769 883 769 883
739 Peru 2004-2005
Encuesta Nacional de Indicadores Nutricionales, 
Bioquímicos, Socioeconómicos y Culturales 
Relacionados con las Enfermedades Crónicas 
Degenerativas (ENIN) National both  20+  20+ 2,039 2,067 2,039 2,067 2,038 2,067
740 Peru 2005 Factores de Riesgo de Enfermedades No Transmisibles Community urban  18+  18+ 199 532 199 532 199 532
741 Peru 2006 Factores de Riesgo de Enfermedades No Transmisibles Community urban  18+  18+ 619 1,056 619 1,056 619 1,056
742 Peru 2007-2008 PERU MIGRANT Study Community both  30+  30+ 465 522 465 522 465 522
743 Peru 2009-2012 CRONICAS Cohort Study Subnational both  35+  35+ 1,518 1,597 1,518 1,597 1,518 1,597
744 Peru 2013
Clinical functional and sociofamilial profiles of the 
elderly from a community in a district of Lima, Peru Community urban  60+  60+ 101 187 101 187 101 187
745 Peru 2013-2014 CRONICAS Cohort Study Subnational both  36+  36+ 1,240 1,285 1,241 1,285 1,240 1,285
746 Philippines 2003 6th National Nutrition Survey National both  20+  20+ 2,143 2,358 2,141 2,358 2,141 2,358
747 Philippines 2005
Cebu Longitudinal Health and Nutrition Survey 2005 
Child Follow-up Community both  20-22  20-22 933 768 933 768 933 768
748 Philippines 2005
Cebu Longitudinal Health and Nutrition Survey 2005 
Mother Follow-up Community both  35-69 1,882 1,879 1,879
749 Philippines 2013-2014 8th National Nutrition Survey National both  18+  18+ 9,556 10,384 9,370 10,274 9,366 10,273
750 Poland 1983-1984 MONICA, Tarnobrzeg Voivodship Community rural  35-64  35-64 1,225 1,431 1,225 1,431 1,225 1,431
751 Poland 1983-1985 MONICA, Warsaw Community urban  35-64  35-64 1,277 1,292 1,271 1,287 1,270 1,286
752 Poland 1987-1988 MONICA, Tarnobrzeg Voivodship Community rural  35-64  35-64 613 671 613 671 613 671
753 Poland 1988-1989 MONICA, Warsaw Community urban  35-64  35-64 705 706 691 701 691 701
754 Poland 1989-1990 Polish Program CINDI (CINDI Lodz 1989-1990) Community urban  25-64  25-64 824 950
755 Poland 1992-1993 MONICA, Tarnobrzeg Voivodship Community rural  35-64  35-64 619 691 619 691 619 691
756 Poland 1993 MONICA, Warsaw Community urban  35-64  35-64 748 761 742 759 742 759
757 Poland 1995-1996 Polish Program CINDI (CINDI Lodz 1995) Community urban  18-64  18-64 854 1,284 835 1,260 835 1,260
758 Poland 1997 NATPOL National both  18+  18+ 521 547 Accutrend
759 Poland 2000
The health status, risk factors of chronic diseases and 
health behaviors of residents of Torun (CINDI Torun 
2000) Community urban  18-83  18-79 930 1,019 928 1,019 928 1,019
760 Poland 2001-2002
The health status, risk factors of chronic diseases and 
health behaviors of residents of Lodz (CINDI Lodz 
2001) Community urban  18-64  18-64 1,000 837 1,000 836 999 836
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The health status, risk factors of chronic diseases and 
health behaviors of residents of Lodz - seniors (CINDI 
Lodz 2002) Community urban  65+  65+ 288 535 287 534 287 534
762 Poland 2002 NATPOL National both  18+  18+ 1,023 1,303 1,022 1,303 1,022 1,303
763 Poland 2003 The European Male Ageing Study Community both  40+ 408 408 408
764 Poland 2004
LIPIDOGRAM2004 Study - National epidemiological 
study of lipid disorders and selected risk factors of 
cardiovascular disease in primary health care in Poland National both  30+  30+ 6,672 9,920 6,672 9,920 6,672 9,920
765 Poland 2003-2005
National Multicenter Health Survey in Poland. Project 
WOBASZ National both  20-74  20-74 6,119 6,809 6,118 6,807 6,116 6,806
766 Poland 2006
The health, risk factors for chronic diseases, attitudes 
and behaviors of health residents of Torun (CINDI 
Torun 2006) Community urban  18-65  18-65 750 1,115 750 1,115 750 1,115
767 Poland 2006
LIPIDOGRAM2006 Study - National epidemiological 
study of lipid disorders and selected risk factors of 
cardiovascular disease in primary health care in Poland National both  32+  32+ 6,440 10,640 6,439 10,638 6,439 10,638
768 Poland 2008 The European Male Ageing Study Community both  40+ 310 310 310
769 Poland 2007-2011
Medical, psychological and socioeconomic aspects of 
aging in Poland National both  55+  55+ 2,427 2,306 2,428 2,299 2,426 2,298
770 Poland 2011 NATPOL National both  18-79  18-79 1,147 1,213 1,148 1,214 1,146 1,213
771 Poland 2011-2014 Mogielica Human Ecology Study Site Community rural  45+  45+ 96 337 96 337 96 337
772 Poland 2013-2014
National Multicenter Health Survey in Poland. Project 
WOBASZ II National both  20+  20+ 2,633 3,233 2,624 3,231 2,623 3,230
773 Poland 2015-2016
LIPIDOGRAM2015 & LIPIDOGEN2015 Study - 
National epidemiological study of lipid disorders and 
selected risk factors of cardiovascular disease in 
primary health care in Poland National both  18+  18+ 5,032 8,688 5,033 8,686 5,031 8,686
774 Portugal 1999-2003 EPIPorto Study Community urban  18+  18+ 897 1,435 868 1,411 866 1,410
775 Portugal 2011-2013
EPITeen - Epidemiological Health Investigation of 
Teenagers in Porto Community urban  20-23  20-23 813 870 813 870 813 870
776 Puerto Rico 2006 Perez et al., Ethn Dis 2008; 18: 434-41 Community urban  25-84  25-84 275 532
777 Qatar 2006 World Health Survey National both  18+  18+ 1,567 1,707 1,528 1,692 1,527 1,684
778 Qatar 2012 STEPS National both  18-64  18-64 525 879 559 868 512 838 CardioChek CardioChek
779 Romania 1986-1987 MONICA, Bucharest Community urban  25-64  25-64 636 807 194 159 194 159
780 Romania 1997
Valorile medii si limitele normalitatii unor constante 
biologice; Infobase 101221a1 National both  30-84  30-84 2,293 3,551
781 Romania 2011-2012
Study for the Evaluation of Prevalence of Hypertension 
and cArdiovascular Risk among the Adult Population 
of Romania - SEPHAR II National both  18-80  18-80 931 1,037 930 1,037 930 1,037
782 Romania 2015-2016
Study for the Evaluation of Prevalence of Hypertension 
and cArdiovascular Risk among the Adult Population 
of Romania - SEPHAR III National both  18-80  18-80 935 1,033 935 1,033 935 1,033
783 Russian Federation 1984-1986 MONICA, Moscow (control) Community urban  35-64  35-64 738 588 715 579 706 564
784 Russian Federation 1984-1986 MONICA, Moscow, Leninsky district Community urban  35-64  35-64 499 568 500 570 488 562
785 Russian Federation 1984-1986 MONICA, Moscow, Cheremushkinsky district Community urban  35-64  35-64 403 433 394 433 394 433
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786 Russian Federation 1985 MONICA, Novosibirsk (intervention) Community urban  25-64  25-64 700 728 601 614 601 613
787 Russian Federation 1985-1986 MONICA, Novosibirsk, Kirowsky district Community urban  25-64  25-64 673 696 652 684 652 684
788 Russian Federation 1985-1986 MONICA, Novosibirsk, Leninsky district Community urban  25-64  25-64 569 571 565 564 565 564
789 Russian Federation 1988 MONICA, Novosibirsk (intervention) Community urban  25-64  25-64 810 799 796 792 796 792
790 Russian Federation 1988-1989 MONICA, Moscow (control) Community urban  35-64  35-64 591 540 588 552 584 536
791 Russian Federation 1988-1989 MONICA, Moscow, Leninsky district Community urban  35-64  35-64 577 604 568 597 568 597
792 Russian Federation 1988-1989 MONICA, Novosibirsk, Kirowsky district Community urban  25-64  25-64 823 726 804 706 803 706
793 Russian Federation 1992 Russian Karelia Survey in Pitkaranta Community both  25-64  25-64 378 454 378 454 378 454
794 Russian Federation 1992-1995 MONICA, Moscow (control) Community urban  35-64  35-64 546 520 545 520 545 520
795 Russian Federation 1992-1995 MONICA, Moscow, Leninsky district Community urban  35-64  35-64 507 819 505 818 505 818
796 Russian Federation 1994-1995 MONICA, Novosibirsk (intervention) Community urban  25-64  25-64 800 832 786 829 786 828
797 Russian Federation 1995 MONICA, Novosibirsk, Kirowsky district Community urban  25-64  25-64 749 752 741 747 741 747
798 Russian Federation 1997 Russian Karelia Survey in Pitkaranta Community both  25-64  25-64 309 439 309 439 309 439
799 Russian Federation 2002 Russian Karelia Survey in Pitkaranta Community both  25-64  25-64 248 331 248 331 248 331
800 Russian Federation 2007 Russian Karelia Survey in Pitkaranta Community both  25-64  25-64 174 271 174 272 174 271
801 Russian Federation 2015-2017 Ural Eye and Medical Study (UEMS) Subnational rural  40+  40+ 1,515 1,861
802 Russian Federation 2015-2017 Ural Eye and Medical Study (UEMS) Subnational urban  40+  40+ 1,030 1,429
803 Rwanda 2012 STEPS National both  18-64  18-64 1,319 2,589 2,318 3,802 1,278 2,517 CardioChek CardioChek
804 Saint Vincent and the Grenadines 2013-2014 STEPS National both  18-69  18-69 361 555 399 578 337 526 CardioChek CardioChek
805 Samoa 1995 McGarvey, Pac Health Dialog 2001; 8: 157-62 National both  29-69  29-59 131 137 129 138 129 137
806 Samoa 2002 STEPS National both  25-64  25-64 634 747 Accutrend
807 Samoa 2010 Samoan Genome-Wide Association Study National both  24-65  24-65 1,170 1,775 1,170 1,773 1,170 1,773
808 Samoa 2013 STEPS National both  18-64  18-64 392 576 Accutrend
809 Sao Tome and Principe 2009 STEPS National both  25-64  25-64 321 495 Accutrend
810 Saudi Arabia 1992 Rahman Al-Nuaim, Int J Cardiol 1997; 62: 227-35 National both  30-64  30-64 1,043 1,012
811 Saudi Arabia 2004-2005 STEPS National both  15-64  15-64 2,200 2,286 2,199 2,286 2,199 2,286 1
812 Saudi Arabia 2011-2012
Jeeluna Study - National Assessment of the Health 
Needs of Adolescents in Saudi Arabia National both  18-19  18-19 879 573 880 573 879 573
813 Saudi Arabia 2013 Saudi Health Information Survey National both  15+  15+ 2,369 2,711 2,537 2,945 2,537 2,945 1
814 Serbia 1984 MONICA, Novi Sad Community urban  25-64  25-64 786 773 777 771 774 769
815 Serbia 1988-1989 MONICA, Novi Sad Community urban  25-64  25-64 777 790 776 786 776 786
816 Serbia 1994-1995 MONICA, Novi Sad Community urban  25-64  25-64 596 666 592 659 591 659
817 Serbia 2013-2014
Stay Fit for Lifelong Health; the Prevalence of Lifestyle 
Health Conditions in Serbian Population National urban  20-69  20-59 1,337 297 1,335 297 1,335 297
818 Seychelles 1989 Seychelles Heart Survey I National both  25-64  25-64 499 549 500 549 499 549
819 Seychelles 1994 Seychelles Heart Survey II National both  25-64  25-64 498 545 498 545 498 545
820 Seychelles 2004 Seychelles Heart Survey III National both  25-64  25-64 559 684 556 680 556 680
821 Seychelles 2013-2014 Seychelles Heart Survey IV National both  25-64  25-64 523 684 518 680 518 680
822 Singapore 1982-1985 Thyroid Heart Study National both  18+  18+ 1,020 984 939 943 939 943
823 Singapore 1992 National Health Survey 1992 National both  18-64  18-64 1,744 1,703
824 Singapore 1993-1995 NUH Heart Study National both  26+  26-79 495 481 486 484 486 481
825 Singapore 1998 National Health Survey 1998 National both  18-64  18-64 2,278 2,263
826 Singapore 2004 National Health Survey 2004 National both  18-73  18-73 2,060 2,094
827 Singapore 2004-2007
Combined follow up of Singapore Cardiovascular 
Cohort study and Singapore Prospective study National both  24+  24+ 2,464 2,673 2,463 2,674 2,462 2,673
828 Singapore 2009-2011 The Singapore Chinese Eye Study Community both  40-80  40-80 1,592 1,600 1,592 1,600 1,592 1,600
829 Singapore 2012-2013 Singapore Health Study 2012 National both  18-79  18-79 954 1,021 954 1,021 954 1,021
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830 Singapore 2014-2015 Singapore Health 2 National both  20-79  20+ 754 941 754 941 754 941
831 Slovakia 1993
Countrywide Integrated Noncommunicable Diseases 
Intervention Programme National both  18-64  18-64 752 1,208 715 1,165 713 1,163
832 Slovakia 1998
Countrywide Integrated Noncommunicable Diseases 
Intervention Programme National both  18-64  18-64 856 1,044 836 1,041 835 1,040
833 Slovakia 2003
Countrywide Integrated Noncommunicable Diseases 
Intervention Programme National both  18-64  18-64 622 867 619 864 619 864
834 Slovakia 2008
Countrywide Integrated Noncommunicable Diseases 
Intervention Programme National both  18-64  18-64 391 561 391 561 391 561
835 Slovakia 2011-2012 European Health Examination Survey National both  18-64  18-64 879 1,076 878 1,074 878 1,074
836 Solomon Islands 2004
A genetic-ecological study of the risk factors for 
lifestyle-related diseases in Oceanian populations Community rural  18-74  18-74 106 109 106 109 106 109
837 Solomon Islands 2004
A genetic-ecological study of the risk factors for 
lifestyle-related diseases in Oceanian populations Community urban  18-79  20-79 91 94 91 94 91 94
838 Solomon Islands 2006 STEPS Subnational both  20-64  20-64 164 266 Accutrend
839 Solomon Islands 2015 STEPS National both  18-69  18-69 683 884 126 161 101 137 CardioChek CardioChek
840 Somalia 2016
The prevalence of selected risk factors for non-
communicable diseases in Hargeisa, Somaliland: a 
cross-sectional study Community urban  20-69  20-69 59 533 58 526 58 525
841 South Africa 1990 Mollentze et al., S Afr Med J 1995; 85: 90-6 Community rural  25-84  25+ 270 571
842 South Africa 1990 Mollentze et al., S Afr Med J 1995; 85: 90-6 Community urban  25-84  25-84 288 465
843 South Africa 1995 Walker et al., QJM 1997; 90: 153-4 Community both  60+  60+ 115 146
844 South Africa 2003
SASPI; Thorogood et al., BMC Public Health 2007; 7: 
326 Community rural  35-74  35-84 49 201
845 South Africa 2008-2009
Cape Town Bellville South Cohort Study - Baseline 
evaluation I Community urban  18+  18+ 222 717 223 717 222 717
846 South Africa 2012
South African National Health and Nutrition 
Examination Survey National both  15+  15+ 1,957 3,449 1,947 3,437 1,947 3,437 1
847 South Africa 2014-2015
Health and Aging in Africa: A Longitudinal Study of an 
INDEPTH Community in South Africa (HAALSI) Community rural  40+  40+ 1,618 2,047 1,682 2,083 1,433 1,863 CardioChek CardioChek
848 South Korea 1998
Korea National Health and Nutrition Examination 
Survey National both  18+  18+ 3,200 3,948 3,200 3,948 3,200 3,948
849 South Korea 2001 Kim et al., Br J Psychiatry 2006; 189: 26-30 Community both  65+  65+ 300 432
850 South Korea 2001
Korea National Health and Nutrition Examination 
Survey National both  18+  18+ 2,279 2,888 2,282 2,890 2,269 2,868
851 South Korea 2002-2003 Korean National Health Insurance National both  40+  40+ 2,989,657 2,479,396
852 South Korea 2005 Kweon et al., J Korean Med Sci 2005; 20: 373-8 Community both  45-84  45-84 4,385 6,691
853 South Korea 2005
Korea National Health and Nutrition Examination 
Survey National both  18+  18+ 2,314 3,085 2,312 3,084 2,311 3,084
854 South Korea 2004-2005 Korean National Health Insurance National both  40+  40+ 3,601,691 3,258,695
855 South Korea 2007
Korea National Health and Nutrition Examination 
Survey National both  18+  18+ 1,152 1,615 1,152 1,615 1,152 1,615
856 South Korea 2006-2007 Korean National Health Insurance National both  40+  40+ 4,564,835 4,607,536
857 South Korea 2008
Korea National Health and Nutrition Examination 
Survey National both  18+  18+ 2,700 3,708 2,699 3,708 2,699 3,708
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858 South Korea 2009
Korea National Health and Nutrition Examination 
Survey National both  18+  18+ 3,098 3,952 3,097 3,952 3,097 3,952
859 South Korea 2008-2009 Korean National Health Insurance National both  40+  40+ 5,764,448 6,089,851
860 South Korea 2010
Korea National Health and Nutrition Examination 
Survey National both  18+  18+ 2,542 3,297 2,542 3,297 2,542 3,297
861 South Korea 2011
Korea National Health and Nutrition Examination 
Survey National both  18+  18+ 2,516 3,330 2,516 3,330 2,516 3,330
862 South Korea 2010-2011 Korean National Health Insurance National both  40+  40+ 6,671,456 7,128,388 6,660,735 7,119,030 6,660,314 7,118,740
863 South Korea 2012
Korea National Health and Nutrition Examination 
Survey National both  18+  18+ 2,340 3,162 2,339 3,161 2,339 3,161
864 South Korea 2013
Korea National Health and Nutrition Examination 
Survey National both  18+  18+ 2,288 2,899 2,288 2,899 2,288 2,899
865 South Korea 2012-2013 Korean National Health Insurance National both  40+  40+ 7,257,240 7,784,255 7,252,867 7,781,010 7,252,410 7,780,763
866 South Korea 2014
Korea National Health and Nutrition Examination 
Survey National both  18+  18+ 2,117 2,816 2,117 2,816 2,117 2,816
867 South Korea 2015
Korea National Health and Nutrition Examination 
Survey National both  18+  18+ 2,290 2,848 2,290 2,848 2,290 2,848
868 South Korea 2014-2015 Korean National Health Insurance National both  40+  40+ 7,870,202 8,357,663 7,867,141 8,355,947 7,866,632 8,355,708
869 South Korea 2016
Korea National Health and Nutrition Examination 
Survey National both  18+  18+ 2,534 3,227 2,532 3,227 2,532 3,227
870 South Korea 2017
Korea National Health and Nutrition Examination 
Survey National both  18+  18+ 2,638 3,200 2,635 3,196 2,635 3,196
871 South Korea 2016-2017 Korean National Health Insurance National both  40+  40+ 8,535,949 9,075,677 8,532,962 9,073,811 8,532,394 9,073,560
872 Spain 1986-1988 MONICA, Catalonia Subnational both  25-64  25-64 1,238 1,261 1,238 1,261 1,238 1,260
873 Spain 1989 Cardiovascular Risk Factors Study in Catalonia Subnational both  15+  15+ 156 158 156 158 156 158 1
874 Spain 1990
Hernandez Lanchas et al., An Med Interna 1992; 9: 64-
71; Site 1 Community urban  20-79  20-49 175 91
875 Spain 1990
Hernandez Lanchas et al., An Med Interna 1992; 9: 64-
71; Site 2 Community urban  20-79  20-69 149 238
876 Spain 1990-1992 MONICA, Catalonia Subnational both  25-64  25-64 1,661 1,152 1,660 1,152 1,660 1,152
877 Spain 1991-1993
Encuesta de Factores de Riesgo Cardiovascular en la 
Región de Murcia (Cardiovascular Risk Factors 
Survey) Subnational both  18-69  18-69 1,151 1,258 1,094 1,208 1,094 1,208
878 Spain 1995 Schroder et al., Eur J Nutr 2004; 43: 77-85 Community both  25-74  25-74 802 868
879 Spain 1994-1996 MONICA, Catalonia Subnational both  25-64  25-64 1,751 1,569 1,751 1,569 1,751 1,569
880 Spain 1998 Tinahones et al, Metabolism 2002; 51: 429-31 Community urban  25-64  25-64 317 538
881 Spain 1999-2000
Factores de riesgo en las islas Baleares: Estudio 
CORSAIB Subnational both  35-74  35-74 812 867 810 863 810 863
882 Spain 2000-2001 EUREYE Study Subnational both  65+  65+ 254 297
883 Spain 2001-2002 Catalan Health Interview Survey Subnational both  18-74  18-74 563 697 573 715 563 697
884 Spain 2001-2003
DIabetes, Nutrición y Obesidad en la población adulta 
de la Región de Murcia (DINO) Subnational both  20+  20+ 718 837 717 837 717 837
885 Spain 2000-2005 CDC of the Canary Islands Subnational both  18-75  18-75 2,881 3,716 2,880 3,716 2,880 3,716
886 Spain 2003 The European Male Ageing Study Community both  40-79 406 402 402
887 Spain 2004 Vioque J et al., Obesity 2008; 16: 664-70 Community urban  24+  24+ 68 101 68 101 68 101
888 Spain 2004
Cardiovascular Risk Study in Castilla y León 
(RECCyL) Subnational both  18+  18+ 1,827 2,019 1,807 1,983 1,807 1,982
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889 Spain 2003-2005 Registre Gironi del Cor (REGICOR) Subnational both  35-79  35-79 2,951 3,280 2,952 3,280 2,951 3,280
890 Spain 2004-2006 PREVICTUS National both  60+  60+ 3,350 3,834 3,012 3,437 3,009 3,434
891 Spain 2008 The European Male Ageing Study Community both  40+ 264 261 261
892 Spain 2007-2009
Harmonizing Equation of Risk in Mediterraneon 
countries EXtremadura Subnational both  25-79  25-79 1,297 1,498 1,296 1,496 1,296 1,496
893 Spain 2008-2010 Study on Nutrition and Cardiovascular Risk in Spain National both  18+  18+ 6,193 6,858 6,193 6,858 6,193 6,858
894 Spain 2009
Cardiovascular Risk Study in Castilla y León 
(RECCyL) Subnational both  20+  20+ 1,291 1,572 1,270 1,558 1,270 1,558
895 Spain 2014
Cardiovascular Risk Study in Castilla y León 
(RECCyL) Subnational both  20+  20+ 1,220 1,509 1,187 1,466 1,186 1,465
896 Spain 2015
Study on Nutrition and Cardiovascular Risk in Spain 
(ENRICA) National both  65+  65+ 704 770 703 770 703 770
897 Sri Lanka 2014 STEPS National both  18-69  18-69 1,352 2,289 CardioChek
898 Sudan (former) 2006 STEPS National both  25-64  25-64 145 317
899 Sudan (former) 2016 STEPS National both  18-69  18-69 1,821 3,762 2,212 4,034 1,712 3,624 CardioChek CardioChek
900 Suriname 2013-2015 The Healthy Life in Suriname Study (HELISUR) Subnational urban  18-70  18-70 424 722 424 722 424 722
901 Swaziland 2014 STEPS National both  18-69  18-69 731 1,507 922 1,706 709 1,462 CardioChek CardioChek
902 Sweden 1980 Welin et al., Diabetologia 1992; 35: 766-70; Site 1 Community urban  67-67 529
903 Sweden 1980 Welin et al., Diabetologia 1992; 35: 766-70; Site 2 Community urban  67-67 66
904 Sweden 1980-1981 Population Study of Women in Gothenburg Community urban  50-72 1,132
905 Sweden 1983 Ogren et al., Lancet 1993; 342: 1138-41; Site 1 Community urban  69-69 206
906 Sweden 1983 Ogren et al., Lancet 1993; 342: 1138-41; Site 2 Community urban  69-69 23
907 Sweden 1983 Ogren et al., Lancet 1993; 342: 1138-41; Site 3 Community urban  69-69 90
908 Sweden 1983 Ogren et al., Lancet 1993; 342: 1138-41; Site 4 Community urban  69-69 53
909 Sweden 1983 Ogren et al., Lancet 1993; 342: 1138-41; Site 5 Community urban  69-69 17
910 Sweden 1983 Ogren et al., Lancet 1993; 342: 1138-41; Site 6 Community urban  69-69 6
911 Sweden 1983 Ogren et al., Lancet 1993; 342: 1138-41; Site 7 Community urban  69-69 30
912 Sweden 1983 Ogren et al., Lancet 1993; 342: 1138-41; Site 8 Community urban  69-69 14
913 Sweden 1980-1984 Uppsala Longitudinal Study of Adult Men Community both  60-60 593 230 219
914 Sweden 1985 MONICA Gothenburg Community urban  25-64  25-64 636 689 631 682 628 682
915 Sweden 1986 MONICA Northern Sweden Subnational both  25-64  25-64 823 802 822 801 822 801
916 Sweden 1990 MONICA Northern Sweden Subnational both  25-64  25-64 773 799 770 803 770 798
917 Sweden 1990 MONICA Gothenburg Community urban  25-64  25-64 773 774 771 772 771 772
918 Sweden 1992 Frisk et al., Acta Odontol Scand 2003; 61: 257-62 Community urban  35-54 148
919 Sweden 1992-1993 Population Study of Women in Gothenburg Community urban  62-84 810
920 Sweden 1993 Rosengren et al., J Intern Med 2000; 247: 111-8 Community urban  50-50 798
921 Sweden 1992-1994 Malmö Diet and Cancer Community urban  46-68  46-68 2,285 3,226 2,260 3,193 2,255 3,184
922 Sweden 1991-1995 Uppsala Longitudinal Study of Adult Men Community both  70-70 1,220 1,218 1,218
923 Sweden 1994 Helicobacter Pylori Community urban  56-65  56-65 170 217 170 217 170 217
924 Sweden 1994 MONICA Northern Sweden Subnational both  25-74  25-74 939 975 939 974 939 974
925 Sweden 1995 MONICA Gothenburg Community urban  25-64  25-64 742 863 740 861 739 861
926 Sweden 1997 Johansson et al., J Intern Med 2002; 252: 551-60 Community urban  35-55  35-55 137 135
927 Sweden 1999 MONICA Northern Sweden Subnational both  25-74  25-74 886 927
928 Sweden 2000 Frisk et al., Acta Odontol Scand 2003; 61: 257-62 Community urban  65+ 561
929 Sweden 2003 The European Male Ageing Study Community both  40+ 404 407 404
930 Sweden 2001-2004 Swedish INTERGENE Cohort Study Subnational both  24-76  24-76 1,516 1,701 1,507 1,698 1,507 1,698
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Prospective Investigation of the Vasculature in Uppsala 
Seniors (PIVUS) Community both  70-70  70-70 506 507 506 507 506 506
932 Sweden 2004
LSH; Hollman et al., Eur J Cardiovasc Nurs 2008; 7: 
21-6 Community urban  45-69  45-69 497 502
933 Sweden 2004 MONICA Northern Sweden Subnational both  26-75  26-75 927 975
934 Sweden 2005 Frisk et al., Acta Odontol Scand 2003; 61: 257-62 Community urban  75+ 538
935 Sweden 2004-2005 European Youth Heart Study (EYHS) II Subnational urban  20-21  20-21 67 109 68 109 67 109
936 Sweden 2004-2005 Population Study of Women in Gothenburg Community urban  38-50 494 493 493
937 Sweden 2008 The European Male Ageing Study Community both  40+ 358 361 355
938 Sweden 2006-2009
Prospective Investigation of the Vasculature in Uppsala 
Seniors (PIVUS) Community both  75-75  75-75 407 419 407 418 407 418
939 Sweden 2009 MONICA Northern Sweden Subnational both  25-74  25-74 848 869
940 Sweden 2007-2012
Malmö Diet and Cancer Cardiovascular Cohort 
Reexamination (MDC-ÅUS) Community urban  62-85  62-85 1,509 2,182 1,507 2,182 1,507 2,182
941 Sweden 2011-2012 EpiHealth National both  45-75  45-75 4,441 5,661 4,441 5,661 4,441 5,661
942 Sweden 2014 MONICA Northern Sweden Subnational both  25-74  25-74 749 800
943 Sweden 2014-2016 Swedish INTERGENE Cohort Study Subnational urban  37-88  37-88 587 638 587 639 587 638
944 Switzerland 1984-1986 The Swiss MONICA Study Wave I Subnational both  25-74  25-74 1,702 1,611 1,700 1,610 1,700 1,610
945 Switzerland 1988-1989 The Swiss MONICA Study Wave II Subnational both  25-74  25-74 1,724 1,617 1,724 1,617 1,724 1,617
946 Switzerland 1992-1993 The Swiss MONICA Study Wave III Subnational both  25-74  25-74 1,520 1,623 1,520 1,623 1,520 1,623
947 Switzerland 2001
Bernstein et al., Arterioscler Thromb Vasc Biol 2002; 
22: 133-40 Community urban  35-74  35-74 3,552 3,531
948 Switzerland 2003-2006 Cohorte Lausannoise (CoLaus) Community urban  35-75  35-75 3,177 3,532 3,177 3,531 3,177 3,531
949 Switzerland 2007-2012 Bus Santé Study Subnational urban  20+  20+ 1,884 1,916 1,884 1,916 1,884 1,916
950 Switzerland 2009-2012 Cohorte Lausannoise (CoLaus) Community urban  40-81  40-81 2,192 2,505 2,192 2,505 2,192 2,505
951 Switzerland 2013-2016 Bus Santé Subnational urban  20-74  20-74 2,011 2,145 2,012 2,145 2,011 2,144
952 Switzerland 2014-2017 Cohorte Lausannoise (CoLaus) Community urban  45-87  45-87 2,022 2,488 2,022 2,487 2,022 2,487
953 Syrian Arab Republic 2002
National Survey on non-communicable diseases and 
factors affecting their development National both  15-64  15-64 1,784 2,958 1
954 Taiwan 1993-1996 Nutrition and Health Survey in Taiwan 1993-1996 National both  18+  18+ 1,444 1,609 1,427 1,602 1,425 1,596
955 Taiwan 1996 Lu et al., Diabet Med 1998; 15: 564-72 Subnational urban  25-84  25-84 695 758
956 Taiwan 1999-2000 Nutrition and Health Survey in Taiwan 1999-2000 National both  65+  65+ 1,257 1,202 1,256 1,203 1,255 1,201
957 Taiwan 2002
Taiwanese Survey on Hypertension, Hyperglycemia 
and Hyperlipidemia National both  15+  15+ 3,167 3,435 3,167 3,435 3,167 3,435 1
958 Taiwan 2005 TCHS  Community urban  40+  40+ 1,147 1,211
959 Taiwan 2005-2008 Nutrition and Health Survey in Taiwan 2005-2008 National both  19+  19+ 1,322 1,371 1,321 1,369 1,320 1,369
960 Taiwan 2007
Taiwanese Survey on Hypertension, Hyperglycemia 
and Hyperlipidemia National both  20+  20+ 2,046 2,365 2,046 2,365 2,046 2,365
961 Taiwan 2013-2016 Nutrition and Health Survey in Taiwan National both  18+  18+ 1,549 1,631 1,546 1,631 1,546 1,631
962 Tajikistan 2016 STEPS National both  18-69  18-69 887 1,377 1,062 1,513 883 1,372 CardioChek CardioChek
963 Tanzania 1990 Swai et al., Int J Epidemiol 1993; 22: 651-9; Site 1 Subnational rural  25+  25+ 1,105 1,641
964 Tanzania 1990 Swai et al., Int J Epidemiol 1993; 22: 651-9; Site 2 Subnational rural  25+  25+ 911 889
965 Tanzania 1990 Swai et al., Int J Epidemiol 1993; 22: 651-9; Site 3 Subnational rural  25+  25+ 241 356
966 Tanzania 2011 STEPS Subnational both  25-64  25-64 748 1,200 Accutrend
967 Tanzania 2012 STEPS National both  25-64  25-64 510 684 Accutrend
968 Tanzania 2014 Dar es Salaam Urban Cohort Hypertension Study Community urban  40+  40+ 150 239 CardioChek
969 Thailand 1991 Thailand National Health Examination Survey I National both  18+  18+ 5,128 6,930
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970 Thailand 1997 Thailand National Health Examination Survey II National both  18-59  18-59 933 1,572
971 Thailand 2000 InterASIA National both  35+  35+ 2,019 3,081 2,016 3,077 2,016 3,077
972 Thailand 2004 Thailand National Health Examination Survey III National both  18+  18+ 18,452 19,888
973 Thailand 2003-2004 The Fifth National Nutrition Survey of Thailand National both  15-74  15-74 1,043 1,298 1,043 1,298 1,043 1,298 1
974 Thailand 2009 Thailand National Health Examination Survey IV National both  15+  15+ 9,607 10,506 9,605 10,501 9,601 10,500 1
975 Timor-Leste 2014 STEPS National both  18-69  18-69 818 1,195 CardioChek
976 Togo 2010 STEPS National both  18-64  18-64 458 610 Accutrend
977 Tokelau 2005 STEPS National both  18-64  18-64 150 176 Accutrend
978 Tokelau 2014 STEPS National both  18-64  18-64 254 277 250 267 247 267 CardioChek CardioChek
979 Tonga 2004 STEPS National both  18-64  18-64 389 543 368 531 366 526 Cholestech Cholestech
980 Tonga 2011 STEPS National both  20-64  20-64 754 1,145 Accutrend
981 Tunisia 1989
Gharbi et al., Rev Epidemiol Sante Publique 2002; 50: 
349-55; Site 1 Community both  35-50  35-50 168 201
982 Tunisia 1989
Gharbi et al., Rev Epidemiol Sante Publique 2002; 50: 
349-55; Site 2 Community both  35-50  35-50 146 155
983 Tunisia 1996-1997 Ariana Healthy Project 1997 Community both  35-65  35-65 644 758 621 742 618 739
984 Tunisia 1996-1997 Tunisian National Nutrition Survey 1996-1997 National both  18+  18+ 1,234 2,388
985 Tunisia 2005 Tunisian National Survey National both  35-71  35-71 2,644 3,782 Accutrend
986 Tunisia 2009-2010 ObeMaghreb Subnational urban  18-49  18-49 980 696 978 696 977 696
987 Tunisia 2016 Tunisian Health Examination Survey National both  15+  15+ 3,807 4,475 4,097 4,513 3,765 4,374 CardioChek CardioChek 1
988 Turkey 1990 Turkish Adult Risk Factor Study National both  20+  20+ 1,342 1,371
989 Turkey 1995 Turkish Adult Risk Factor Study National both  25+  25+ 832 864
990 Turkey 1998 Turkish Adult Risk Factor Study National both  28+  28+ 858 883 851 880 851 880
991 Turkey 1999 Tezcan et al., Trop Med Int Health 2003; 8: 660-7 Community urban  25-64  25-64 483 727
992 Turkey 2000 Turkish Adult Risk Factor Study National both  30+  30+ 891 932 885 928 885 928
993 Turkey 2000-2002
The Healthy Nutrition for Healthy Heart Study; 
Sanisoglu et al., BMC Public Health 2006; 6: 92 National both  30+  30+ 4,778 10,657 4,778 10,657 4,778 10,657
994 Turkey 2001-2002 Turkish Adult Risk Factor Study National both  32+  32+ 1,122 1,226 1,121 1,224 1,121 1,223
995 Turkey 2003 Gokcel et al., Diabetes Care 2003; 26: 3031-4 Community both  20-79  20-79 607 1,030
996 Turkey 2003-2004 Turkish Adult Risk Factor Study National both  34+  34+ 1,092 1,129 1,091 1,128 1,091 1,128
997 Turkey 2003-2005
Prevalence of prehypertension and associated risk 
factors among Turkish adults: Trabzon Hypertension 
Study Subnational both  20+  20+ 2,205 2,593 2,205 2,593 2,205 2,593
998 Turkey 2005-2006 Turkish Adult Risk Factor Study National both  35+  35+ 934 1,004 933 1,004 932 1,004
999 Turkey 2007-2008 Turkish Adult Risk Factor Study National both  37+  37+ 1,039 1,071 1,035 1,064 1,032 1,064
1000 Turkey 2009-2010 Turkish Adult Risk Factor Study National both  39+  39+ 734 794 735 799 733 793
1001 Turkey 2011 Chronic Diseases and Risk Factors Survey in Turkey National both  15+  15+ 6,760 7,717 6,760 7,717 6,760 7,717 1
1002 Turkey 2009-2012
Prevalence of diabetes and associated risk factors 
among adult population in Trabzon city Subnational both  20+  20+ 1,525 2,078 1,529 2,085 1,518 2,074
1003 Turkey 2012-2013 Turkish Adult Risk Factor Study National both  37+  40+ 1,008 1,084 1,006 1,082 1,006 1,082
1004 Turkey 2014-2015 Turkish Adult Risk Factor Study National both  44+  44+ 845 903 840 901 840 901
1005 Turkey 2017 STEPS National both  18+  18+ 1,130 1,815 1,244 1,899 1,095 1,771 CardioChek CardioChek
1006 Turkmenistan 2013 STEPS National both  18-64  18-64 1,092 1,875 CardioChek
1007 Turkmenistan 2018 STEPS National both  18-69  18-69 1,466 2,006 1,636 2,151 1,442 1,964 CardioChek CardioChek
1008 Tuvalu 2015 STEPS National both  18-69  18-69 389 518 379 491 337 469 CardioChek CardioChek
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The Prevalence and Distribution of Non-communicable 
Diseases and Their Risk Factors in Kasese District, 
Uganda Subnational both  25-79  25-79 255 219 Reflotron
1010 Uganda 2014 STEPS National both  18-69  18-69 918 1,531 1,394 1,965 874 1,477 CardioChek CardioChek
1011 United Arab Emirates 2017-2018 STEPS National both  18+  18+ 1,411 1,586 1,454 1,567 1,390 1,536 CardioChek CardioChek
1012 United Kingdom 1983-1984 MONICA, Belfast Subnational both  25-64  25-64 1,142 1,170 1,120 1,142 1,116 1,139
1013 United Kingdom 1984-1986 Scottish Heart Health Survey Subnational both  40-59  40-59 4,068 3,926 3,870 3,777 3,867 3,774
1014 United Kingdom 1986-1987
Dietary and Nutritional Survey of British Adults 1986-
1987 National both  18-64  18-64 935 937 931 934 931 934
1015 United Kingdom 1986-1987 MONICA, Belfast Subnational both  25-64  25-64 1,145 1,148 1,142 1,151 1,137 1,146
1016 United Kingdom 1987-1988 Edinburgh Artery Study Community urban  54-75  54-75 801 772 795 771 795 771
1017 United Kingdom 1991-1992 Health Survey for England National both  18+  18+ 2,425 2,568
1018 United Kingdom 1991-1992 MONICA, Belfast Subnational both  25-64  25-64 977 925 974 923 974 923
1019 United Kingdom 1992 MONICA, Glasgow Community urban  25-64  25-64 676 726 637 694 637 694
1020 United Kingdom 1993
Whickham Survey; Vanderpump et al., Diabet Med 
1996; 13: 741-7 Community urban  35+  35+ 762 940
1021 United Kingdom 1993 Health Survey for England National both  18+  18+ 5,599 5,984
1022 United Kingdom 1994 Health Survey for England National both  18+  18+ 5,222 5,704
1023 United Kingdom 1995 MONICA, Glasgow Community urban  25-64  25-64 818 877 780 853 780 853
1024 United Kingdom 1994-1995 National Diet and Nutrition Survey (NDNS) National both  65+  65+ 594 540 593 541 593 540
1025 United Kingdom 1995 Scottish Health Survey (SHeS) Subnational both  18-64  18-64 2,768 3,246
1026 United Kingdom 1997 National Diet and Nutrition Survey (NDNS) National both  18-18  18-18 32 33 32 33 32 33
1027 United Kingdom 1998 Health Survey for England National both  18+  18+ 4,940 5,514 4,927 5,498 4,924 5,495
1028 United Kingdom 1998 Scottish Health Survey (SHeS) Subnational both  18-74  18-74 2,704 3,256 2,679 3,242 2,679 3,241
1029 United Kingdom 1998-2000 The British Regional Heart Study National urban  60-79 3,938 3,912 3,912
1030 United Kingdom 1999 MRC National Survey of Health and Development National both  53-54  53-54 1,277 1,281 1,141 1,235 1,141 1,235
1031 United Kingdom 1999-2001 British Women's Heart and Health Study National both  60-79 3,697 3,691 3,691 4
1032 United Kingdom 2000 Health Survey for England National both  65+  65+ 224 489 213 466 213 466
1033 United Kingdom 1999-2004 Hertfordshire Cohort Study Subnational both  59-73  60-73 1,459 1,329 1,459 1,329 1,459 1,329
1034 United Kingdom 2000-2001 National Diet and Nutrition Survey 2000-2001 National both  19-64  19-64 580 693 579 693 579 693
1035 United Kingdom 2003 The European Male Ageing Study Community both  40+ 396 396 396
1036 United Kingdom 2003 Health Survey for England National both  18+  18+ 3,735 4,386 3,737 4,387 3,735 4,386
1037 United Kingdom 2003 Scottish Health Survey (SHeS) Subnational both  18+  18+ 1,846 2,175 1,847 2,175 1,846 2,175
1038 United Kingdom 2004-2005
English Longitudinal Study of Ageing Wave 2 2004-
2005 National both  52+  52+ 2,701 3,203 2,696 3,203 2,696 3,203
1039 United Kingdom 2005 Health Survey for England National both  65+  65+ 1,008 1,190 1,008 1,190 1,008 1,190
1040 United Kingdom 2006 Health Survey for England National both  18+  18+ 3,341 3,992 3,342 3,992 3,341 3,992
1041 United Kingdom 2008 The European Male Ageing Study Community both  40+ 311 307 307
1042 United Kingdom 2008 Health Survey for England National both  18+  18+ 3,274 3,857 3,274 3,856 3,274 3,856
1043 United Kingdom 2008 Scottish Health Survey (SHeS) Subnational both  18+  18+ 396 459 396 459 396 459
1044 United Kingdom 2008-2009
English Longitudinal Study of Ageing Wave 4 2008-
2009 National both  50+  50+ 2,871 3,500 2,869 3,497 2,869 3,497
1045 United Kingdom 2009 Health Survey for England National both  18+  18+ 1,058 1,214 1,058 1,214 1,058 1,214
1046 United Kingdom 2006-2010 MRC National Survey of Health and Development National both  60-65  60-65 1,004 1,060 1,004 1,060 1,004 1,060
1047 United Kingdom 2009 Scottish Health Survey (SHeS) Subnational both  18+  18+ 359 467 359 467 359 467
1048 United Kingdom 2010 Health Survey for England National both  18+  18+ 1,680 2,129 1,680 2,129 1,680 2,129
1049 United Kingdom 2008-2012 National Diet and Nutrition Survey (NDNS) National both  18+  18+ 460 593 460 593 460 593
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1050 United Kingdom 2010 Scottish Health Survey (SHeS) Subnational both  18+  18+ 336 432 336 432 336 432
1051 United Kingdom 2011 Health Survey for England National both  18+  18+ 1,712 2,172 1,710 2,172 1,709 2,172
1052 United Kingdom 2011 Scottish Health Survey (SHeS) Subnational both  18+  18+ 319 366 319 366 319 366
1053 United Kingdom 2012 Health Survey for England National both  18+  18+ 1,718 2,169 1,715 2,169 1,715 2,169
1054 United Kingdom 2012-2013
English Longitudinal Study of Ageing Wave 6 2012-
2013 National both  50+  50+ 2,731 3,308 2,729 3,307 2,729 3,307
1055 United Kingdom 2013 Health Survey for England National both  18+  18+ 2,039 2,391 2,037 2,390 2,037 2,390
1056 United Kingdom 2014 Health Survey for England National both  18+  18+ 1,785 2,067 1,786 2,067 1,785 2,067
1057 United Kingdom 2013-2014 National Diet and Nutrition Survey (NDNS) National both  18+  18+ 293 443 293 443 293 443
1058 United Kingdom 2015 Health Survey for England National both  18+  18+ 1,749 2,109 1,749 2,110 1,749 2,109
1059 United Kingdom 2015 MRC National Survey of Health and Development National both  69-70  69-70 952 1,010 949 1,009 948 1,008
1060 United Kingdom 2016 Health Survey for England National both  18+  18+ 1,659 2,064 1,659 2,066 1,659 2,064
1061 United Kingdom 2015-2016 National Diet and Nutrition Survey (NDNS) National both  18+  18+ 300 396 300 396 300 396
1062 United Kingdom 2017 Health Survey for England National both  18+  18+ 1,694 2,141 1,694 2,141 1,694 2,141
1063 United Kingdom 2016-2017 National Diet and Nutrition Survey (NDNS) National both  18+  18+ 130 171 129 171 129 171
1064 United States of America 1976-1980 US NHANES II National both  20-74  20-74 5,601 6,245 4,558 5,225 4,558 5,225 2
1065 United States of America 1979-1980 MONICA, Stanford Subnational urban  25-64  25-64 692 791 689 789 689 789 7
1066 United States of America 1981-1982 The Bogalusa Heart Study Community rural  18-22  18-22 38 24 37 24 37 24
1067 United States of America 1983-1985 The Bogalusa Heart Study Community rural  18-22  18-22 50 24 49 24 49 24
1068 United States of America 1985-1986
Coronary Artery Risk Development in Young Adults 
(CARDIA) Subnational urban  18-30  18-30 2,307 2,757 2,306 2,757 2,306 2,757
1069 United States of America 1985-1986 MONICA, Stanford Subnational urban  25-64  25-64 703 827 703 825 703 825 7
1070 United States of America 1987-1989 Atherosclerosis Risk in Communities Study Subnational both  44-66  44-66 4,974 6,070 4,969 6,071 4,968 6,067
1071 United States of America 1987-1988 The Bogalusa Heart Study Community rural  18-22  18-22 40 27 40 27 40 27
1072 United States of America 1989-1990 Cardiovascular Health Study Subnational both  65+  65+ 2,451 3,287 2,447 3,282 2,446 3,282
1073 United States of America 1989-1990 MONICA, Stanford Subnational urban  25-64  25-64 694 803 694 802 694 801 7
1074 United States of America 1990-1992 Atherosclerosis Risk in Communities Study Subnational both  46-70  46-70 4,528 5,579 4,509 5,549 4,508 5,549
1075 United States of America 1990-1991
Coronary Artery Risk Development in Young Adults 
(CARDIA) Subnational urban  23-35  23-35 1,929 2,314 1,929 2,314 1,929 2,314
1076 United States of America 1988-1994 US NHANES III National both  18+  18+ 7,846 8,592 7,773 8,532 7,771 8,528
1077 United States of America 1992-1994 The Bogalusa Heart Study Community rural  18-21  18-21 53 33 53 33 53 33
1078 United States of America 1992-1993
Coronary Artery Risk Development in Young Adults 
(CARDIA) Subnational urban  25-37  25-37 1,814 2,192 1,813 2,192 1,812 2,192
1079 United States of America 1992-1993 Cardiovascular Health Study Subnational both  65+  65+ 1,970 2,714 1,964 2,710 1,964 2,710
1080 United States of America 1993-1995 Atherosclerosis Risk in Communities Study Subnational both  50-73  48-73 3,991 4,991 3,987 4,988 3,987 4,988
1081 United States of America 1993-1994 Cardiovascular Health Study Subnational both  65+  65+ 1,764 2,464
1082 United States of America 1994-1995 Cardiovascular Health Study Subnational both  65+  65+ 1,617 2,352
1083 United States of America 1995-1996 The Bogalusa Heart Study Community rural  20-39  20-39 548 829 548 829 548 829
1084 United States of America 1995-1996
Coronary Artery Risk Development in Young Adults 
(CARDIA) Subnational urban  28-40  28-40 1,729 2,140 1,730 2,140 1,729 2,140
1085 United States of America 1996-1998 Atherosclerosis Risk in Communities Study Subnational both  50-75  50-75 3,528 4,447 3,527 4,446 3,527 4,446
1086 United States of America 1996-1997 Cardiovascular Health Study Subnational both  65+  65+ 1,330 1,996
1087 United States of America 1996-1997 Study of Women's Health Across the Nation Subnational both  40-55 3,218 3,218 3,218 8
1088 United States of America 1997-1998 Cardiovascular Health Study Subnational both  65+  65+ 1,185 1,804
1089 United States of America 1997-1999 Study of Women's Health Across the Nation Subnational both  40-55 2,738 2,735 2,735 8
1090 United States of America 1999-2000 US NHANES 1999-2000 National both  18+  18+ 2,172 2,187 2,170 2,186 2,170 2,185
1091 United States of America 1999-2001 Study of Women's Health Across the Nation Subnational both  40-56 2,331 2,328 2,328 8
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1092 United States of America 2000-2001
Coronary Artery Risk Development in Young Adults 
(CARDIA) Subnational urban  33-45  33-45 1,560 1,941 1,559 1,941 1,558 1,941
1093 United States of America 2000-2002 Study of Women's Health Across the Nation Subnational both  40-57 2,280 2,280 2,280 8
1094 United States of America 2001-2002 US NHANES 2001-2002 National both  18+  18+ 2,511 2,389 2,511 2,389 2,511 2,389
1095 United States of America 2003-2004 US NHANES 2003-2004 National both  18+  18+ 2,419 2,341 2,419 2,340 2,419 2,340
1096 United States of America 2005-2006
Coronary Artery Risk Development in Young Adults 
(CARDIA) Subnational urban  38-50  38-50 1,522 1,982 1,521 1,982 1,520 1,982
1097 United States of America 2005-2006 Cardiovascular Health Study Subnational both  65+  65+ 375 660 375 660 375 660
1098 United States of America 2005-2006 US NHANES 2005-2006 National both  18+  18+ 2,413 2,247 2,413 2,246 2,413 2,246
1099 United States of America 2007-2008 US NHANES 2007-2008 National both  18+  18+ 2,760 2,777 2,597 2,601 2,597 2,601
1100 United States of America 2009-2010 US NHANES 2009-2010 National both  18+  18+ 2,909 2,999 2,908 2,999 2,908 2,999
1101 United States of America 2010-2011
Coronary Artery Risk Development in Young Adults 
(CARDIA) Subnational urban  43-55  43-55 1,509 1,968 1,509 1,967 1,508 1,967
1102 United States of America 2011-2013 Atherosclerosis Risk in Communities Study Subnational both  67-90  67-90 1,823 2,462 1,823 2,462 1,823 2,462
1103 United States of America 2011-2012 US NHANES 2011-2012 National both  18+  18+ 2,575 2,561 2,574 2,562 2,574 2,561
1104 United States of America 2013-2014 US NHANES 2013-2014 National both  18+  18+ 2,684 2,894 2,682 2,895 2,682 2,894
1105 United States of America 2015-2016 US NHANES 2015-2016 National both  18+  18+ 2,606 2,728 2,604 2,727 2,604 2,727
1106 Uruguay 2006 STEPS National both  25-64  25-64 185 471 186 478 184 471
1107 Uruguay 2011-2012 CESCAS Study Community urban  30-79  30-79 634 909 635 909 634 909
1108 Uruguay 2012-2016
Genotype, Phenotype and Environment of 
Hypertension in Uruguay (GEFA-HT-UY) Community urban  19+  20+ 129 192 129 192 129 192
1109 Uzbekistan 2002 Demographic and Health Survey Uzbekistan 2002 Subnational urban  18-59  18-49 550 626 547 622 547 622
1110 Uzbekistan 2014 STEPS National both  18-64  18-64 1,249 1,961 Multicare
1111 Vanuatu 2011 STEPS National both  25-64  25-64 2,062 1,952 Accutrend
1112 Venezuela 2000
Zulia Coronary Heart Disease Risk Factor Study; Florez
et al., Diabetes Res Clin Pract 2005; 69: 63-77 Subnational both  25+  25+ 832 1,939
1113 Venezuela 2004-2005
CArdiovascular Risk factors Multiple Evaluation in 
Latin America (CARMELA) Community urban  25-64  25-64 713 1,135 713 1,135 713 1,135
1114 Venezuela 2005-2006
Brajkovich et al., Rev Ven Endoc Metab 2006; 4: 31-
32 Community urban  20-65  20-65 204 438 204 439 204 438
1115 Venezuela 2007-2008
Venezuelan Study of Metabolic Syndrome, Obesity and 
Lifestyle (VEMSOLS) Community urban  20-79  20+ 107 230 107 230 107 230
1116 Venezuela 2008-2009
Venezuelan Study of Metabolic Syndrome, Obesity and 
Lifestyle (VEMSOLS) Community rural  20+  20-79 51 89 48 89 48 89
1117 Venezuela 2010-2011
Venezuelan Study of Metabolic Syndrome, Obesity and 
Lifestyle (VEMSOLS) Community urban  20+  20+ 51 154 49 149 49 149
1118 Venezuela 2015-2017
Cardio-Metabolic Health Venezuelan Study 
(EVESCAM) National both  20+  20+ 1,053 2,338 1,045 2,328 1,043 2,325
1119 Viet Nam 2005
Non-communicable disease risk factors in Ho Chi 
Minh City Community urban  25-64  25-64 504 717 Accu-Chek
1120 Viet Nam 2008-2009
The survey on diabetes and its risk factors in 2 northern 
provinces of Vietnam (DM-S) Subnational both  25+  25+ 785 1,345 785 1,345 785 1,345
1121 Viet Nam 2009 STEPS National both  25-64  25-64 5,369 6,581 Accutrend
1122 Viet Nam 2015 STEPS National both  18-69  18-69 1,217 1,650 1,295 1,703 1,200 1,636 CardioChek CardioChek
1123 Yemen 2007-2009 Hypertension and Diabetes in Yemen (HYDY) National rural  18-70  18-70 494 704 Multicare
1124 Yemen 2007-2009 Hypertension and Diabetes in Yemen (HYDY) National urban  18-70  18-70 875 1,039 Multicare
1125 Zambia 2008 STEPS Subnational urban  25+  25+ 347 731 Accutrend
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1126 Zambia 2017 STEPS National both  18-69  18-69 768 1,545 CardioChek
1127 Zimbabwe 2005 STEPS National both  25+  25+ 504 1,628 504 1,628 504 1,628
* In surveys that used a portable device for measuring lipids.
1. The first age group started from <18 years old, but had a mean age ≥18 years.
2. National study conducted between 1977 and 1979, included in the analysis as a 1980 study.
3. This research uses data from China Health and Nutrition Survey (CHNS). We thank the National Institute of Nutrition and Food Safety, China Center for Disease Control and Prevention, Carolina Population Center (5 R24 HD050924), the University of North Carolina at Chapel 
Hill, the NIH (R01‐HD30880, DK056350, R24-HD050924, and R01‐HD38700) and the Fogarty International Center, NIH for financial support for the CHNS data collection and analysis files from 1989 to 2011 and future surveys, and the China‐Japan Friendship Hospital, Ministry 
of Health for support for CHNS 2009.
4. The British Women’s Heart and Health Study is supported by the British Heart Foundation (PG/13/66/30442). British Women’s Heart and Health Study data are available to bona fide researchers for research purposes. Please refer to the BWHHS data sharing policy at 
http://www.ucl.ac.uk/british-womens-heart-health-study.
5. The Older Persons in Jamaica Study was funded by the National Health Fund, Jamaica.
6. The Longitudinal Aging Study Amsterdam is supported by a grant from the Netherlands Ministry of Health Welfare and Sports, Directorate of Long-Term Care.
7. We thank Prof Stephen Fortmann for data from the Stanford Five-City Project.
8. The bibliographic citation for this data source is: Sutton-Tyrrell, Kim, Faith Selzer, MaryFran Sowers, Robert Neer, Lynda Powell, Ellen Gold, Gail Greendale, Gerson Weiss, Karen Matthews, and Sonja McKinlay. Study of Women's Health Across the Nation (SWAN), 1996-
1997: Baseline Dataset. ICPSR28762-v2. Ann Arbor, MI: Inter-university Consortium for Political and Social Research[distributor], 2014-02-04. http://doi.org/10.3886/ICPSR28762.v2
9. Electrophoresis was used for measuring lipid fractions. As this method may be inaccurate in quantifying lipid fractions, mean HDL and non-HDL cholesterol were not included in this analysis.
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Supplementary Table 2. List of analysis regions and “super-regions”, and countries in each 
region. The hierarchical structure of the statistical model consisted of country, region, super-




Sub-Saharan Africa (48) 
Central Africa (6): Angola, Central African Republic, Congo, DR Congo, 
Equatorial Guinea, Gabon 
East Africa (17):  Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, 
Madagascar, Malawi, Mauritius†, Mozambique, Rwanda, Seychelles†, Somalia, 
Sudan (former), Tanzania, Uganda, Zambia 
Southern Africa (6): Botswana, Lesotho, Namibia, South Africa, Swaziland, 
Zimbabwe 
West Africa (19): Benin, Burkina Faso, Cabo Verde, Cameroon, Chad, Cote 
d'Ivoire, Gambia, Ghana, Guinea, Guinea Bissau, Liberia, Mali, Mauritania, Niger, 
Nigeria, Sao Tome and Principe, Senegal, Sierra Leone, Togo 
Central Asia, Middle East 
and North Africa (28) 
Central Asia (9): Armenia, Azerbaijan, Georgia, Kazakhstan, Kyrgyzstan, 
Mongolia, Tajikistan, Turkmenistan, Uzbekistan 
Middle East and North Africa (19): Algeria, Bahrain, Egypt, Iran, Iraq, Jordan, 
Kuwait, Lebanon, Libya, Morocco, Occupied Palestinian Territory, Oman, Qatar, 
Saudi Arabia, Syrian Arab Republic, Tunisia, Turkey, United Arab Emirates, Yemen 
South Asia (6) South Asia (6): Afghanistan, Bangladesh, Bhutan, India, Nepal, Pakistan 
East and Southeast Asia 
(16) 
East Asia (4): China, China (Hong Kong SAR), North Korea, Taiwan 
Southeast Asia (12): Brunei Darussalam, Cambodia, Indonesia, Lao PDR, Malaysia, 
Maldives, Myanmar, Philippines, Sri Lanka, Thailand, Timor-Leste, Viet Nam 
Oceania (17) 
Polynesia and Micronesia (13): American Samoa, Cook Islands, French Polynesia, 
Kiribati, Marshall Islands, Micronesia (Federated States of), Nauru, Niue, Palau, 
Samoa, Tokelau, Tonga, Tuvalu 
Melanesia (4): Fiji, Papua New Guinea, Solomon Islands, Vanuatu 
High-income Asia Pacific 
(3) High-income Asia Pacific (3): Japan, Singapore, South Korea 
Latin America and 
Caribbean (35) 
Andean Latin America (3): Bolivia, Ecuador, Peru 
Caribbean (18): Antigua and Barbuda, Bahamas, Barbados, Belize, Bermuda, Cuba, 
Dominica, Dominican Republic, Grenada, Guyana, Haiti, Jamaica, Puerto Rico, 
Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Suriname, 
Trinidad and Tobago 
Central Latin America (9): Colombia, Costa Rica, El Salvador, Guatemala, 
Honduras, Mexico, Nicaragua, Panama, Venezuela 
Southern Latin America (5): Argentina, Brazil, Chile, Paraguay, Uruguay 
High-income Western 
countries (27) 
High-income English-speaking countries* (6): Australia, Canada, Ireland, New 
Zealand, United Kingdom, United States of America 
North Western Europe (12): Austria, Belgium, Denmark, Finland, Germany, 
Greenland, Iceland, Luxembourg, Netherlands, Norway, Sweden, Switzerland 
South Western Europe (9): Andorra, Cyprus, France, Greece, Israel, Italy, Malta, 
Portugal, Spain 
Central and Eastern 
Europe (20) 
Central Europe (13): Albania, Bosnia and Herzegovina, Bulgaria, Croatia, Czech 
Republic, Hungary, Macedonia (TFYR), Montenegro, Poland, Romania, Serbia, 
Slovakia, Slovenia 
Eastern Europe (7): Belarus, Estonia, Latvia, Lithuania, Moldova, Russian 
Federation, Ukraine 
† Mauritius and Seychelles were grouped with Polynesia and Micronesia in the hierarchical 
analysis, because of their epidemiological similarity. 
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* Although high-income English-speaking countries are geographically separated, they exhibit 
remarkably similar trends in cardiometabolic risk factors and outcomes.2-5 They were therefore 
grouped together so that the statistical model shares information amongst them more than it 
does with other countries that are geographically closer but epidemiologically more distinct. 
 
We did not have data on population by age group for American Samoa, Bermuda, French 
Polynesia, Greenland, and Tokelau. Country-specific estimates were made but were not used in 
calculation of regional and global means because the latter requires weighting by age-specific 
population. 
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Supplementary Table 3. Analytical range of portable devices used for measuring lipids. 
Numbers in brackets show the restricted range of cholesterol levels used for calculating 
cholesterol means for each portable device. 
Portable device Analytical range (mmol/L) Total cholesterol HDL cholesterol 
Accutrend 3.88-7.76 (4.0-7.5)  
Accu-Chek 3.88-7.76 (4.0-7.5)  
CardioChek 2.59-10.36 (2.8-10.0) 0.39-2.59 (0.4-2.4) 
Cholestech 2.58-12.92 (2.8-12.6) 0.39-2.59 (0.4-2.4) 
LipidoCare 2.59-11.65 (2.8-11.3) 0.65-2.47 (0.8-2.3) 
LipidPro 2.59-10.36 (2.8-10.0)  
Multicare 3.30-10.20 (3.5-10.0) 0.39-2.59 (0.4-2.4) 
Reflotron 2.59-12.90 (2.8-12.6) 0.26-2.59 (0.4-2.4) 
HDL: high-density lipoprotein. 
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Supplementary Table 4. Model specifications and regression coefficients to adjust for the 
differences in mean total, non-HDL and HDL cholesterol between portable device and 
laboratory measurement. 
 
The dependent variable in all regressions was means, fitted using a linear model. 




Conversion regression for Accutrend and Accu-Chek (TC) 
Variables Coefficients (95% CI) 
Intercept -3.5 (-3.7, -3.31) 
Unadjusted mean TC (calculated over restricted cholesterol range: 4.0-
7.5 mmol/L) 1.65 (1.61, 1.68) 
Mean age of age group 0.00781 (0.00446, 0.0112) 
Male sex -0.199 (-0.315, -0.0823) 
Unadjusted mean TC * mean age of age group -0.00162 (-0.00227, -0.000978) 
Unadjusted mean TC * male sex 0.0286 (0.00677, 0.0505) 
Number of data points used to fit the model = 4,363  
R2 = 0.952  
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Conversion regression for CardioChek and LipidPro (TC) 
Variables Coefficients (95% CI) 
Intercept -0.251 (-0.283, -0.218) 
Unadjusted mean TC (calculated over restricted cholesterol range: 2.8-
10.0 mmol/L) 1.05 (1.04, 1.06) 
Mean age of age group 0.00112 (0.000573, 0.00167) 
Male sex -0.0322 (-0.0527, -0.0116) 
Unadjusted mean TC * mean age of age group -0.00027 (-0.00038, -0.000159) 
Unadjusted mean TC * male sex 0.00481 (0.000847, 0.00876) 
Number of data points used to fit the model = 4,552  
R2 = 0.996  
  
40
Conversion regression for Cholestech and Reflotron (TC) 
Variables Coefficients (95% CI) 
Intercept -0.229 (-0.257, -0.201) 
Unadjusted mean TC (calculated over restricted cholesterol range: 2.8-
12.6 mmol/L) 1.04 (1.04, 1.05) 
Mean age of age group 0.00191 (0.00143, 0.00239) 
Male sex -0.0604 (-0.0782, -0.0425) 
Unadjusted mean TC * mean age of age group -0.000412 (-0.000508, -0.000316) 
Unadjusted mean TC * male sex 0.0103 (0.00686, 0.0137) 
Number of data points used to fit the model = 4,553  
R2 = 0.997  
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Conversion regression for LipidoCare (TC) 
Variables Coefficients (95% CI) 
Intercept -0.241 (-0.27, -0.211) 
Unadjusted mean TC (calculated over restricted cholesterol range: 2.8-
11.3 mmol/L) 1.05 (1.04, 1.05) 
Mean age of age group 0.00179 (0.00128, 0.00229) 
Male sex -0.0528 (-0.0716, -0.034) 
Unadjusted mean TC * mean age of age group -0.000392 (-0.000493, -0.00029) 
Unadjusted mean TC * male sex 0.00883 (0.00521, 0.0125) 
Number of data points used to fit the model = 4,552  
R2 = 0.997  
  
42
Conversion regression for Multicare (TC) 
Variables Coefficients (95% CI) 
Intercept -1.29 (-1.37, -1.2) 
Unadjusted mean TC (calculated over restricted cholesterol range: 3.5-
10.0 mmol/L) 1.24 (1.22, 1.25) 
Mean age of age group 0.011 (0.00953, 0.0124) 
Male sex -0.228 (-0.279, -0.177) 
Unadjusted mean TC * mean age of age group -0.00219 (-0.00247, -0.0019) 
Unadjusted mean TC * male sex 0.0381 (0.0284, 0.0478) 
Number of data points used to fit the model = 4,503  
R2 = 0.981  
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Conversion regression for CardioChek (non-HDL cholesterol)* 
Variables Coefficients (95% CI) 
Intercept -0.129 (0.159, -0.0982) 
Unadjusted mean non-HDL cholesterol (calculated as TC minus HDL 
cholesterol, using only TC and HDL cholesterol values within 
restricted cholesterol range: 2.8-10.0 mmol/L for TC and 0.4-2.4 
mmol/L for HDL cholesterol) 
1.07 (1.03, 1.11) 
Mean age of age group 0.000217 (-0.000285, 0.000718) 
Male sex -0.0262 (-0.0449, -0.00758) 
Unadjusted mean TC (calculated over restricted cholesterol range: 2.8-
10.0 mmol/L) -0.0385 (-0.0769, -0.00013) 
Unadjusted mean HDL cholesterol (calculated over restricted 
cholesterol range: 0.4-2.4 mmol/L) 0.0514 (0.0105, 0.0924) 
Unadjusted mean non-HDL cholesterol * mean age of age group -0.000119 (-0.000256, 0.0000181) 
Unadjusted mean non-HDL cholesterol * male sex 0.0051 (0.000312, 0.00988) 
Number of data points used to fit the model = 3,956  
R2 = 0.995  
* Both total and HDL cholesterol were measured using the portable device CardioChek. 
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Conversion regression for Cholestech and Reflotron (non-HDL cholesterol)* 
Variables Coefficients (95% CI) 
Intercept -0.122 (-0.149, -0.0958) 
Unadjusted mean non-HDL cholesterol (calculated as TC minus HDL 
cholesterol, using only TC and HDL cholesterol values within 
restricted cholesterol range: 2.8-12.6 mmol/L for TC and 0.4-2.4 
mmol/L for HDL cholesterol) 
1.07 (1.04, 1.1) 
Mean age of age group 0.0009 (0.000464, 0.00134) 
Male sex -0.0477 (-0.064, -0.0315) 
Unadjusted mean TC (calculated over restricted cholesterol range: 2.8-
12.6 mmol/L) -0.0468 (-0.0793, -0.0142) 
Unadjusted mean HDL cholesterol (calculated over restricted 
cholesterol range: 0.4-2.4 mmol/L) 0.0629 (0.0281, 0.0976) 
Unadjusted mean non-HDL cholesterol * mean age of age group -0.000285 (-0.000404, -0.000166) 
Unadjusted mean non-HDL cholesterol * male sex 0.0112 (0.00708, 0.0154) 
Number of data points used to fit the model = 3,957  
R2 = 0.996  
* Both total and HDL cholesterol were measured using the portable device Cholestech or Reflotron. 
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Conversion regression for LipidoCare (non-HDL cholesterol)* 
Variables Coefficients (95% CI) 
Intercept 0.027 (-0.0096, 0.0636) 
Unadjusted mean non-HDL cholesterol (calculated as TC minus HDL 
cholesterol, using only TC and HDL cholesterol values within 
restricted cholesterol range: 2.8-11.3 mmol/L for TC and 0.8-2.3 
mmol/L for HDL cholesterol) 
0.522 (0.493, 0.55) 
Mean age of age group 0.00102 (0.000442, 0.0016) 
Male sex -0.0213 (-0.0428, 0.0002) 
Unadjusted mean TC (calculated over restricted cholesterol range: 2.8-
11.3 mmol/L) 0.515 (0.487, 0.542) 
Unadjusted mean HDL cholesterol (calculated over restricted 
cholesterol range: 0.8-2.3 mmol/L) -0.631 (-0.665, -0.596) 
Unadjusted mean non-HDL cholesterol * mean age of age group -0.000379 (-0.000537, -0.000222) 
Unadjusted mean non-HDL cholesterol * male sex 0.00346 (-0.00204, 0.00896) 
Number of data points used to fit the model = 3,921  
R2 = 0.993  
* Both total and HDL cholesterol were measured using the portable device LipidoCare. 
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Conversion regression for Multicare (non-HDL cholesterol)* 
Variables Coefficients (95% CI) 
Intercept -0.867 (-0.931, -0.802) 
Unadjusted mean non-HDL cholesterol (calculated as TC minus HDL 
cholesterol, using only TC and HDL cholesterol values within 
restricted cholesterol range: 3.5-10.0 mmol/L for TC and 0.4-2.4 
mmol/L for HDL cholesterol) 
1.49 (1.42, 1.56) 
Mean age of age group 0.00449 (0.00342, 0.00555) 
Male sex -0.195 (-0.234, -0.157) 
Unadjusted mean TC (calculated over restricted cholesterol range: 3.5-
10.0 mmol/L) -0.345 (-0.414, -0.275) 
Unadjusted mean HDL cholesterol (calculated over restricted 
cholesterol range: 0.4-2.4 mmol/L) 0.539 (0.466, 0.612) 
Unadjusted mean non-HDL cholesterol * mean age of age group -0.00122 (-0.0015, -0.000933) 
Unadjusted mean non-HDL cholesterol * male sex 0.0464 (0.0366, 0.0561) 
Number of data points used to fit the model = 3,912  
R2 = 0.982  
* Both total and HDL cholesterol were measured using the portable device Multicare. 
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Conversion regression for Accutrend (non-HDL cholesterol)* 
Variables Coefficients (95% CI) 
Intercept -2.52 (-2.66, -2.38) 
Unadjusted mean non-HDL cholesterol (calculated as TC minus HDL 
cholesterol, using only TC values within restricted cholesterol range: 
4.0-7.5 mmol/L) 
1.79 (1.67, 1.92) 
Mean age of age group -0.00214 (-0.00446, 0.000178) 
Male sex -0.236 (-0.32, -0.152) 
Unadjusted mean TC (calculated over restricted cholesterol range: 4.0-
7.5 mmol/L) -0.378 (-0.507, -0.248) 
Mean HDL cholesterol 0.956 (0.828, 1.08) 
Unadjusted mean non-HDL cholesterol * mean age of age group 0.000485 (-0.000117, 0.00109) 
Unadjusted mean non-HDL cholesterol * male sex 0.0517 (0.0307, 0.0727) 
Number of data points used to fit the model = 3,814  
R2 = 0.954  




Conversion regression for Multicare (non-HDL cholesterol)* 
Variables Coefficients (95% CI) 
Intercept -0.863 (-0.924, -0.803) 
Unadjusted mean non-HDL cholesterol (calculated as TC minus HDL 
cholesterol, using only TC values within restricted cholesterol range: 
3.5-10.0 mmol/L) 
1.59 (1.52, 1.67) 
Mean age of age group 0.00406 (0.00306, 0.00506) 
Male sex -0.185 (-0.221, -0.149) 
Unadjusted mean TC (calculated over restricted cholesterol range: 3.5-
10.0 mmol/L) -0.453 (-0.526, -0.379) 
Mean HDL cholesterol 0.648 (0.574, 0.723) 
Unadjusted mean non-HDL cholesterol * mean age of age group -0.00111 (-0.00137, -0.000839) 
Unadjusted mean non-HDL cholesterol * male sex 0.0442 (0.035, 0.0533) 
Number of data points used to fit the model = 3,927  
R2 = 0.984  




Conversion regression for CardioChek, Cholestech, Multicare and Reflotron (HDL cholesterol) 
Variables Coefficients (95% CI) 
Intercept -0.0441 (-0.061, -0.0273) 
Unadjusted mean HDL cholesterol (calculated over restricted 
cholesterol range: 0.4-2.4 mmol/L) 1.04 (1.03, 1.05) 
Mean age of age group -0.00101 (-0.0013, -0.000723) 
Male sex 0.05 (0.038, 0.0619) 
Unadjusted mean HDL cholesterol * mean age of age group 0.000923 (0.000707, 0.00114) 
Unadjusted mean HDL cholesterol * male sex -0.0379 (-0.0471, -0.0288) 
Number of data points used to fit the model = 3,997  
R2 = 0.986  
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Conversion regression for LipidoCare (HDL cholesterol) 
Variables Coefficients (95% CI) 
Intercept -0.241 (-0.267, -0.214) 
Unadjusted mean HDL cholesterol (calculated over restricted 
cholesterol range: 0.8-2.3 mmol/L) 1.17 (1.15, 1.19) 
Mean age of age group -0.00152 (-0.00198, -0.00106) 
Male sex -0.0225 (-0.0423, -0.00273) 
Unadjusted mean HDL cholesterol * mean age of age group 0.00125 (0.000909, 0.00159) 
Unadjusted mean HDL cholesterol * male sex 0.0223 (0.00732, 0.0373) 
Number of data points used to fit the model = 3,962  
R2 = 0.974  
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Supplementary Table 5. Results of model validation. 
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Median Q1 Q3 (p*) Median Q1 Q3 (p*)
2,870 91 -0.04 -0.26 0.17 0.0000 0.21 0.10 0.39 0.0000
Central and eastern Europe 288 90 -0.01 -0.21 0.23 0.8661 0.23 0.11 0.40 0.8661
Central Asia, Middle East and north Africa 573 86 -0.10 -0.36 0.10 0.0000 0.24 0.10 0.45 0.0000
East and southeast Asia 85 91 0.26 -0.04 0.45 0.0000 0.30 0.17 0.45 0.0000
High-income Asia Pacific 159 99 0.12 0.04 0.26 0.0000 0.15 0.07 0.26 0.0000
High-income western countries 1,071 95 -0.07 -0.24 0.13 0.0000 0.19 0.10 0.34 0.0000
Latin America and the Caribbean 241 94 0.02 -0.20 0.19 0.6557 0.19 0.09 0.33 0.6557
Oceania 159 75 -0.03 -0.34 0.25 0.4194 0.31 0.11 0.58 0.4194
South Asia 135 88 -0.08 -0.43 0.14 0.0014 0.25 0.13 0.52 0.0014
Sub-Saharan Africa 159 82 -0.13 -0.39 0.13 0.0002 0.28 0.13 0.53 0.0002
Rural 300 82 -0.15 -0.42 0.15 0.0000 0.29 0.15 0.57 0.0000
Urban 914 90 -0.02 -0.24 0.19 0.0096 0.21 0.10 0.40 0.0096
Both rural and urban 1,656 92 -0.03 -0.24 0.16 0.0000 0.20 0.09 0.37 0.0000
Community 847 86 -0.07 -0.34 0.18 0.0000 0.26 0.11 0.47 0.0000
Subnational 708 90 -0.10 -0.30 0.11 0.0000 0.22 0.10 0.40 0.0000
National 1,315 94 0.01 -0.18 0.19 0.7346 0.19 0.09 0.34 0.7346
18-40 940 92 -0.01 -0.18 0.15 0.0501 0.17 0.09 0.32 0.0501
40-60 925 89 -0.05 -0.27 0.15 0.0000 0.21 0.09 0.38 0.0000
60 and above 1,005 91 -0.05 -0.31 0.21 0.0000 0.26 0.12 0.47 0.0000
1980-1989 275 85 -0.09 -0.39 0.24 0.0056 0.33 0.16 0.48 0.0056
1990-1999 484 89 -0.05 -0.32 0.17 0.0003 0.24 0.10 0.43 0.0003
2000-2009 1,112 89 -0.06 -0.27 0.16 0.0000 0.22 0.10 0.42 0.0000
2010-2018 999 95 -0.01 -0.18 0.17 0.1785 0.18 0.08 0.31 0.1785
Data poor 165 90 0.10 -0.12 0.34 0.0009 0.26 0.11 0.43 0.0009
Average data density 471 86 -0.01 -0.25 0.23 0.6390 0.24 0.11 0.44 0.6390








Urban or rural 
studies
Super-region
Mean TC, Test 1, Women





Median Q1 Q3 (p*) Median Q1 Q3 (p*)
2,853 92 0.03 -0.19 0.27 0.0000 0.23 0.11 0.41 0.0000
Central and eastern Europe 205 91 0.05 -0.25 0.31 0.3030 0.29 0.16 0.46 0.3030
Central Asia, Middle East and north Africa 293 95 0.02 -0.21 0.25 0.3192 0.23 0.11 0.38 0.3192
East and southeast Asia 211 80 -0.01 -0.26 0.16 0.1600 0.21 0.10 0.54 0.1600
High-income Asia Pacific
High-income western countries 1,531 95 0.07 -0.14 0.30 0.0000 0.21 0.10 0.37 0.0000
Latin America and the Caribbean 348 95 0.03 -0.17 0.24 0.2182 0.22 0.09 0.44 0.2182
Oceania 146 74 -0.14 -0.53 0.28 0.0332 0.40 0.20 0.69 0.0332
South Asia 26 100 0.08 -0.22 0.29 0.3032 0.26 0.13 0.38 0.3032
Sub-Saharan Africa 93 84 -0.16 -0.56 0.09 0.0001 0.25 0.15 0.56 0.0001
Rural 315 90 0.04 -0.23 0.36 0.0335 0.30 0.15 0.50 0.0335
Urban 878 92 0.08 -0.13 0.28 0.0000 0.21 0.10 0.38 0.0000
Both rural and urban 1,660 92 0.01 -0.21 0.25 0.0479 0.23 0.10 0.39 0.0479
Community 937 92 0.08 -0.17 0.31 0.0000 0.25 0.12 0.42 0.0000
Subnational 734 90 0.01 -0.19 0.26 0.0058 0.22 0.10 0.44 0.0058
National 1,182 93 0.02 -0.20 0.24 0.1098 0.23 0.10 0.38 0.1098
18-40 898 92 0.03 -0.16 0.26 0.0003 0.21 0.10 0.38 0.0003
40-60 895 89 0.00 -0.22 0.21 0.8472 0.21 0.10 0.39 0.8472
60 and above 1,060 94 0.07 -0.18 0.33 0.0000 0.26 0.12 0.44 0.0000
1980-1989 359 91 0.07 -0.18 0.30 0.0034 0.26 0.13 0.43 0.0034
1990-1999 601 90 0.01 -0.22 0.28 0.0575 0.25 0.11 0.42 0.0575
2000-2009 1,031 91 0.05 -0.16 0.28 0.0000 0.22 0.10 0.40 0.0000
2010-2018 862 95 0.00 -0.20 0.24 0.1769 0.22 0.10 0.39 0.1769
Data poor 165 91 0.10 -0.17 0.34 0.0335 0.26 0.15 0.48 0.0335
Average data density 420 88 -0.05 -0.36 0.22 0.0061 0.29 0.16 0.50 0.0061







Mean TC, Test 1, Men
Data




Error (mmol/L)† Absolute error (mmol/L)
No data from this region were among the held-out data
Super-region
Urban or rural 
studies
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Median Q1 Q3 (p*) Median Q1 Q3 (p*)
2,971 83 -0.04 -0.23 0.16 0.0000 0.20 0.09 0.35 0.0000
Central and eastern Europe 195 89 -0.18 -0.30 -0.01 0.0000 0.23 0.14 0.35 0.0000
Central Asia, Middle East and north Africa 407 78 -0.02 -0.22 0.21 0.7609 0.22 0.10 0.41 0.7609
East and southeast Asia 264 74 -0.08 -0.30 0.13 0.0002 0.21 0.10 0.47 0.0002
High-income Asia Pacific 353 92 -0.08 -0.23 0.09 0.0000 0.17 0.09 0.30 0.0000
High-income western countries 1,132 85 -0.02 -0.17 0.15 0.1350 0.16 0.07 0.31 0.1350
Latin America and the Caribbean 289 87 -0.03 -0.26 0.21 0.3297 0.24 0.12 0.40 0.3297
Oceania 117 76 -0.06 -0.34 0.32 0.7074 0.34 0.15 0.55 0.7074
South Asia 119 78 0.09 -0.10 0.31 0.0029 0.27 0.09 0.42 0.0029
Sub-Saharan Africa 95 75 -0.02 -0.34 0.23 0.4590 0.30 0.14 0.74 0.4590
Rural 357 80 -0.02 -0.25 0.23 0.5027 0.24 0.10 0.45 0.5027
Urban 804 81 0.00 -0.19 0.20 0.7213 0.19 0.08 0.36 0.7213
Both rural and urban 1,810 85 -0.06 -0.24 0.14 0.0000 0.20 0.10 0.34 0.0000
Community 911 81 -0.02 -0.23 0.19 0.0567 0.22 0.09 0.38 0.0567
Subnational 713 84 -0.03 -0.17 0.17 0.3497 0.17 0.08 0.33 0.3497
National 1,347 85 -0.06 -0.26 0.14 0.0000 0.20 0.10 0.34 0.0000
18-40 922 82 -0.08 -0.25 0.10 0.0000 0.19 0.09 0.33 0.0000
40-60 916 82 -0.05 -0.23 0.14 0.0000 0.19 0.09 0.34 0.0000
60 and above 1,133 86 0.01 -0.19 0.23 0.0973 0.21 0.10 0.40 0.0973
1980-1989 208 69 -0.01 -0.17 0.28 0.5523 0.24 0.09 0.45 0.5523
1990-1999 232 75 0.01 -0.18 0.20 0.4562 0.19 0.10 0.37 0.4562
2000-2009 1,507 82 -0.04 -0.22 0.17 0.0007 0.20 0.09 0.35 0.0007
2010-2018 1,024 90 -0.06 -0.24 0.13 0.0000 0.20 0.09 0.34 0.0000
Average data density 446 83 -0.04 -0.24 0.24 0.9675 0.24 0.11 0.42 0.9675
Data rich 2,525 83 -0.04 -0.23 0.15 0.0000 0.19 0.09 0.34 0.0000
Post-2000 data removed 1,519 87 -0.06 -0.25 0.13 0.0000 0.19 0.09 0.34 0.0000











Mean TC, Test 2, Women
Data




Error (mmol/L)† Absolute error (mmol/L)
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Median Q1 Q3 (p*) Median Q1 Q3 (p*)
2,921 82 -0.03 -0.23 0.17 0.0000 0.20 0.09 0.36 0.0000
Central and eastern Europe 223 83 -0.16 -0.35 0.09 0.0000 0.24 0.12 0.40 0.0000
Central Asia, Middle East and north Africa 381 83 -0.08 -0.27 0.11 0.0000 0.19 0.09 0.35 0.0000
East and southeast Asia 243 72 0.03 -0.19 0.22 0.2802 0.20 0.11 0.46 0.2802
High-income Asia Pacific 290 93 0.00 -0.09 0.13 0.1158 0.11 0.06 0.20 0.1158
High-income western countries 1,137 84 -0.01 -0.19 0.19 0.7688 0.19 0.09 0.32 0.7688
Latin America and the Caribbean 314 86 -0.09 -0.27 0.17 0.0072 0.24 0.12 0.41 0.0072
Oceania 103 69 -0.06 -0.38 0.27 0.2241 0.32 0.16 0.58 0.2241
South Asia 143 66 0.02 -0.38 0.26 0.3390 0.29 0.18 0.54 0.3390
Sub-Saharan Africa 87 68 -0.08 -0.35 0.32 0.4349 0.34 0.16 0.61 0.4349
Rural 340 78 -0.03 -0.26 0.20 0.1302 0.23 0.10 0.45 0.1302
Urban 765 79 0.01 -0.23 0.20 0.5382 0.21 0.10 0.37 0.5382
Both rural and urban 1,816 84 -0.05 -0.22 0.16 0.0000 0.19 0.09 0.34 0.0000
Community 971 80 -0.03 -0.25 0.17 0.0004 0.21 0.10 0.37 0.0004
Subnational 641 78 -0.04 -0.23 0.16 0.0134 0.21 0.09 0.39 0.0134
National 1,309 85 -0.03 -0.20 0.18 0.0832 0.19 0.09 0.34 0.0832
18-40 902 80 -0.07 -0.25 0.14 0.0000 0.20 0.10 0.34 0.0000
40-60 909 82 -0.05 -0.23 0.13 0.0000 0.19 0.09 0.34 0.0000
60 and above 1,110 84 0.01 -0.19 0.23 0.1308 0.21 0.10 0.40 0.1308
1980-1989 268 77 0.08 -0.14 0.23 0.0063 0.20 0.09 0.37 0.0063
1990-1999 360 81 -0.03 -0.20 0.16 0.1780 0.18 0.09 0.35 0.1780
2000-2009 1,356 81 -0.02 -0.21 0.18 0.0531 0.20 0.09 0.35 0.0531
2010-2018 937 86 -0.08 -0.26 0.14 0.0000 0.21 0.10 0.37 0.0000
Average data density 467 78 -0.09 -0.35 0.17 0.0000 0.29 0.13 0.49 0.0000
Data rich 2,454 83 -0.02 -0.20 0.17 0.0071 0.19 0.09 0.33 0.0071
Post-2000 data removed 875 84 -0.03 -0.24 0.22 0.0773 0.23 0.12 0.39 0.0773
Random set of data removed 2,046 81 -0.03 -0.21 0.15 0.0000 0.18 0.09 0.35 0.0000
Super-region









Mean TC, Test 2, Men
Data




Error (mmol/L)† Absolute error (mmol/L)
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Median Q1 Q3 (p*) Median Q1 Q3 (p*)
2,333 83 0.03 -0.14 0.24 0.0000 0.19 0.08 0.36 0.0000
Central and eastern Europe 195 93 0.04 -0.10 0.17 0.0193 0.15 0.07 0.25 0.0193
Central Asia, Middle East and north Africa 265 91 0.00 -0.16 0.20 0.4336 0.17 0.08 0.30 0.4336
East and southeast Asia 101 86 0.08 -0.23 0.25 0.1754 0.24 0.14 0.38 0.1754
High-income Asia Pacific 469 51 0.47 0.03 0.69 0.0000 0.47 0.18 0.69 0.0000
High-income western countries 1,010 91 -0.02 -0.16 0.12 0.0055 0.15 0.07 0.27 0.0055
Latin America and the Caribbean 152 93 0.01 -0.16 0.16 0.7819 0.16 0.06 0.30 0.7819
Oceania 52 75 0.00 -0.26 0.31 0.9528 0.27 0.11 0.46 0.9528
South Asia 39 90 -0.08 -0.22 0.01 0.0268 0.16 0.08 0.36 0.0268
Sub-Saharan Africa 50 86 -0.11 -0.28 0.07 0.0053 0.22 0.09 0.36 0.0053
Rural 261 57 0.19 -0.17 0.84 0.0000 0.42 0.17 0.84 0.0000
Urban 685 91 0.01 -0.14 0.19 0.0309 0.16 0.07 0.28 0.0309
Both rural and urban 1,387 84 0.02 -0.13 0.23 0.0000 0.18 0.08 0.36 0.0000
Community 664 75 0.06 -0.15 0.38 0.0000 0.23 0.11 0.50 0.0000
Subnational 565 89 -0.02 -0.16 0.13 0.1110 0.14 0.07 0.28 0.1110
National 1,104 84 0.04 -0.11 0.27 0.0000 0.19 0.07 0.35 0.0000
18-40 718 89 0.05 -0.09 0.23 0.0000 0.16 0.07 0.31 0.0000
40-60 736 75 0.02 -0.12 0.23 0.0000 0.17 0.07 0.35 0.0000
60 and above 879 85 0.01 -0.18 0.29 0.0003 0.21 0.09 0.44 0.0003
1980-1989 262 79 0.07 -0.11 0.28 0.0000 0.20 0.08 0.41 0.0000
1990-1999 459 63 0.15 -0.09 0.57 0.0000 0.31 0.12 0.62 0.0000
2000-2009 863 85 0.03 -0.13 0.24 0.0000 0.18 0.08 0.35 0.0000
2010-2018 749 94 -0.03 -0.17 0.13 0.0094 0.15 0.07 0.27 0.0094
Data poor 153 93 0.03 -0.15 0.20 0.3682 0.17 0.08 0.28 0.3682
Average data density 316 84 -0.04 -0.23 0.21 0.4483 0.22 0.10 0.36 0.4483
Data rich 1,864 82 0.03 -0.12 0.27 0.0000 0.18 0.08 0.37 0.0000
Mean non-HDL cholesterol, Test 1, Women
Data















Median Q1 Q3 (p*) Median Q1 Q3 (p*)
2,367 89 0.05 -0.13 0.21 0.0000 0.18 0.08 0.32 0.0000
Central and eastern Europe 265 89 0.11 -0.02 0.26 0.0000 0.16 0.07 0.32 0.0000
Central Asia, Middle East and north Africa 519 89 -0.05 -0.23 0.13 0.0000 0.19 0.09 0.32 0.0000
East and southeast Asia 66 77 -0.03 -0.26 0.31 0.8731 0.29 0.14 0.43 0.8731
High-income Asia Pacific 132 100 0.02 -0.08 0.12 0.3582 0.11 0.06 0.15 0.3582
High-income western countries 1,048 90 0.10 -0.07 0.27 0.0000 0.18 0.08 0.32 0.0000
Latin America and the Caribbean 211 93 -0.01 -0.19 0.14 0.1870 0.16 0.09 0.26 0.1870
Oceania 54 69 -0.04 -0.29 0.37 0.9931 0.35 0.16 0.57 0.9931
South Asia
Sub-Saharan Africa 72 76 0.01 -0.32 0.21 0.1485 0.25 0.15 0.42 0.1485
Rural 359 91 0.00 -0.19 0.20 0.6685 0.19 0.09 0.33 0.6685
Urban 625 89 0.04 -0.15 0.21 0.0031 0.18 0.08 0.31 0.0031
Both rural and urban 1,383 89 0.05 -0.11 0.21 0.0000 0.17 0.08 0.31 0.0000
Community 877 89 0.03 -0.16 0.19 0.0262 0.18 0.08 0.32 0.0262
Subnational 423 86 0.05 -0.14 0.22 0.0060 0.19 0.09 0.33 0.0060
National 1,067 91 0.06 -0.10 0.21 0.0000 0.16 0.08 0.31 0.0000
18-40 742 92 0.03 -0.14 0.18 0.0113 0.16 0.08 0.29 0.0113
40-60 746 85 0.04 -0.13 0.18 0.0016 0.16 0.08 0.27 0.0016
60 and above 879 91 0.08 -0.12 0.27 0.0000 0.21 0.10 0.37 0.0000
1980-1989 257 85 0.08 -0.11 0.23 0.0001 0.18 0.09 0.32 0.0001
1990-1999 298 90 0.07 -0.08 0.22 0.0000 0.17 0.08 0.28 0.0000
2000-2009 983 89 0.04 -0.14 0.22 0.0000 0.19 0.08 0.33 0.0000
2010-2018 829 91 0.03 -0.15 0.18 0.0067 0.16 0.09 0.31 0.0067
Data poor 162 90 -0.06 -0.24 0.19 0.0575 0.21 0.11 0.35 0.0575
Average data density 330 82 0.01 -0.21 0.23 0.5580 0.22 0.11 0.40 0.5580






Mean non-HDL cholesterol, Test 1, Men
Data




Error (mmol/L)† Absolute error (mmol/L)
No data from this region were among the held-out data
All
Super-region
Urban or rural 
studies
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Median Q1 Q3 (p*) Median Q1 Q3 (p*)
2,261 81 0.01 -0.14 0.17 0.0342 0.16 0.07 0.29 0.0342
Central and eastern Europe 197 88 0.05 -0.07 0.16 0.0008 0.13 0.06 0.25 0.0008
Central Asia, Middle East and north Africa 326 73 0.01 -0.15 0.22 0.1930 0.18 0.08 0.33 0.1930
East and southeast Asia 183 64 0.11 -0.19 0.34 0.0051 0.29 0.13 0.49 0.0051
High-income Asia Pacific 241 94 0.00 -0.07 0.08 0.8826 0.08 0.04 0.15 0.8826
High-income western countries 919 83 0.00 -0.14 0.15 0.3720 0.15 0.07 0.25 0.3720
Latin America and the Caribbean 207 87 -0.04 -0.21 0.16 0.0294 0.19 0.08 0.32 0.0294
Oceania 40 63 0.30 0.17 0.48 0.0000 0.33 0.21 0.49 0.0000
South Asia 119 77 -0.05 -0.29 0.13 0.1458 0.21 0.09 0.40 0.1458
Sub-Saharan Africa 29 62 -0.22 -0.80 0.01 0.0006 0.29 0.13 0.80 0.0006
Rural 238 78 0.01 -0.21 0.21 0.9587 0.21 0.09 0.36 0.9587
Urban 697 84 0.03 -0.11 0.18 0.0004 0.15 0.07 0.26 0.0004
Both rural and urban 1,326 80 0.00 -0.15 0.15 0.7615 0.15 0.06 0.29 0.7615
Community 755 80 0.03 -0.15 0.19 0.0237 0.18 0.08 0.31 0.0237
Subnational 491 83 0.01 -0.13 0.17 0.1183 0.15 0.06 0.26 0.1183
National 1,015 81 0.00 -0.14 0.14 0.9941 0.14 0.06 0.29 0.9941
18-40 705 81 -0.01 -0.16 0.13 0.1500 0.15 0.07 0.27 0.1500
40-60 712 81 0.00 -0.13 0.15 0.6016 0.14 0.07 0.26 0.6016
60 and above 844 81 0.04 -0.13 0.22 0.0001 0.18 0.08 0.35 0.0001
1980-1989 254 89 0.03 -0.10 0.17 0.0029 0.14 0.06 0.22 0.0029
1990-1999 202 75 0.07 -0.12 0.20 0.0116 0.17 0.09 0.29 0.0116
2000-2009 984 78 0.01 -0.15 0.18 0.1611 0.17 0.07 0.34 0.1611
2010-2018 821 84 -0.01 -0.16 0.14 0.3072 0.15 0.07 0.28 0.3072
Average data density 365 73 -0.04 -0.25 0.21 0.2208 0.23 0.10 0.41 0.2208
Data rich 1,896 83 0.02 -0.12 0.16 0.0016 0.14 0.07 0.27 0.0016
Post-2000 data removed 683 82 0.04 -0.10 0.22 0.0000 0.16 0.07 0.34 0.0000











Mean non-HDL cholesterol, Test 2, Women
Data




Error (mmol/L)† Absolute error (mmol/L)
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Median Q1 Q3 (p*) Median Q1 Q3 (p*)
2,421 77 0.00 -0.17 0.18 0.7216 0.17 0.08 0.31 0.7216
Central and eastern Europe 228 85 0.02 -0.13 0.15 0.3976 0.14 0.07 0.27 0.3976
Central Asia, Middle East and north Africa 314 74 -0.02 -0.21 0.19 0.5000 0.20 0.09 0.34 0.5000
East and southeast Asia 222 64 0.05 -0.23 0.26 0.3250 0.25 0.13 0.38 0.3250
High-income Asia Pacific 249 91 0.00 -0.09 0.10 0.9965 0.10 0.05 0.19 0.9965
High-income western countries 1,018 78 0.02 -0.14 0.18 0.0245 0.16 0.08 0.28 0.0245
Latin America and the Caribbean 264 83 -0.04 -0.20 0.15 0.1148 0.18 0.10 0.35 0.1148
Oceania 40 58 0.24 -0.25 0.49 0.0408 0.43 0.26 0.59 0.0408
South Asia 66 47 -0.33 -0.67 -0.01 0.0000 0.45 0.18 0.73 0.0000
Sub-Saharan Africa 20 60 -0.15 -0.66 0.23 0.0826 0.35 0.19 0.66 0.0826
Rural 326 74 0.01 -0.24 0.22 0.5434 0.23 0.11 0.39 0.5434
Urban 712 77 0.01 -0.15 0.20 0.2143 0.17 0.09 0.32 0.2143
Both rural and urban 1,383 78 -0.01 -0.17 0.16 0.8222 0.16 0.07 0.29 0.8222
Community 896 77 0.00 -0.18 0.20 0.9364 0.19 0.09 0.34 0.9364
Subnational 513 80 0.02 -0.13 0.19 0.0093 0.16 0.07 0.28 0.0093
National 1,012 76 -0.01 -0.18 0.15 0.1779 0.17 0.08 0.31 0.1779
18-40 742 74 -0.04 -0.20 0.15 0.0014 0.18 0.09 0.32 0.0014
40-60 770 77 -0.01 -0.17 0.15 0.3484 0.16 0.07 0.29 0.3484
60 and above 909 80 0.05 -0.13 0.21 0.0000 0.18 0.08 0.34 0.0000
1980-1989 257 75 0.00 -0.17 0.19 0.9799 0.18 0.09 0.30 0.9799
1990-1999 270 79 0.00 -0.15 0.19 0.2665 0.16 0.09 0.27 0.2665
2000-2009 1,076 73 0.00 -0.17 0.19 0.5753 0.18 0.08 0.35 0.5753
2010-2018 818 83 0.00 -0.17 0.15 0.4592 0.16 0.07 0.28 0.4592
Average data density 340 70 0.01 -0.26 0.25 0.9954 0.25 0.12 0.44 0.9954
Data rich 2,081 79 0.00 -0.16 0.16 0.6968 0.16 0.08 0.29 0.6968
Post-2000 data removed 760 76 -0.01 -0.21 0.20 0.4137 0.20 0.10 0.35 0.4137
Random set of data removed 1,661 78 0.01 -0.15 0.17 0.3000 0.16 0.07 0.30 0.3000
Hold out pattern









Mean non-HDL cholesterol, Test 2, Men
Data




Error (mmol/L)† Absolute error (mmol/L)
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Median Q1 Q3 (p*) Median Q1 Q3 (p*)
2,349 90 0.01 -0.08 0.11 0.0000 0.09 0.05 0.16 0.0000
Central and eastern Europe 77 99 -0.05 -0.12 0.04 0.0226 0.09 0.05 0.14 0.0226
Central Asia, Middle East and north Africa 387 83 0.07 -0.05 0.15 0.0000 0.12 0.06 0.19 0.0000
East and southeast Asia 124 87 -0.02 -0.10 0.11 0.6817 0.11 0.05 0.17 0.6817
High-income Asia Pacific 132 85 0.13 0.05 0.24 0.0000 0.13 0.06 0.24 0.0000
High-income western countries 1,268 92 -0.03 -0.09 0.06 0.0000 0.08 0.04 0.14 0.0000
Latin America and the Caribbean 141 98 0.03 -0.05 0.09 0.0131 0.07 0.04 0.13 0.0131
Oceania 42 86 0.03 -0.06 0.17 0.4646 0.11 0.05 0.23 0.4646
South Asia 120 76 0.16 0.11 0.24 0.0000 0.17 0.12 0.24 0.0000
Sub-Saharan Africa 58 100 0.03 -0.01 0.14 0.0009 0.06 0.03 0.14 0.0009
Rural 215 83 0.06 -0.02 0.15 0.0000 0.10 0.05 0.18 0.0000
Urban 729 89 0.02 -0.07 0.12 0.0002 0.10 0.05 0.17 0.0002
Both rural and urban 1,405 91 0.00 -0.08 0.10 0.3767 0.09 0.04 0.15 0.3767
Community 627 88 0.05 -0.03 0.14 0.0000 0.10 0.05 0.17 0.0000
Subnational 714 88 0.00 -0.09 0.09 0.5538 0.09 0.04 0.17 0.5538
National 1,008 93 -0.01 -0.08 0.10 0.5867 0.09 0.04 0.16 0.5867
18-40 766 91 0.03 -0.06 0.12 0.0000 0.09 0.04 0.16 0.0000
40-60 722 89 0.01 -0.08 0.10 0.1002 0.09 0.05 0.16 0.1002
60 and above 861 89 0.00 -0.09 0.11 0.4448 0.10 0.05 0.18 0.4448
1980-1989 223 82 -0.01 -0.11 0.10 0.5766 0.10 0.05 0.17 0.5766
1990-1999 290 91 -0.01 -0.09 0.08 0.7555 0.09 0.04 0.15 0.7555
2000-2009 939 88 0.02 -0.06 0.13 0.0000 0.10 0.05 0.17 0.0000
2010-2018 897 93 0.01 -0.08 0.10 0.0762 0.09 0.04 0.16 0.0762
Data poor 158 94 0.04 -0.08 0.14 0.0158 0.11 0.06 0.18 0.0158
Average data density 305 88 0.00 -0.10 0.08 0.7629 0.09 0.05 0.16 0.7629










Mean HDL cholesterol, Test 1, Women
Data




Error (mmol/L)† Absolute error (mmol/L)
61
Median Q1 Q3 (p*) Median Q1 Q3 (p*)
2,382 92 0.00 -0.08 0.08 0.9468 0.08 0.04 0.13 0.9468
Central and eastern Europe 145 91 -0.05 -0.10 0.05 0.0026 0.09 0.05 0.14 0.0026
Central Asia, Middle East and north Africa 332 86 0.02 -0.05 0.11 0.0009 0.08 0.03 0.16 0.0009
East and southeast Asia 146 99 -0.04 -0.11 0.03 0.0000 0.08 0.04 0.12 0.0000
High-income Asia Pacific 132 99 0.03 -0.04 0.07 0.0048 0.06 0.03 0.10 0.0048
High-income western countries 1,246 94 -0.01 -0.07 0.07 0.1985 0.07 0.04 0.12 0.1985
Latin America and the Caribbean 241 91 0.04 -0.04 0.11 0.0000 0.07 0.04 0.14 0.0000
Oceania 91 59 -0.09 -0.26 0.12 0.0068 0.19 0.12 0.31 0.0068
South Asia 6 83 -0.16 -0.16 -0.15 0.0313 0.16 0.15 0.16 0.0313
Sub-Saharan Africa 43 95 0.00 -0.09 0.15 0.2670 0.11 0.07 0.16 0.2670
Rural 309 89 0.03 -0.06 0.12 0.0010 0.09 0.04 0.16 0.0010
Urban 661 93 0.01 -0.06 0.10 0.0000 0.08 0.04 0.13 0.0000
Both rural and urban 1,412 92 -0.02 -0.09 0.06 0.0000 0.07 0.04 0.13 0.0000
Community 889 90 0.02 -0.06 0.11 0.0000 0.08 0.04 0.15 0.0000
Subnational 432 94 -0.01 -0.07 0.07 0.2245 0.07 0.03 0.12 0.2245
National 1,061 92 -0.02 -0.09 0.06 0.0000 0.07 0.04 0.12 0.0000
18-40 742 92 -0.01 -0.08 0.07 0.0360 0.08 0.04 0.13 0.0360
40-60 735 90 0.00 -0.08 0.07 0.6052 0.08 0.04 0.13 0.6052
60 and above 905 93 0.01 -0.07 0.09 0.0151 0.08 0.04 0.14 0.0151
1980-1989 245 85 -0.01 -0.08 0.08 0.6952 0.08 0.04 0.16 0.6952
1990-1999 326 87 0.00 -0.07 0.10 0.1208 0.08 0.04 0.14 0.1208
2000-2009 1,015 94 -0.01 -0.08 0.08 0.6163 0.08 0.04 0.13 0.6163
2010-2018 796 92 0.01 -0.08 0.07 0.9824 0.07 0.04 0.13 0.9824
Data poor 161 88 0.05 -0.07 0.17 0.0000 0.12 0.06 0.19 0.0000
Average data density 302 85 -0.05 -0.14 0.05 0.0000 0.10 0.05 0.17 0.0000
Data rich 1,919 93 0.00 -0.07 0.08 0.2054 0.07 0.03 0.12 0.2054









Mean HDL cholesterol, Test 1, Men
Data




Error (mmol/L)† Absolute error (mmol/L)
62
Median Q1 Q3 (p*) Median Q1 Q3 (p*)
2,437 75 0.00 -0.08 0.08 0.4522 0.08 0.04 0.15 0.4522
Central and eastern Europe 189 75 0.02 -0.06 0.10 0.0726 0.08 0.04 0.14 0.0726
Central Asia, Middle East and north Africa 286 66 0.00 -0.08 0.07 0.6409 0.08 0.04 0.17 0.6409
East and southeast Asia 216 73 0.00 -0.08 0.09 0.8147 0.08 0.03 0.14 0.8147
High-income Asia Pacific 245 84 -0.02 -0.09 0.05 0.0004 0.06 0.03 0.10 0.0004
High-income western countries 1,092 72 0.01 -0.08 0.09 0.1257 0.09 0.04 0.16 0.1257
Latin America and the Caribbean 221 88 -0.03 -0.10 0.05 0.0003 0.07 0.04 0.14 0.0003
Oceania 40 65 -0.14 -0.24 -0.04 0.0000 0.15 0.06 0.24 0.0000
South Asia 120 73 0.11 0.03 0.19 0.0000 0.13 0.06 0.19 0.0000
Sub-Saharan Africa 28 93 0.01 -0.07 0.05 0.8842 0.06 0.04 0.10 0.8842
Rural 299 69 0.02 -0.08 0.13 0.0233 0.10 0.05 0.19 0.0233
Urban 687 67 0.03 -0.08 0.11 0.0002 0.10 0.05 0.16 0.0002
Both rural and urban 1,451 79 -0.01 -0.08 0.06 0.0014 0.07 0.04 0.13 0.0014
Community 822 72 0.02 -0.07 0.10 0.0003 0.08 0.04 0.16 0.0003
Subnational 529 70 0.02 -0.09 0.10 0.1156 0.09 0.05 0.16 0.1156
National 1,086 79 -0.02 -0.09 0.06 0.0009 0.08 0.04 0.13 0.0009
18-40 771 74 0.02 -0.06 0.10 0.0000 0.08 0.04 0.15 0.0000
40-60 748 73 0.00 -0.09 0.07 0.5525 0.08 0.04 0.14 0.5525
60 and above 918 77 -0.01 -0.09 0.07 0.0183 0.08 0.04 0.15 0.0183
1980-1989 184 60 0.02 -0.08 0.11 0.2408 0.09 0.05 0.18 0.2408
1990-1999 221 71 0.02 -0.07 0.08 0.1157 0.07 0.04 0.14 0.1157
2000-2009 1,188 73 0.00 -0.08 0.08 0.9607 0.08 0.04 0.14 0.9607
2010-2018 844 81 0.00 -0.08 0.08 0.8982 0.08 0.04 0.14 0.8982
Average data density 365 80 -0.02 -0.09 0.08 0.1008 0.09 0.05 0.16 0.1008
Data rich 2,072 74 0.01 -0.08 0.08 0.1157 0.08 0.04 0.14 0.1157
Post-2000 data removed 1,012 79 0.00 -0.09 0.08 0.6130 0.08 0.04 0.14 0.6130











Mean HDL cholesterol, Test 2, Women
Data




Error (mmol/L)† Absolute error (mmol/L)
63
Median Q1 Q3 (p*) Median Q1 Q3 (p*)
2,382 79 0.01 -0.06 0.07 0.0287 0.07 0.03 0.13 0.0287
Central and eastern Europe 159 86 0.01 -0.03 0.06 0.0422 0.06 0.02 0.10 0.0422
Central Asia, Middle East and north Africa 327 66 0.02 -0.08 0.10 0.1354 0.09 0.04 0.16 0.1354
East and southeast Asia 212 75 0.02 -0.06 0.09 0.0344 0.08 0.04 0.15 0.0344
High-income Asia Pacific 242 88 -0.03 -0.08 0.00 0.0000 0.04 0.02 0.08 0.0000
High-income western countries 1,007 80 0.01 -0.05 0.07 0.0028 0.06 0.03 0.11 0.0028
Latin America and the Caribbean 255 85 0.00 -0.08 0.07 0.5987 0.08 0.03 0.14 0.5987
Oceania 40 60 -0.02 -0.19 0.10 0.2424 0.14 0.04 0.23 0.2424
South Asia 121 75 0.04 -0.02 0.12 0.0014 0.09 0.04 0.17 0.0014
Sub-Saharan Africa 19 84 0.01 -0.08 0.11 0.6226 0.10 0.07 0.15 0.6226
Rural 246 79 0.01 -0.07 0.09 0.2752 0.08 0.03 0.14 0.2752
Urban 693 73 0.02 -0.06 0.09 0.0470 0.08 0.03 0.13 0.0470
Both rural and urban 1,443 81 0.00 -0.06 0.06 0.4108 0.06 0.03 0.12 0.4108
Community 861 74 0.01 -0.07 0.09 0.0921 0.08 0.04 0.14 0.0921
Subnational 483 80 0.01 -0.06 0.08 0.0082 0.07 0.03 0.13 0.0082
National 1,038 82 0.00 -0.06 0.05 0.8147 0.06 0.02 0.11 0.8147
18-40 720 78 0.02 -0.05 0.08 0.0019 0.07 0.03 0.13 0.0019
40-60 740 76 0.00 -0.07 0.07 0.5225 0.07 0.03 0.13 0.5225
60 and above 922 82 0.00 -0.06 0.06 0.9069 0.06 0.03 0.12 0.9069
1980-1989 186 61 0.05 -0.04 0.14 0.0001 0.10 0.04 0.18 0.0001
1990-1999 221 73 0.02 -0.06 0.08 0.0650 0.08 0.04 0.14 0.0650
2000-2009 1,144 80 0.00 -0.07 0.06 0.3022 0.06 0.03 0.12 0.3022
2010-2018 831 83 0.00 -0.06 0.07 0.1440 0.06 0.03 0.12 0.1440
Average data density 353 82 -0.02 -0.12 0.07 0.0022 0.10 0.04 0.16 0.0022
Data rich 2,029 78 0.01 -0.05 0.07 0.0001 0.06 0.03 0.12 0.0001
Post-2000 data removed 901 91 0.00 -0.05 0.06 0.2062 0.05 0.03 0.10 0.2062
Random set of data removed 1,481 71 0.01 -0.07 0.08 0.0778 0.08 0.03 0.14 0.0778
Hold out pattern









Mean HDL cholesterol, Test 2, Men
Data




Error (mmol/L)† Absolute error (mmol/L)
TC, total cholesterol; HDL, high-density lipoprotein; Q1, first quartile; Q3, third quartile; p, p value.
† Estimated values minus held out values.
* p values for model error comparisons were calculated using the non-parametric Wilcoxon signed-rank test (two-sided) for paired data. The p values are calculated assuming independence of 
the held-out observations. They should therefore be interpreted as an approximation because there is some dependence among the held-out observations, within each of the five repetitions for 
example.
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Supplementary Figure 1. Flowchart of literature search for additional data sources. 
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16,186 citations retrieved from 
Medline
7,388 kept for full-text review
8,150 excluded after title and abstract review, because 
they did not contain relevant data, or because data were 
from non-random and/or non-representative samples
275 excluded because they were secondary publication 
with no primary data reported, e.g. reviews
29 excluded because they contained only self-reported 
data
115 excluded because the sample only consisted of 
children under ten years of age
229 excluded because data were already accessed via 
primary data access
3,865 could not retrieve full-text (mostly published in the 
1960s and 1970s)
1,720 excluded after full-text review, because they did 
not contain relevant data, or because data were from 
non-random and/or non-representative samples
7 excluded because they contained only self-reported 
data
76 excluded because they were secondary publication 
with no primary data reported, e.g. reviews
16 excluded because the sample only consisted of 
children under ten years of age
141 excluded because data were already accessed via 
primary data access
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